<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn pub-type="epub" publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">56883</article-id><article-id pub-id-type="doi">10.7554/eLife.56883</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Genetics and Genomics</subject></subj-group><subj-group subj-group-type="heading"><subject>Medicine</subject></subj-group></article-categories><title-group><article-title><italic>KDM5A</italic> mutations identified in autism spectrum disorder using forward genetics</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-180240"><name><surname>El Hayek</surname><given-names>Lauretta</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-6820-9316</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-180241"><name><surname>Tuncay</surname><given-names>Islam Oguz</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-180242"><name><surname>Nijem</surname><given-names>Nadine</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-180243"><name><surname>Russell</surname><given-names>Jamie</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-180244"><name><surname>Ludwig</surname><given-names>Sara</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-180245"><name><surname>Kaur</surname><given-names>Kiran</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-87860"><name><surname>Li</surname><given-names>Xiaohong</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-180246"><name><surname>Anderton</surname><given-names>Priscilla</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-180247"><name><surname>Tang</surname><given-names>Miao</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con9"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-180248"><name><surname>Gerard</surname><given-names>Amanda</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="con10"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-180249"><name><surname>Heinze</surname><given-names>Anja</given-names></name><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="fn" rid="con11"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-180250"><name><surname>Zacher</surname><given-names>Pia</given-names></name><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="fn" rid="con12"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-180251"><name><surname>Alsaif</surname><given-names>Hessa S</given-names></name><xref ref-type="aff" rid="aff8">8</xref><xref ref-type="fn" rid="con13"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-180252"><name><surname>Rad</surname><given-names>Aboulfazl</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0001-8627-8828</contrib-id><xref ref-type="aff" rid="aff9">9</xref><xref ref-type="fn" rid="con14"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-180253"><name><surname>Hassanpour</surname><given-names>Kazem</given-names></name><xref ref-type="aff" rid="aff10">10</xref><xref ref-type="fn" rid="con15"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-180254"><name><surname>Abbaszadegan</surname><given-names>Mohammad Reza</given-names></name><xref ref-type="aff" rid="aff11">11</xref><xref ref-type="aff" rid="aff12">12</xref><xref ref-type="fn" rid="con16"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-180255"><name><surname>Washington</surname><given-names>Camerun</given-names></name><xref ref-type="aff" rid="aff13">13</xref><xref ref-type="fn" rid="con17"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-180256"><name><surname>DuPont</surname><given-names>Barbara R</given-names></name><xref ref-type="aff" rid="aff13">13</xref><xref ref-type="fn" rid="con18"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-180257"><name><surname>Louie</surname><given-names>Raymond J</given-names></name><xref ref-type="aff" rid="aff13">13</xref><xref ref-type="fn" rid="con19"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><collab>CAUSES Study</collab><xref ref-type="aff" rid="aff14">14</xref><xref ref-type="fn" rid="con20"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-180259"><name><surname>Couse</surname><given-names>Madeline</given-names></name><xref ref-type="aff" rid="aff14">14</xref><xref ref-type="fn" rid="con21"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-180260"><name><surname>Faden</surname><given-names>Maha</given-names></name><xref ref-type="aff" rid="aff15">15</xref><xref ref-type="fn" rid="con22"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-180261"><name><surname>Rogers</surname><given-names>R Curtis</given-names></name><xref ref-type="aff" rid="aff13">13</xref><xref ref-type="fn" rid="con23"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-136281"><name><surname>Abou Jamra</surname><given-names>Rami</given-names></name><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="fn" rid="con24"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-180262"><name><surname>Elias</surname><given-names>Ellen R</given-names></name><xref ref-type="aff" rid="aff16">16</xref><xref ref-type="fn" rid="con25"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-180263"><name><surname>Maroofian</surname><given-names>Reza</given-names></name><xref ref-type="aff" rid="aff17">17</xref><xref ref-type="fn" rid="con26"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-33715"><name><surname>Houlden</surname><given-names>Henry</given-names></name><xref ref-type="aff" rid="aff17">17</xref><xref ref-type="fn" rid="con27"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-180264"><name><surname>Lehman</surname><given-names>Anna</given-names></name><xref ref-type="aff" rid="aff14">14</xref><xref ref-type="fn" rid="con28"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-23923"><name><surname>Beutler</surname><given-names>Bruce</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con29"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-81322"><name><surname>Chahrour</surname><given-names>Maria H</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-3174-1480</contrib-id><email>Maria.Chahrour@UTSouthwestern.edu</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="aff" rid="aff18">18</xref><xref ref-type="aff" rid="aff19">19</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund2"/><xref ref-type="other" rid="fund3"/><xref ref-type="fn" rid="con30"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution>Eugene McDermott Center for Human Growth and Development, University of Texas Southwestern Medical Center</institution><addr-line><named-content content-type="city">Dallas</named-content></addr-line><country>United States</country></aff><aff id="aff2"><label>2</label><institution>Department of Neuroscience, University of Texas Southwestern Medical Center</institution><addr-line><named-content content-type="city">Dallas</named-content></addr-line><country>United States</country></aff><aff id="aff3"><label>3</label><institution>Center for the Genetics of Host Defense, University of Texas Southwestern Medical Center</institution><addr-line><named-content content-type="city">Dallas</named-content></addr-line><country>United States</country></aff><aff id="aff4"><label>4</label><institution>Department of Molecular and Human Genetics, Baylor College of Medicine</institution><addr-line><named-content content-type="city">Houston</named-content></addr-line><country>United States</country></aff><aff id="aff5"><label>5</label><institution>Texas Children’s Hospital</institution><addr-line><named-content content-type="city">Houston</named-content></addr-line><country>United States</country></aff><aff id="aff6"><label>6</label><institution>Institute of Human Genetics, University of Leipzig Medical Center</institution><addr-line><named-content content-type="city">Leipzig</named-content></addr-line><country>Germany</country></aff><aff id="aff7"><label>7</label><institution>The Saxon Epilepsy Center Kleinwachau</institution><addr-line><named-content content-type="city">Radeberg</named-content></addr-line><country>Germany</country></aff><aff id="aff8"><label>8</label><institution>Department of Genetics, King Faisal Specialist Hospital and Research Centre</institution><addr-line><named-content content-type="city">Riyadh</named-content></addr-line><country>Saudi Arabia</country></aff><aff id="aff9"><label>9</label><institution>Cellular and Molecular Research Center, Sabzevar University of Medical Sciences</institution><addr-line><named-content content-type="city">Sabzevar</named-content></addr-line><country>Islamic Republic of Iran</country></aff><aff id="aff10"><label>10</label><institution>Non-Communicable Diseases Research Center, Sabzevar University of Medical Sciences</institution><addr-line><named-content content-type="city">Sabzevar</named-content></addr-line><country>Islamic Republic of Iran</country></aff><aff id="aff11"><label>11</label><institution>Pardis Clinical and Genetics Laboratory</institution><addr-line><named-content content-type="city">Mashhad</named-content></addr-line><country>Islamic Republic of Iran</country></aff><aff id="aff12"><label>12</label><institution>Division of Human Genetics, Avicenna Research Institute, Mashhad University of Medical Sciences</institution><addr-line><named-content content-type="city">Mashhad</named-content></addr-line><country>Islamic Republic of Iran</country></aff><aff id="aff13"><label>13</label><institution>Greenwood Genetic Center</institution><addr-line><named-content content-type="city">Greenwood</named-content></addr-line><country>United States</country></aff><aff id="aff14"><label>14</label><institution>Department of Medical Genetics, University of British Columbia, British Columbia Children’s and Women’s Hospital Research Institute</institution><addr-line><named-content content-type="city">Vancouver</named-content></addr-line><country>Canada</country></aff><aff id="aff15"><label>15</label><institution>Department of Genetics, King Saud Medical City</institution><addr-line><named-content content-type="city">Riyadh</named-content></addr-line><country>Saudi Arabia</country></aff><aff id="aff16"><label>16</label><institution>Department of Pediatrics and Genetics, University of Colorado School of Medicine</institution><addr-line><named-content content-type="city">Aurora</named-content></addr-line><country>United States</country></aff><aff id="aff17"><label>17</label><institution>Department of Neuromuscular Diseases, University College London, Queen Square Institute of Neurology</institution><addr-line><named-content content-type="city">London</named-content></addr-line><country>United Kingdom</country></aff><aff id="aff18"><label>18</label><institution>Department of Psychiatry, University of Texas Southwestern Medical Center</institution><addr-line><named-content content-type="city">Dallas</named-content></addr-line><country>United States</country></aff><aff id="aff19"><label>19</label><institution>Peter O’Donnell Jr. Brain Institute, University of Texas Southwestern Medical Center</institution><addr-line><named-content content-type="city">Dallas</named-content></addr-line><country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Brose</surname><given-names>Nils</given-names></name><role>Reviewing Editor</role><aff><institution>Max Planck Institute of Experimental Medicine</institution><country>Germany</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Zoghbi</surname><given-names>Huda Y</given-names></name><role>Senior Editor</role><aff><institution>Texas Children's Hospital</institution><country>United States</country></aff></contrib></contrib-group><pub-date date-type="publication" publication-format="electronic"><day>22</day><month>12</month><year>2020</year></pub-date><pub-date pub-type="collection"><year>2020</year></pub-date><volume>9</volume><elocation-id>e56883</elocation-id><history><date date-type="received" iso-8601-date="2020-03-12"><day>12</day><month>03</month><year>2020</year></date><date date-type="accepted" iso-8601-date="2020-12-06"><day>06</day><month>12</month><year>2020</year></date></history><permissions><copyright-statement>© 2020, El Hayek et al</copyright-statement><copyright-year>2020</copyright-year><copyright-holder>El Hayek et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-56883-v1.pdf"/><abstract><p>Autism spectrum disorder (ASD) is a constellation of neurodevelopmental disorders with high phenotypic and genetic heterogeneity, complicating the discovery of causative genes. Through a forward genetics approach selecting for defective vocalization in mice, we identified <italic>Kdm5a</italic> as a candidate ASD gene. To validate our discovery, we generated a <italic>Kdm5a</italic> knockout mouse model (<italic>Kdm5a</italic><sup>-/-</sup>) and confirmed that inactivating <italic>Kdm5a</italic> disrupts vocalization. In addition, <italic>Kdm5a</italic><sup>-/-</sup> mice displayed repetitive behaviors, sociability deficits, cognitive dysfunction, and abnormal dendritic morphogenesis. Loss of KDM5A also resulted in dysregulation of the hippocampal transcriptome. To determine if <italic>KDM5A</italic> mutations cause ASD in humans, we screened whole exome sequencing and microarray data from a clinical cohort. We identified pathogenic <italic>KDM5A</italic> variants in nine patients with ASD and lack of speech. Our findings illustrate the power and efficacy of forward genetics in identifying ASD genes and highlight the importance of KDM5A in normal brain development and function.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>autism spectrum disorder</kwd><kwd>forward genetics</kwd><kwd>chromatin regulator</kwd><kwd>vocalization</kwd><kwd>histone demethylase</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000928</institution-id><institution>Welch Foundation</institution></institution-wrap></funding-source><award-id>I-1946-20180324</award-id><principal-award-recipient><name><surname>Chahrour</surname><given-names>Maria H</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution>Walter and Lillian Cantor Foundation</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Chahrour</surname><given-names>Maria H</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100007914</institution-id><institution>University of Texas Southwestern Medical Center</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Chahrour</surname><given-names>Maria H</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>Successful autism spectrum disorder gene discovery using forward genetics identifies <italic>KDM5A</italic>, which encodes a histone H3 lysine 4 demethylase, as a disease gene.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Autism spectrum disorder (ASD) is characterized by deficits in communication, diminished social skills, and stereotyped behaviors. It is one of the most heritable of neuropsychiatric disorders (<xref ref-type="bibr" rid="bib14">Colvert et al., 2015</xref>). Thousands of genetic variations, both common and rare, contribute to ASD risk (<xref ref-type="bibr" rid="bib25">Geschwind and State, 2015</xref>). Causative genes identified to date encode molecules involved in a myriad of molecular pathways, with chromatin remodeling being one of the top pathways disrupted in ASD (<xref ref-type="bibr" rid="bib19">De Rubeis et al., 2014</xref>). Due to the high phenotypic and genetic heterogeneity of ASD (<xref ref-type="bibr" rid="bib5">Betancur, 2011</xref>; <xref ref-type="bibr" rid="bib42">Mitchell, 2011</xref>), identification of genes underlying disease has been tedious and has required large-scale studies sequencing tens of thousands of patient samples (<xref ref-type="bibr" rid="bib7">Boyle et al., 2017</xref>; <xref ref-type="bibr" rid="bib36">Li et al., 2013</xref>). Despite recent strides being made in our understanding of the complex genetics of ASD, identified genes account for only ~30% of ASD cases with no single gene contributing to greater than 2% of cases (<xref ref-type="bibr" rid="bib18">de la Torre-Ubieta et al., 2016</xref>; <xref ref-type="bibr" rid="bib20">Dias and Walsh, 2020</xref>).</p><p>We utilized a forward genetics approach to rapidly identify new mutations causing ASD-related behaviors in mice. We screened mice bearing <italic>N</italic>-ethyl-<italic>N</italic>-nitrosourea (ENU)-induced mutations (<xref ref-type="bibr" rid="bib62">Wang et al., 2015</xref>) for defects in ultrasonic vocalizations (USVs) and nest-building behavior. Automated meiotic mapping implicated <italic>Kdm5a</italic> as a candidate ASD gene and a nonsense mutation at that locus segregated with defective USVs and nest building. In addition to these phenotypes, targeted knockout of <italic>Kdm5a</italic> resulted in repetitive behaviors, deficits in social interaction, learning, and memory, and abnormal neuronal morphology. <italic>KDM5A</italic> encodes a chromatin regulator that belongs to the KDM5 family of lysine-specific histone H3 demethylases. Histone H3 lysine 4 trimethyl (H3K4me3) marks are present at gene promoters and active enhancers, and are regulated by multiple factors, including the KDM5 family members KDM5B and KDM5C (<xref ref-type="bibr" rid="bib53">Shen et al., 2017</xref>). Mutations in lysine demethylases that regulate the demethylation of the H3K4me3 marks have been strongly linked to a host of neurodevelopmental disorders. Finally, we identified nine patients with ASD and lack of speech who have pathogenic <italic>KDM5A</italic> variants.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>Forward genomics identifies <italic>Kdm5a</italic> as a candidate ASD gene</title><p>To identify candidate ASD genes, we screened ENU mutagenized mice for ASD-like behavioral phenotypes. Specifically, we screened for abnormalities in USVs (<xref ref-type="bibr" rid="bib48">Portfors, 2007</xref>) and in nest-building behavior (<xref ref-type="bibr" rid="bib15">Crawley, 2004</xref>). USV quantification is a well-documented tool to assess social communication in mice (<xref ref-type="bibr" rid="bib51">Scattoni et al., 2009</xref>; <xref ref-type="bibr" rid="bib8">Branchi et al., 2001</xref>), and USV deficits are indicators of abnormal brain development. Mouse models of neurodevelopmental disorders, including ASD models, tend to vocalize less frequently or display abnormal vocalization parameters compared to wild type (WT) mice (<xref ref-type="bibr" rid="bib34">Lai et al., 2014</xref>). In addition, the ability to build a communal nest is an indicator of sociability in mice (<xref ref-type="bibr" rid="bib16">Crawley, 2007</xref>). We performed ENU mutagenesis in male C57BL/6J WT mice as previously described (<xref ref-type="bibr" rid="bib62">Wang et al., 2015</xref>) and bred them to obtain ~30–50 third generation (G3) mice per pedigree (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>). All G1 males were subjected to whole exome sequencing, and all G2 and G3 mice from each pedigree were genotyped for variants identified in the G1 pedigree founder.</p><p>We analyzed the ability of G3 mice to emit USVs at postnatal day (P) 4, scoring several different USV parameters (Materials and methods), and measured the quality of nests built at P29-32. For each USV parameter scored and for the nest-building behavior, mapping and linkage analysis was performed for every mutation, under the recessive, semidominant (additive), and dominant modes of inheritance, using Linkage Analyzer which detects phenovariance statistically linked to genotype as determined by a linear regression model (<xref ref-type="bibr" rid="bib62">Wang et al., 2015</xref>). We screened a total of 350 G3 mice in eight pedigrees, that carried 409 mutations, and identified a causative allelic variant (<italic>Selbst</italic>) with abnormal USVs and nesting behavior (<xref ref-type="fig" rid="fig1">Figure 1</xref>). The <italic>Selbst</italic> phenotype showed clear recessive inheritance of reduced USV peak frequency (<xref ref-type="fig" rid="fig1">Figure 1A and C</xref>) and impaired nest-building ability (<xref ref-type="fig" rid="fig1">Figure 1B</xref> and <xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2B</xref>). Whole exome sequencing and mapping identified a single peak on chromosome 6 linked to both the USV (p=2.9×10<sup>−5</sup>) and the nesting (p=7.0×10<sup>−5</sup>) phenotypes (<xref ref-type="fig" rid="fig1">Figure 1D and E</xref>). The peak corresponded to a single nucleotide substitution in <italic>Kdm5a</italic> resulting in a nonsense mutation (p.C322*) predicted to cause loss of the protein. <italic>Kdm5a</italic> encodes a chromatin regulator belonging to a family of histone lysine demethylases. It is expressed ubiquitously in humans and mice (<xref ref-type="bibr" rid="bib54">Smith et al., 2019</xref>), including in the brain (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2</xref>).</p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Mapping <italic>Selbst</italic>, an ASD-like phenotype of altered vocalization.</title><p>(<bold>A, B</bold>) Quantitative phenotype data (maximum peak frequency (<bold>A</bold>) and nesting score (<bold>B</bold>)) were used for linkage analyses (n = 17 WT, 24 Het, 3 Mut). Corresponding phenotypic data plotted against genotype at the <italic>Kdm5a</italic> mutation site are shown. Values are mean ± SEM ((<bold>A</bold>) ***p=0.0001; (<bold>B</bold>) time p&lt;0.0001, genotype ***p=0.0003, time x genotype p=0.5155). Data were analyzed using ordinary one-way ANOVA (<bold>A</bold>) or two-way ANOVA (<bold>B</bold>), followed by Tukey's multiple comparisons test. (<bold>C</bold>) Representative spectrograms of vocalizations from WT, heterozygous (Het), and homozygous (Mut) mutant mice (n = 3 WT, 3 Het, 3 Mut). (<bold>D, E</bold>) Linkage plots showing <italic>P</italic> values calculated using the recessive model for the ultrasonic vocalization (USV) (<bold>D</bold>) and the nesting (<bold>E</bold>) phenotypes. The -log<sub>10</sub> <italic>P</italic> values (y axis) are plotted against the chromosomal positions of 60 mutations (x axis) identified in the G1 founder of the pedigree. Horizontal red and pink lines indicate thresholds of p=0.05 with or without Bonferroni correction, respectively.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-56883-fig1-v1.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 1.</label><caption><title>Summary of the gene identification pipeline.</title><p>Related to <xref ref-type="fig" rid="fig1">Figure 1</xref>. Mutagenized G0 males were bred to WT C57BL/6J (<bold>B6</bold>) females (grey). G1 males, carrying mutations derived from the G0 male, were crossed to WT B6 females (grey). G2 females were then backcrossed to their G1 father to produce ~30–50 G3 mice with ENU-induced mutations. Asterisks represent mutations derived from the G0 male. Large asterisks indicate initial germline transmission. USVs were recorded from P4 G3 pups and nest building was assessed between P29 and P32.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-56883-fig1-figsupp1-v1.tif"/></fig><fig id="fig1s2" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 2.</label><caption><title><italic>KDM5A</italic> is ubiquitously expressed across tissues.</title><p>Related to <xref ref-type="fig" rid="fig1">Figure 1</xref>. (<bold>A</bold>) Human <italic>KDM5A</italic> tissue expression data publicly available from GTEx (Genotype-Tissue Expression Portal). (<bold>B</bold>) <italic>Kdm5a</italic> expression in the mouse brain, with inset showing high hippocampal expression. Data publicly available from the Allen Mouse Brain Atlas.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-56883-fig1-figsupp2-v1.tif"/></fig></fig-group></sec><sec id="s2-2"><title>Targeted <italic>Kdm5a</italic> knockout results in ASD-like behavioral phenotypes in mice</title><p>In order to investigate the physiological function of KDM5A and to genetically confirm that the <italic>Kdm5a</italic> nonsense mutation is the cause of the <italic>Selbst</italic> phenotype, we generated a <italic>Kdm5a</italic> constitutive knockout mouse model (<italic>Kdm5a</italic><sup>-/-</sup>). We targeted the mouse <italic>Kdm5a</italic> locus using CRISPR/Cas9 technology to insert a single base pair in exon 13, which was predicted to result in a frameshift mutation in codon 581 and to terminate translation after the inclusion of 8 aberrant amino acids (<xref ref-type="fig" rid="fig2">Figure 2A</xref>). We performed western blot analysis on cortical tissue and demonstrated loss of KDM5A in <italic>Kdm5a</italic><sup>-/-</sup> mice compared to WT and heterozygous littermates (<xref ref-type="fig" rid="fig2">Figure 2B</xref>).</p><fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>Loss of <italic>Kdm5a</italic> results in abnormal vocalizations, repetitive behaviors, and deficits in social behavior, learning, and memory.</title><p>(<bold>A</bold>) Generation of <italic>Kdm5a</italic><sup>-/-</sup> constitutive knockout (KO) mice. Schematic of the targeted <italic>Kdm5a</italic> locus disrupting exon 13 resulting in a frameshift and loss of KDM5A. (<bold>B</bold>) Western blot analysis from cortical tissue lysates of WT, <italic>Kdm5a</italic><sup>+/-</sup> (Het), or <italic>Kdm5a</italic><sup>-/-</sup> (KO) mice showed a ~ 50% decrease in KDM5A protein level in the Het and complete loss of KDM5A in the KO mice compared to WT. Representative immunoblots from three independent experiments (n = 3 WT, 3 Het, 3 KO). (<bold>C</bold>) KO mice have severe reduction in the maximum peak frequency of ultrasonic vocalizations (USVs) and in the number of USVs measured at P4 (***p&lt;0.0001; n = 22 WT, 49 Het, 9 KO). (<bold>D</bold>) KO mice spent 60% of the time wringing and clasping their forepaws compared to 5% for WT and 4% for Het littermates (***p&lt;0.0001; n = 25 WT, 25 Het, 10 KO). (<bold>E</bold>) KO mice spent more time self-grooming compared to WT and Het littermates (*p=0.0107; n = 6 WT, 7 Het, 5 KO). During the duration of the analysis, WT and Het mice had ~1-2 grooming events, while KO mice had ~3-4 grooming events. (<bold>F</bold>) KO mice traveled a longer distance, and spent less time in the center and more time in the periphery of the open field compared to WT and Het littermates (total distance: **p=0.0014, time in center: **p=0.0015, time in periphery: *p=0.0143; n = 13 WT, 13 Het, 7 KO). (<bold>G</bold>) KO mice showed decreased social interaction with a novel partner mouse compared to WT and Het littermates (**p=0.0021; n = 11 WT, 8 Het, 6 KO). For (<bold>C</bold>), (<bold>D</bold>), (<bold>E</bold>), (<bold>F</bold>), and (<bold>G</bold>) data were analyzed using ordinary one-way ANOVA followed by Tukey's multiple comparisons test. (<bold>H</bold>) Compared to their control littermates, KO mice have an impaired learning shown by the latency to locate the hidden platform that does not decrease during the training phase of the Morris water maze task (day p&lt;0.0001, genotype ***p&lt;0.0001, day x genotype p=0.0012; n = 13 WT, 10 Het, 6 KO). Data were analyzed using two-way ANOVA followed by Tukey's multiple comparisons test. (<bold>I</bold>) KO mice performed poorly in the Morris water maze probe test compared to their control littermates and spent more time in non-target quadrants (Others) (WT: **p=0.0057, Het: **p=0.0034, KO: ***p&lt;0.0001, target WT vs target KO: ***p=0.0004, target Het vs target KO: ***p&lt;0.0001, target WT vs target Het: p=0.4433; n = 13 WT, 10 Het, 6 KO). Data were analyzed using unpaired t test for the within-genotype analyses and ordinary one-way ANOVA followed by Tukey's multiple comparisons test for the across-genotype analyses. All behaviors, except USV analysis, were assessed at 5–9 weeks of age. All values are mean ± SEM.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-56883-fig2-v1.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 1.</label><caption><title>Loss of <italic>Kdm5a</italic> does not affect growth.</title><p>Related to <xref ref-type="fig" rid="fig2">Figure 2</xref>. (<bold>A</bold>) Both male and female <italic>Kdm5a</italic><sup>-/-</sup> (constitutive knockout, KO) mice do not show any significant change in body weight compared to wild type (WT) or <italic>Kdm5a</italic><sup>+/-</sup> (Het) littermates (males: time p&lt;0.0001, genotype p=0.1292, time x genotype p&lt;0.0001; males: n = 7–11 WT, 7–11 Het, 3–5 KO; females: time p&lt;0.0001, genotype p=0.0904, time x genotype p&lt;0.0001; females: n = 7–16 WT, 6–14 Het, 6–8 KO). Data were analyzed using a mixed-effects model (restricted maximum likelihood; REML) followed by Tukey's multiple comparisons test. (<bold>B</bold>) Male and female KO mice do not show any significant change in body length compared to WT or Het littermates (nose-to-rump length measured at 6–8 weeks of age; males: p=0.7368, n = 7 WT, 12 Het, 5 KO; females: p=0.1064, n = 7 WT, 12 Het, 8 KO). (<bold>C</bold>) Brain to body weight ratios measured at 6–8 weeks of age were not significantly different between genotypes (males: p=0.4618, n = 7 WT, 12 Het, 3 KO; females: p=0.1016, n = 6 WT, 11 Het, 6 KO). Values are mean ± SEM. For (<bold>B</bold>) and (<bold>C</bold>), data were analyzed using ordinary one-way ANOVA followed by Tukey's multiple comparisons test. (<bold>D</bold>) KO mice are born in expected Mendelian ratios. The number of mice born from each genotype was not significantly different from the number of expected mice based on Mendelian ratios. Data from seven litters, &gt;postnatal day (P)0, X<sup>2</sup> test, p=0.4419.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-56883-fig2-figsupp1-v1.tif"/></fig><fig id="fig2s2" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 2.</label><caption><title>Altered vocalizations following loss of <italic>Kdm5a</italic>.</title><p>Related to <xref ref-type="fig" rid="fig2">Figure 2</xref>. (<bold>A</bold>) <italic>Kdm5a</italic> KO mice have an increased latency to emit ultrasonic vocalizations (USVs), an increased interval between USVs, and reductions in duration, amplitude, and frequency of USVs (latency to call: ***p=0.0002, n = 22 WT, 49 Het, 9 KO; mean interval between USVs: ***p&lt;0.0001, n = 22 WT, 49 Het, 9 KO; mean USV duration: **p=0.0061, n = 22 WT, 49 Het, 7 KO; max peak amplitude: ***p=0.0003, n = 22 WT, 49 Het, 9 KO; mean peak frequency: ***p≤0.0001, n = 22 WT, 49 Het, 9 KO). USVs were measured at P4. Values are mean ± SEM. Data were analyzed using ordinary one-way ANOVA followed by Tukey's multiple comparisons test. (<bold>B</bold>) Nest-building scoring, with 0 being no nest construction to 3 being a well-structured nest.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-56883-fig2-figsupp2-v1.tif"/></fig><media id="fig2video1" mime-subtype="mp4" mimetype="video" xlink:href="elife-56883-fig2-video1.mp4"><label>Figure 2—video 1.</label><caption><title>Related to <xref ref-type="fig" rid="fig2">Figure 2</xref>.</title><p>Video recording of male WT and <italic>Kdm5a</italic><sup>-/-</sup> mice during the modified tail suspension test at 6–7 weeks of age to quantify forepaw wringing.</p></caption></media><media id="fig2video2" mime-subtype="mp4" mimetype="video" xlink:href="elife-56883-fig2-video2.mp4"><label>Figure 2—video 2.</label><caption><title>Related to <xref ref-type="fig" rid="fig2">Figure 2</xref>.</title><p>Video recording of female WT and <italic>Kdm5a</italic><sup>-/-</sup> mice during the modified tail suspension test at 6–7 weeks of age to quantify forepaw wringing.</p></caption></media></fig-group><p><italic>Kdm5a</italic><sup>-/-</sup> mice were born in expected Mendelian ratios, exhibited normal body weight, body length, and brain to body weight ratio compared with control littermates (WT and <italic>Kdm5a</italic><sup>+/-</sup>) (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>). To validate that the <italic>Selbst</italic> phenotype was due to loss of KDM5A, we analyzed the ability of the <italic>Kdm5a</italic><sup>-/-</sup> mice to emit USVs. We found that <italic>Kdm5a</italic><sup>-/-</sup> mice had reduced peak frequency of emitted USVs, which replicates the <italic>Selbst</italic> phenotype, and a severe reduction in the number of USVs (~84% decrease) compared with control littermates (<xref ref-type="fig" rid="fig2">Figure 2C</xref> and <xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2A</xref>).</p><p>We assessed whether <italic>Kdm5a</italic><sup>-/-</sup> mice have ASD-like behavioral phenotypes. First, we characterized repetitive behaviors by measuring forepaw wringing and clasping through a modified tail suspension test (<xref ref-type="bibr" rid="bib23">Gandal et al., 2012</xref>). We found that the <italic>Kdm5a</italic><sup>-/-</sup> mice spent more time wringing and clasping their forepaws compared with control littermates (<xref ref-type="fig" rid="fig2">Figure 2D</xref>, <xref ref-type="video" rid="fig2video1">Figure 2—video 1</xref>, and <xref ref-type="video" rid="fig2video2">Figure 2—video 2</xref>). We also measured self-grooming behavior and found that <italic>Kdm5a</italic><sup>-/-</sup> mice spent twice as much time self-grooming compared to control littermates (<xref ref-type="fig" rid="fig2">Figure 2E</xref>). Next, to asses gross locomotor activity, exploratory behavior, and anxiety, we performed the open field test. We noticed a slight increase in the total distance traveled by the <italic>Kdm5a</italic><sup>-/-</sup> mice, indicating a mild hyperactivity phenotype (<xref ref-type="fig" rid="fig2">Figure 2F</xref>). In addition, we found that the <italic>Kdm5a</italic><sup>-/-</sup> mice spent significantly less time in the center of the arena indicating a possible anxiety phenotype (<xref ref-type="fig" rid="fig2">Figure 2F</xref>). To assess any social behavior deficits, we measured direct social interaction (<xref ref-type="bibr" rid="bib9">Chang et al., 2017</xref>; <xref ref-type="bibr" rid="bib17">Crawley, 2012</xref>) and found that the <italic>Kdm5a</italic><sup>-/-</sup> mice spent significantly less time (~50%) interacting with novel partner mice compared to control littermates (<xref ref-type="fig" rid="fig2">Figure 2G</xref>). We then conducted the Morris water maze test to analyze the ability of <italic>Kdm5a</italic><sup>-/-</sup> mice to learn and memorize. WT and <italic>Kdm5a<sup>+/-</sup></italic> littermates had normal learning abilities shown by the decrease in latency to locate the hidden platform over a period of 4 days, as well as normal memory by showing preference for the quadrant where the platform was during the probe test (target quadrant). However, <italic>Kdm5a</italic><sup>-/-</sup> mice displayed severe disabilities in both learning and memory. Their latency to reach the hidden platform did not decrease over time and they did not show preference for the target quadrant during the probe test (<xref ref-type="fig" rid="fig2">Figure 2H and I</xref>).</p></sec><sec id="s2-3"><title>Abnormal dendritic morphogenesis of cortical neurons in <italic>Kdm5a</italic> knockout mice</title><p>To assess the role of KDM5A in neuronal development, we measured dendritic complexity, length, and spine density <italic>in vivo</italic> by Golgi-Cox staining of brains from <italic>Kdm5a</italic><sup>-/-</sup> and WT littermates. Sholl analysis revealed a severe reduction (~67%) in dendritic complexity of cortical neurons from <italic>Kdm5a</italic><sup>-/-</sup> mice (<xref ref-type="fig" rid="fig3">Figure 3A and B</xref>). Furthermore, cortical neurons from <italic>Kdm5a</italic><sup>-/-</sup> mice had significant reduction in dendritic length (∼50% decrease) and dendritic spine density (∼33% decrease) compared with neurons from WT littermates (<xref ref-type="fig" rid="fig3">Figure 3C and D</xref>).</p><fig id="fig3" position="float"><label>Figure 3.</label><caption><title><italic>Kdm5a</italic> knockout mice have impaired dendritic morphogenesis.</title><p>(<bold>A</bold>) Sholl analysis from Golgi-Cox-stained neurons revealed a reduction in dendritic complexity of cortical neurons from KO mice (red) compared to WT (black) littermates (***p&lt;0.0001). Data were analyzed using two-way ANOVA followed by Tukey's multiple comparisons test. (Right) Representative tracings of Golgi-Cox-stained cortical layer II/III neurons. Golgi-Cox staining showed significantly reduced dendritic complexity (B, **p=0.0066), length (C, ***p&lt;0.0001), and spine density (D, ***p&lt;0.0001) of cortical neurons from KO mice compared to WT littermates. Data were obtained from basal dendrites of cortical layer II/III neurons from mice at 14–16 weeks of age. Data were analyzed using unpaired t test. All values are mean ± SEM (n = 15 WT, 15 KO).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-56883-fig3-v1.tif"/></fig></sec><sec id="s2-4"><title><italic>KDM5A</italic> mutations in patients with ASD</title><p>The human homolog, <italic>KDM5A</italic>, is extremely intolerant to loss-of-function variation based on data from the Genome Aggregation Database (gnomAD) (probability of loss-of-function intolerance (pLI) = 1.00) (<xref ref-type="bibr" rid="bib24">Genome Aggregation Database Consortium et al., 2020</xref>). Prior to our study, it was not known whether <italic>KDM5A</italic> loss-of-function mutations result in ASD or in other neurodevelopmental disorders. To date only a single recessive missense variant in <italic>KDM5A</italic> has been reported to be associated with an undefined developmental disorder (intellectual disability and facial dysmorphisms) in one family (<xref ref-type="bibr" rid="bib44">Najmabadi et al., 2011</xref>). It is worth noting that genes encoding other members of the KDM5 family, <italic>KDM5B and KDM5C</italic>, are disrupted in neurodevelopmental disorders (<xref ref-type="bibr" rid="bib19">De Rubeis et al., 2014</xref>; <xref ref-type="bibr" rid="bib35">Lebrun et al., 2018</xref>; <xref ref-type="bibr" rid="bib2">Al-Mubarak et al., 2017</xref>; <xref ref-type="bibr" rid="bib1">Adegbola et al., 2008</xref>; <xref ref-type="bibr" rid="bib60">Vallianatos et al., 2018</xref>).</p><p>Through the forward genetics approach and the targeted mouse model, we identified a role for <italic>Kdm5a</italic> in regulating mouse vocalizations, nesting, repetitive behaviors, social interaction, cognitive function, and neuronal morphogenesis. Based on our findings, we sought to identify individuals with pathogenic <italic>KDM5A</italic> mutations and neurobehavioral phenotypes. Through global collaborative efforts, we identified nine individuals from seven families where clinical whole exome sequencing or chromosomal microarray analysis revealed pathogenic variants in <italic>KDM5A</italic> that segregated with phenotype in these families (<xref ref-type="fig" rid="fig4">Figure 4A</xref> and Clinical presentation). Apart from the <italic>KDM5A</italic> variants, no variants were identified in known disease-causing genes that accounted for the clinical phenotype of the nine individuals. Three individuals carried homozygous deletions removing four exons (in two individuals) or ten exons (in one individual) of <italic>KDM5A</italic>, three individuals carried homozygous recessive variants (two splice site and one missense), and the remaining three individuals were heterozygous for <italic>de novo</italic> variants (two missense and one nonsense) (<xref ref-type="fig" rid="fig4">Figure 4B</xref>, <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1</xref>, <xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2</xref>, and <xref ref-type="table" rid="table1">Table 1</xref>). All the identified variants were absent from exome or genome sequencing data of 141,456 unrelated individuals in gnomAD (<xref ref-type="bibr" rid="bib24">Genome Aggregation Database Consortium et al., 2020</xref>), confirming their rarity.</p><fig-group><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>Identification of <italic>KDM5A</italic> mutations in patients with ASD.</title><p>(<bold>A</bold>) Pedigrees of seven families with <italic>KDM5A</italic> mutations in nine probands with ASD. Double lines: first cousin status; circles: females; squares: males; shaded symbols: affected individuals. (<bold>B</bold>) A schematic of KDM5A domains and location of the identified mutations. <italic>De novo</italic> and recessive mutations are indicated in red and blue, respectively. The <italic>Selbst</italic> mutation is a cysteine to premature stop codon substitution at position 322 of the protein. ARID, A-T rich interaction domain; JmjC, Jumonji C; JmjN, Jumonji N; PHD, plant homeodomain; PLU1, putative DNA/chromatin binding motif; Zn, zinc finger. (<bold>C</bold>) Western blot analysis of lymphoblastoid cell line lysates from affected individuals (KD-1–3, KD-2–4, KD-5–3, and KD-6–3) and unaffected family members (KD-1–1, KD-2–1, KD-2–2, KD-5–1, KD-5–2, KD-5–4, KD-6–1, and KD-6–2) showed reduced KDM5A protein in affected individuals KD-1–3, KD-5–3, and KD-6–3, and a truncated KDM5A protein in affected individual KD-2–4. Western blot analysis of HEK293T cells with knock-in of the splice site mutation present in affected individuals KD-4–3 and KD-4–4 (Var) and HEK293T cells which underwent transfection but kept the reference sequence (Ctrl 1 and Ctrl 2), showed a decrease in KDM5A protein level in the targeted cells compared to control cells. β-actin and vinculin were used as loading controls. The black arrowhead points to the KDM5A band (196 kDa) and the white arrowhead points to the truncated KDM5A band (174 kDa).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-56883-fig4-v1.tif"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 1.</label><caption><title>Related to <xref ref-type="fig" rid="fig4">Figure 4</xref>.</title><p>(<bold>A</bold>) Deletion map in family KD-2. Patients KD-2–3 and KD-2–4 have exons 6 through 9 of <italic>KDM5A</italic> deleted (~10 kb), which leads to the formation of a truncated protein. (<bold>B</bold>) Sanger sequencing in family KD-1. Patient KD-1–3 has a <italic>de novo</italic> missense mutation (A to T) in the first methionine of KDM5A, which gets substituted by a leucine. Data shown for reverse sequence. (<bold>C</bold>) Sanger sequencing of HEK293T cells with knock-in of the splice site mutation present in KD-4. The successful knock-in clone has a homozygous G to T substitution.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-56883-fig4-figsupp1-v1.tif"/></fig><fig id="fig4s2" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 2.</label><caption><title>Related to <xref ref-type="fig" rid="fig4">Figure 4</xref>.</title><p>The Met1 (<bold>A</bold>), Arg1428 (<bold>B</bold>), and Phe477 (<bold>C</bold>) residues of KDM5A (denoted by the asterisks) are highly conserved across species. Met1, Arg1428, and Phe477 are mutated in KD-1–3, KD-3–3, and KD-5–3, respectively.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-56883-fig4-figsupp2-v1.tif"/></fig><media id="fig4video1" mime-subtype="mp4" mimetype="video" xlink:href="elife-56883-fig4-video1.mp4"><label>Figure 4—video 1.</label><caption><title>Related to <xref ref-type="fig" rid="fig4">Figure 4</xref>.</title><p>Video recording of patient KD-4–3.</p></caption></media><media id="fig4video2" mime-subtype="mp4" mimetype="video" xlink:href="elife-56883-fig4-video2.mp4"><label>Figure 4—video 2.</label><caption><title>Related to <xref ref-type="fig" rid="fig4">Figure 4</xref>.</title><p>Video recording of patient KD-4–4.</p></caption></media></fig-group><table-wrap id="table1" position="float"><label>Table 1.</label><caption><title>Clinical phenotype of patients with <italic>KDM5A</italic> mutations identified in this study.</title><p>All findings reported at latest exam. Mutations are reported on human genome GRCh37/hg19 coordinates. MAF, minor allele frequency in gnomAD; NP, not present; UK, unknown. * Proband received extensive speech therapy since early childhood.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="middle">Patient</th><th align="center" valign="middle">KD-1-3</th><th align="center" valign="middle">KD-2-3</th><th align="center" valign="middle">KD-2-4</th><th align="center" valign="middle">KD-3-3</th><th align="center" valign="middle">KD-4-3</th><th align="center" valign="middle">KD-4-4</th><th align="center" valign="middle">KD-5-3</th><th align="center" valign="middle">KD-6-3</th><th align="center" valign="middle">KD-7-3</th></tr></thead><tbody><tr><td align="left" valign="middle">Sex</td><td align="center" valign="middle">Male</td><td align="center" valign="middle">Female</td><td align="center" valign="middle">Male</td><td align="center" valign="middle">Male</td><td align="center" valign="middle">Female</td><td align="center" valign="middle">Male</td><td align="center" valign="middle">Female</td><td align="center" valign="middle">Female</td><td align="center" valign="middle">Female</td></tr><tr><td align="left" valign="middle">Age at latest evaluation (years)</td><td align="center" valign="middle">5</td><td align="center" valign="middle">12</td><td align="center" valign="middle">8</td><td align="center" valign="middle">18</td><td align="center" valign="middle">3</td><td align="center" valign="middle">20</td><td align="center" valign="middle">4</td><td align="center" valign="middle">40</td><td align="center" valign="middle">13</td></tr><tr><td align="left" valign="middle">Nucleotide change(NM_001042603)</td><td align="center" valign="middle">c.1A&gt;T</td><td align="center" valign="middle">Deletion of exons 6 through 9</td><td align="center" valign="middle">Deletion of exons 6 through 9</td><td align="center" valign="middle">c.4283G&gt;T</td><td align="center" valign="middle">c.2541+1G&gt;T</td><td align="center" valign="middle">c.2541+1G&gt;T</td><td align="center" valign="middle">c.1429T&gt;G</td><td align="center" valign="middle">c.4048C&gt;T</td><td align="center" valign="middle">Deletion of exons 1 through 10</td></tr><tr><td align="left" valign="middle">Amino acid change</td><td align="center" valign="middle">p.Met1Leu</td><td align="center" valign="middle">---</td><td align="center" valign="middle">---</td><td align="center" valign="middle">p.Arg1428Leu</td><td align="center" valign="middle">---</td><td align="center" valign="middle">---</td><td align="center" valign="middle">p.Phe477Val</td><td align="center" valign="middle">p.Arg1350*</td><td align="center" valign="middle">---</td></tr><tr><td align="left" valign="middle">MAF (%)</td><td align="center" valign="middle">NP</td><td align="center" valign="middle">---</td><td align="center" valign="middle">---</td><td align="center" valign="middle">NP</td><td align="center" valign="middle">NP</td><td align="center" valign="middle">NP</td><td align="center" valign="middle">NP</td><td align="center" valign="middle">NP</td><td align="center" valign="middle">---</td></tr><tr><td align="left" valign="middle">Inheritance</td><td align="center" valign="middle"><italic>de novo</italic></td><td align="center" valign="middle">Recessive</td><td align="center" valign="middle">Recessive</td><td align="center" valign="middle"><italic>de novo</italic></td><td align="center" valign="middle">Recessive</td><td align="center" valign="middle">Recessive</td><td align="center" valign="middle">Recessive</td><td align="center" valign="middle"><italic>de novo</italic></td><td align="center" valign="middle">Recessive</td></tr><tr><td align="left" valign="middle">Weight (percentile)</td><td align="center" valign="middle">95th</td><td align="center" valign="middle">90th</td><td align="center" valign="middle">99th</td><td align="center" valign="middle">1st</td><td align="center" valign="middle">84th</td><td align="center" valign="middle">&lt;1st</td><td align="center" valign="middle">50th</td><td align="center" valign="middle">10th</td><td align="center" valign="middle">&lt;1st</td></tr><tr><td align="left" valign="middle">Height (percentile)</td><td align="center" valign="middle">98th</td><td align="center" valign="middle">96th</td><td align="center" valign="middle">99th</td><td align="center" valign="middle">&lt;1st</td><td align="center" valign="middle">99th</td><td align="center" valign="middle">7th</td><td align="center" valign="middle">30th</td><td align="center" valign="middle">25th</td><td align="center" valign="middle">&lt;1st</td></tr><tr><td align="left" valign="middle">Head circumference (percentile)</td><td align="center" valign="middle">50th</td><td align="center" valign="middle">&lt;5th</td><td align="center" valign="middle">99th</td><td align="center" valign="middle">UK</td><td align="center" valign="middle">50th</td><td align="center" valign="middle">&lt;5th</td><td align="center" valign="middle">&lt;5th</td><td align="center" valign="middle">&lt;3rd</td><td align="center" valign="middle">&lt;2nd</td></tr><tr><td align="left" valign="middle">ASD</td><td align="center" valign="middle">+</td><td align="center" valign="middle">+</td><td align="center" valign="middle">+</td><td align="center" valign="middle">+</td><td align="center" valign="middle">+</td><td align="center" valign="middle">+</td><td align="center" valign="middle">+</td><td align="center" valign="middle">UK</td><td align="center" valign="middle">UK</td></tr><tr><td align="left" valign="middle">Absent speech</td><td align="center" valign="middle">+</td><td align="center" valign="middle">+</td><td align="center" valign="middle">+</td><td align="center" valign="middle">- *</td><td align="center" valign="middle">+</td><td align="center" valign="middle">+</td><td align="center" valign="middle">+</td><td align="center" valign="middle">Few words</td><td align="center" valign="middle">+</td></tr><tr><td align="left" valign="middle">Intellectual disability</td><td align="center" valign="middle">+</td><td align="center" valign="middle">+</td><td align="center" valign="middle">+</td><td align="center" valign="middle">+</td><td align="center" valign="middle">+</td><td align="center" valign="middle">+</td><td align="center" valign="middle">+</td><td align="center" valign="middle">+</td><td align="center" valign="middle">+</td></tr><tr><td align="left" valign="middle">Developmental delay</td><td align="center" valign="middle">+</td><td align="center" valign="middle">+</td><td align="center" valign="middle">+</td><td align="center" valign="middle">+</td><td align="center" valign="middle">-</td><td align="center" valign="middle">+</td><td align="center" valign="middle">+</td><td align="center" valign="middle">+</td><td align="center" valign="middle">+</td></tr><tr><td align="left" valign="middle">Seizures</td><td align="center" valign="middle">+</td><td align="center" valign="middle">+</td><td align="center" valign="middle">-</td><td align="center" valign="middle">+</td><td align="center" valign="middle">-</td><td align="center" valign="middle">-</td><td align="center" valign="middle">-</td><td align="center" valign="middle">+</td><td align="center" valign="middle">-</td></tr><tr><td align="left" valign="middle">Motor impairment</td><td align="center" valign="middle">+</td><td align="center" valign="middle">+</td><td align="center" valign="middle">+</td><td align="center" valign="middle">-</td><td align="center" valign="middle">+</td><td align="center" valign="middle">+</td><td align="center" valign="middle">+</td><td align="center" valign="middle">+</td><td align="center" valign="middle">+</td></tr><tr><td align="left" valign="middle">Muscle hypotonia</td><td align="center" valign="middle">+</td><td align="center" valign="middle">+</td><td align="center" valign="middle">+</td><td align="center" valign="middle">-</td><td align="center" valign="middle">-</td><td align="center" valign="middle">+</td><td align="center" valign="middle">+</td><td align="center" valign="middle">-</td><td align="center" valign="middle">+</td></tr><tr><td align="left" valign="middle">Feeding difficulties</td><td align="center" valign="middle">+</td><td align="center" valign="middle">+</td><td align="center" valign="middle">+</td><td align="center" valign="middle">+</td><td align="center" valign="middle">-</td><td align="center" valign="middle">+</td><td align="center" valign="middle">+</td><td align="center" valign="middle">-</td><td align="center" valign="middle">-</td></tr><tr><td align="left" valign="middle">Facial dysmorphisms</td><td align="center" valign="middle">-</td><td align="center" valign="middle">+</td><td align="center" valign="middle">+</td><td align="center" valign="middle">+</td><td align="center" valign="middle">-</td><td align="center" valign="middle">-</td><td align="center" valign="middle">+</td><td align="center" valign="middle">+</td><td align="center" valign="middle">+</td></tr><tr><td align="left" valign="middle">Abnormal MRI</td><td align="center" valign="middle">UK</td><td align="center" valign="middle">Hypoplastic corpus callosum</td><td align="center" valign="middle">Hypoplastic corpus callosum, mild hippocampal atrophy</td><td align="center" valign="middle">UK</td><td align="center" valign="middle">-</td><td align="center" valign="middle">UK</td><td align="center" valign="middle">Periventricular leukomalacia</td><td align="center" valign="middle">Gliosis of the parieto-central pyramidal tracts and mild atrophy of the parietal region</td><td align="center" valign="middle">UK</td></tr><tr><td align="left" valign="middle">Cardiac defects</td><td align="center" valign="middle">Murmur</td><td align="center" valign="middle">Atrial septal defect</td><td align="center" valign="middle">-</td><td align="center" valign="middle">Ventricular septal defect</td><td align="center" valign="middle">-</td><td align="center" valign="middle">-</td><td align="center" valign="middle">Atrial septal defect</td><td align="center" valign="middle">-</td><td align="center" valign="middle">Murmur, coarctation of the aorta</td></tr></tbody></table></table-wrap><p>All nine individuals with <italic>KDM5A</italic> mutations presented clinically with ASD and a spectrum of neurodevelopmental phenotypes including complete lack of speech, intellectual disability, and developmental delay (<xref ref-type="table" rid="table1">Table 1</xref> and Clinical presentation). The proband from the first family (KD-1–3) was heterozygous for a missense mutation in the first methionine of KDM5A (p.Met1Leu), which we validated via Sanger sequencing (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1B</xref>). The mutation alters the highly conserved initiation methionine in KDM5A (<xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2A</xref>). Western blot analysis of lymphoblastoid cell lines showed a reduction in KDM5A in the proband compared to the unaffected father (<xref ref-type="fig" rid="fig4">Figure 4C</xref>). Family KD-2 had two affected children homozygous for a ~ 10 kb deletion that removed exons 6 through 9 of <italic>KDM5A</italic> without disrupting the reading frame (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1A</xref>). Western blot analysis of lymphoblastoid cell lines revealed a truncated protein of the predicted molecular weight (174 kDa) in the proband compared to the unaffected parents (<xref ref-type="fig" rid="fig4">Figure 4C</xref>). The proband in the third family (KD-3–3) was heterozygous for a missense mutation in a highly conserved arginine residue of KDM5A (p.Arg1428Leu) (<xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2B</xref>). The two affected children in family KD-4, who were offspring of a consanguineous mating, presented with the most severe phenotype that appeared to worsen with age given the phenotype of the older sibling (<xref ref-type="table" rid="table1">Table 1</xref>, Clinical presentation, <xref ref-type="video" rid="fig4video1">Figure 4—video 1</xref>, and <xref ref-type="video" rid="fig4video2">Figure 4—video 2</xref>). Both siblings carried a homozygous recessive variant disrupting the donor splice site of exon 18 (c.2541+1G &gt; T). We introduced this mutation into the <italic>KDM5A</italic> locus in HEK293T cells using CRISPR/Cas9 (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1C</xref>) and analyzed its impact on KDM5A using western blot analysis. We found that the splice site mutation resulted in a severe reduction in KDM5A in the targeted cells compared to control cells (<xref ref-type="fig" rid="fig4">Figure 4C</xref>). Another proband, KD-5–3, was homozygous for a missense mutation in a highly conserved residue in KDM5A (p.Phe477Val, <xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2C</xref>) and resulted in a reduction in KDM5A in lymphoblastoid cells from the proband compared to the unaffected family members (<xref ref-type="fig" rid="fig4">Figure 4C</xref>). The proband in family KD-6 was heterozygous for a nonsense mutation in KDM5A that also caused a reduction in KDM5A in the proband compared to the unaffected parents (<xref ref-type="fig" rid="fig4">Figure 4C</xref>). In family KD-7, the proband was homozygous for a ~ 50 kb deletion that removed exons 1 through 10 of <italic>KDM5A</italic>. The deletion is predicted to result in loss of KDM5A transcript and protein.</p></sec><sec id="s2-5"><title>Impaired transcriptional profile in the hippocampus following loss of KDM5A</title><p>KDM5A is a histone lysine demethylase that removes methyl groups from lysine 4 of histone H3, resulting in repression of target genes. In order to identify KDM5A targets, we profiled transcripts from hippocampi of WT and <italic>Kdm5a</italic><sup>-/-</sup> mice. The RNA-seq data was of high quality and clustered robustly by genotype (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1</xref> and <xref ref-type="fig" rid="fig5s2">Figure 5—figure supplement 2A</xref>). Loss of KDM5A resulted in dysregulation of 450 genes (FDR-corrected p≤0.05 and log<sub>2</sub> fold change ≥|0.3|) (<xref ref-type="supplementary-material" rid="fig5sdata1">Figure 5—source data 1</xref>), of which 191 genes were upregulated and 259 genes were downregulated (<xref ref-type="fig" rid="fig5">Figure 5A and B</xref>). Interestingly, upregulated genes included those involved in the regulation of neurological processes (<italic>Ednrb</italic>, <italic>Gba</italic>, <italic>Mtmr2</italic>, <italic>Nov</italic>, <italic>Npy2r</italic>) and RNA splicing (<italic>Cdc40</italic>, <italic>Dhx38</italic>, <italic>Lsm3</italic>, <italic>Lsm8</italic>, <italic>Sart3</italic>, <italic>Sfswap</italic>, <italic>Snrpb2</italic>, <italic>Tfip11</italic>, <italic>Uhmk1</italic>, <italic>Wbp11</italic>), while downregulated genes included those involved in neurogenesis (e.g. <italic>Myoc</italic>, <italic>Nphp1</italic>, <italic>Otx2</italic>, <italic>Sema3b</italic>, <italic>Sgk1</italic>, <italic>Six3os1</italic>, <italic>Trpv4</italic>) and cell proliferation (e.g. <italic>Ace</italic>, <italic>Adora2a</italic>, <italic>Aqp1</italic>, <italic>Cdh3</italic>, <italic>Enpp2</italic>, <italic>Nde1</italic>) (<xref ref-type="fig" rid="fig5s2">Figure 5—figure supplement 2B</xref> and <xref ref-type="supplementary-material" rid="fig5s2sdata1">Figure 5—figure supplement 2—source data 1</xref>). Expression of the other members of the KDM5 family, <italic>Kdm5b</italic>, <italic>Kdm5c</italic>, and <italic>Kdm5d</italic>, remained unchanged upon loss of <italic>Kdm5a</italic> (<xref ref-type="fig" rid="fig5s3">Figure 5—figure supplement 3</xref>). We confirmed the differential expression of the top upregulated gene, <italic>Efcab6</italic>, and the top downregulated gene, <italic>Ptgds</italic>, with qRT-PCR. We also confirmed the upregulation of <italic>Shh</italic>, known for its role in hippocampal neurogenesis, proliferation, and differentiation, and potential role in synaptic plasticity (<xref ref-type="bibr" rid="bib64">Yao et al., 2015</xref>; <xref ref-type="bibr" rid="bib65">Yao et al., 2016</xref>), and its downstream target <italic>Ccnd1</italic>, a mediator of cell cycle progression (<xref ref-type="fig" rid="fig5">Figure 5C</xref>). The expression of homologs of several known ASD genes was altered upon loss of <italic>Kdm5a: Ccnk</italic>, <italic>Cnr1</italic>, <italic>Hsd11b1</italic>, <italic>Oxtr</italic>, <italic>Ptprb</italic>, and <italic>Styk1</italic> were upregulated, whereas <italic>Ace</italic>, <italic>Adora2a</italic>, <italic>Dmpk</italic>, <italic>Mfrp</italic>, <italic>Myo5c</italic>, <italic>Ppp1r1b</italic>, <italic>Setdb2</italic>, <italic>Slc29a4</italic>, and <italic>Stk39</italic> were downregulated (<xref ref-type="fig" rid="fig5">Figure 5D</xref>). To further emphasize the importance of KDM5A in brain development, we compared the set of genes dysregulated in the <italic>Kdm5a</italic><sup>-/-</sup> hippocampus to genes involved in neurodevelopment based on data from the BrainSpan Atlas of the Developing Human Brain (<xref ref-type="bibr" rid="bib41">Miller et al., 2014</xref>). We found that several of the genes dysregulated in <italic>Kdm5a</italic><sup>-/-</sup> mice are homologs of essential neurodevelopmental genes (<xref ref-type="fig" rid="fig5">Figure 5E</xref>).</p><fig-group><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>Transcriptional dysregulation in hippocampi of <italic>Kdm5a</italic> knockout mice.</title><p>(<bold>A</bold>) Heatmap showing hippocampal gene expression profiles in WT and <italic>Kdm5a</italic><sup>-/-</sup> (KO) mice at 6–8 weeks of age (n = 5 WT, 5 KO). Red and blue indicate upregulation and downregulation, respectively. Data plotted from genes with a log<sub>2</sub> fold change ≥ |0.3| and FDR-corrected p≤0.05. (<bold>B</bold>) Volcano plot of the RNA-seq data showing the log<sub>2</sub> fold change in gene expression in <italic>Kdm5a</italic><sup>-/-</sup> compared to WT hippocampi. (<bold>C</bold>) qRT-PCR gene expression validation of the most upregulated and downregulated genes in <italic>Kdm5a</italic><sup>-/-</sup> hippocampi, <italic>Efcab6</italic> and <italic>Ptgds</italic>, respectively, as well as upregulation of <italic>Shh</italic> and its downstream target <italic>Ccnd1</italic>. Values are mean ± SEM (<italic>Efcab6</italic>: **p=0.0084, <italic>Ptgds</italic>: ***p&lt;0.0001, <italic>Shh</italic>: **p=0.0056, <italic>Ccnd1</italic>: *p=0.0114; n = 5 WT, 5 KO). Data were analyzed using unpaired t test. Genes dysregulated following loss of <italic>Kdm5a</italic> overlap with homologs of known ASD genes (<bold>D</bold>) and of genes underlying neurodevelopment (<bold>E</bold>). Red and blue indicate upregulated and downregulated genes, respectively.</p><p><supplementary-material id="fig5sdata1"><label>Figure 5—source data 1.</label><caption><title>Genes dysregulated in the hippocampus of <italic>Kdm5a</italic> KO mice.</title><p>A total of 450 genes were differentially dysregulated in the <italic>Kdm5a</italic> KO compared to WT (FDR-corrected p≤0.05; log<sub>2</sub> fold change ≥ |0.3|; n = 5 WT, 5 KO).</p></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-56883-fig5-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-56883-fig5-v1.tif"/></fig><fig id="fig5s1" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 1.</label><caption><title>Quality control metrics of RNA-seq reads as determined by FastQC and STAR.</title><p>Related to <xref ref-type="fig" rid="fig5">Figure 5</xref>. (<bold>A</bold>) Phred quality score distribution across all bases. All sequences had a quality score above 30. (<bold>B</bold>) Quality score distribution over all sequences. (<bold>C</bold>) The mean GC content (%) distribution for all sequences. (<bold>D</bold>) STAR alignment results showing that for each sample sequenced (n = 5 WT, 5 KO), 87% to 88% of reads uniquely mapped to the reference mouse genome, with less than 1% of reads unmapped.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-56883-fig5-figsupp1-v1.tif"/></fig><fig id="fig5s2" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 2.</label><caption><title>Related to <xref ref-type="fig" rid="fig5">Figure 5</xref>.</title><p>(<bold>A</bold>) Principal component analysis of hippocampal RNA-seq data (n = 5 WT, 5 KO). (<bold>B</bold>) Scatterplot of GO categories with semantically similar terms clustered together. Each circle represents a GO category with size corresponding to the number of genes in that category. GO terms with p&lt;0.05 are plotted. Upregulated genes (red) are significantly enriched in genes involved in the regulation of neurological processes (1), RNA splicing (2), and cell division (3), and downregulated genes (blue) are involved in cell-cell signaling (4), cell proliferation (5), and tissue development (6).</p><p><supplementary-material id="fig5s2sdata1"><label>Figure 5—figure supplement 2—source data 1.</label><caption><title>Gene ontology analysis of genes dysregulated in the hippocampus of <italic>Kdm5a</italic><sup>-/-</sup> mice.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-56883-fig5-figsupp2-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-56883-fig5-figsupp2-v1.tif"/></fig><fig id="fig5s3" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 3.</label><caption><title>Expression levels of <italic>Kdm5b</italic>, <italic>Kdm5c</italic>, and <italic>Kdm5d</italic> remain unchanged following loss of <italic>Kdm5a</italic>.</title><p>Related to <xref ref-type="fig" rid="fig5">Figure 5</xref>. RNA-seq analysis from the hippocampus of WT and <italic>Kdm5a</italic> KO mice showed no changes in expression of the other KDM5 family members. Values are mean ± SEM (n = 5 WT, 5 KO; <italic>Kdm5b:</italic> p=0.3764, <italic>Kdm5c:</italic> p=0.7742, <italic>Kdm5d:</italic> p=0.9347). Data were analyzed using unpaired t test.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-56883-fig5-figsupp3-v1.tif"/></fig></fig-group></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>Forward genetics has long been recognized as an unbiased genome-wide method to identify genes underlying many biological processes (<xref ref-type="bibr" rid="bib6">Beutler, 2016</xref>). By screening ENU mutagenized mice for ASD-like behaviors, we identified <italic>Kdm5a</italic> as a candidate ASD gene that regulates vocalization and nesting. To our knowledge, this is the first successful identification of an ASD gene through a forward genetics strategy. In our screen, we observed damaging homozygous mutations in ~0.2% of all genes in three or more mice, and we were able to successfully identify a candidate ASD gene, indicating the efficiency of this strategy for highly heterogeneous disorders. We generated a <italic>Kdm5a</italic> knockout mouse model in order to validate the <italic>Selbst</italic> phenotype and to characterize the function of KDM5A. We found that <italic>Kdm5a</italic><sup>-/-</sup> mice indeed showed significant alterations in their emitted USVs indicating abnormal brain development upon loss of <italic>Kdm5a</italic>. Furthermore, <italic>Kdm5a</italic><sup>-/-</sup> mice showed increased self-grooming and remarkable repetitive forepaw wringing and clasping, a characteristic ASD-like phenotype observed in mouse models of several neurodevelopmental disorders, one of the most well-characterized examples being mouse models of Rett syndrome (<xref ref-type="bibr" rid="bib10">Chao et al., 2010</xref>). <italic>Kdm5a</italic><sup>-/-</sup> mice also had mild hyperactivity and showed signs of anxiety in the open field test. Additional behavioral characterization is required to thoroughly assess anxiety in the <italic>Kdm5a</italic><sup>-/-</sup> mice. Furthermore, <italic>Kdm5a</italic><sup>-/-</sup> mice displayed social behavior deficits and abnormalities in learning and memory. In addition, loss of KDM5A resulted in severe neuronal morphogenesis abnormalities, which included a decrease in dendritic complexity, length, and spine density. These findings reveal an essential role for KDM5A in dendritic morphogenesis and maturation, processes essential for the establishment of neuronal circuitry and wiring of the brain (<xref ref-type="bibr" rid="bib22">Dong et al., 2015</xref>). Collectively, the neurobehavioral phenotypes observed in the <italic>Kdm5a</italic><sup>-/-</sup> mice uncover the function of KDM5A in the brain and recapitulate phenotypes observed in patients with <italic>KDM5A</italic> mutations, including deficits in sociability, cognitive function, and repetitive behaviors.</p><p>Chromatin regulation is essential for gene expression and brain development. Mutations in several genes coding for chromatin remodelers and epigenetic modulators have been linked to neurodevelopmental disorders including ASD, with causative mutations identified in several chromatin remodelers (e.g. <italic>CHD8</italic> and <italic>ARID1B</italic>) (<xref ref-type="bibr" rid="bib46">O'Roak et al., 2012</xref>; <xref ref-type="bibr" rid="bib59">Turner et al., 2016</xref>). Moreover, two genes in the KDM5 family, <italic>KDM5B</italic> and <italic>KDM5C</italic>, are disrupted in neurodevelopmental disorders, including intellectual disability and ASD (<xref ref-type="bibr" rid="bib19">De Rubeis et al., 2014</xref>; <xref ref-type="bibr" rid="bib31">Iossifov et al., 2014</xref>; <xref ref-type="bibr" rid="bib33">Jensen et al., 2005</xref>). This is the first report implicating disruption of <italic>KDM5A</italic> as a cause of ASD. The fact that mutations in <italic>KDM5A</italic>, <italic>KDM5B</italic>, and <italic>KDM5C</italic> all cause neurodevelopmental disorders, indicates that their function in the brain is nonredundant.</p><p>We found seven pathogenic <italic>KDM5A</italic> variants in patients with ASD, in conjunction with lack of speech, intellectual disability, and developmental delay. Despite the phenotypic variability typically observed within the different genetic subtypes of ASD, all the patients with <italic>KDM5A</italic> mutations reported in our study have a complete absence of speech, suggesting a potential role for KDM5A in regulating social communication in humans. Both inherited and <italic>de novo</italic> mutations were identified in <italic>KDM5A</italic>, similar to many other ASD genes including <italic>KDM5B</italic> (<xref ref-type="bibr" rid="bib35">Lebrun et al., 2018</xref>), <italic>CHD8</italic> (<xref ref-type="bibr" rid="bib26">Guo et al., 2018</xref>), and <italic>DOCK8</italic> (<xref ref-type="bibr" rid="bib19">De Rubeis et al., 2014</xref>; <xref ref-type="bibr" rid="bib26">Guo et al., 2018</xref>). We analyzed the impact of the <italic>KDM5A</italic> mutations and found that they resulted in decreased protein levels and in one case a truncated protein. The recessive missense mutation in KD-5 results in a single amino acid substitution in one of the enzymatic domains of KDM5A, the Jumanji C (JmjC) domain (<xref ref-type="bibr" rid="bib47">Pilka et al., 2015</xref>; <xref ref-type="bibr" rid="bib28">Horton et al., 2016</xref>). The homozygous deletion in KD-2 results in loss of the plant homeodomain 1 (PHD1), which binds unmodified H3K4 (<xref ref-type="bibr" rid="bib58">Torres et al., 2015</xref>) and was shown to enhance the demethylase catalytic activity (<xref ref-type="bibr" rid="bib38">Longbotham et al., 2019</xref>). Furthermore, the fact that the KD-2 deletion results in a truncated protein which is also present in the healthy carrier parents argues against the mutation being dominant negative. Further functional studies are needed to understand how the identified mutations may affect KDM5A localization, enzymatic function, chromatin binding ability, or interaction(s) with binding partners. The fact that we identified both monoallelic as well as biallelic mutations in <italic>KDM5A</italic> emphasizes the sensitivity of the brain to KDM5A levels.</p><p>KDM5A demethylates H3K4me3, a histone mark known to be associated with memory formation (<xref ref-type="bibr" rid="bib12">Collins et al., 2019a</xref>; <xref ref-type="bibr" rid="bib27">Gupta et al., 2010</xref>) and memory retrieval (<xref ref-type="bibr" rid="bib63">Webb et al., 2017</xref>). Perturbations in histone demethylases and methyltransferases at this mark give rise to neurodevelopmental disorders, including ASD and intellectual disability (<xref ref-type="bibr" rid="bib61">Vallianatos and Iwase, 2015</xref>), emphasizing the importance of H3K4me3 in learning and memory (<xref ref-type="bibr" rid="bib13">Collins et al., 2019b</xref>). Thus, we analyzed changes in the hippocampal transcriptome upon loss of KDM5A. By demethylating H3K4me3, an activating histone mark, KDM5A would be expected to repress the expression of its target genes, suggesting that genes upregulated in the hippocampus of the <italic>Kdm5a</italic><sup>-/-</sup> mice are potential direct targets of KDM5A. Genes upregulated in <italic>Kdm5a</italic><sup>-/-</sup> clustered in regulation of neurological processes and RNA splicing, suggesting a role for KDM5A in these pathways. In addition, <italic>Shh</italic>, which plays an essential role in hippocampal neurogenesis and neural progenitor cell proliferation and differentiation, and its downstream target <italic>Ccnd1</italic>, were also upregulated in <italic>Kdm5a</italic><sup>-/-</sup>, indicating a potential mechanism by which KDM5A could be exerting its function in the hippocampus. Downregulated genes were involved in neurogenesis and cell proliferation, suggesting that loss of KDM5A altered these processes that are essential for normal hippocampal function. The most upregulated gene, a potential direct target of KDM5A, was <italic>Efcab6</italic> (EF-Hand Calcium Binding Domain 6; log<sub>2</sub> fold change = 1.34, FDR-corrected p=7.68×10<sup>−18</sup>), which represses transcription of the androgen receptor by recruiting histone deacetylase complexes (<xref ref-type="bibr" rid="bib45">Niki et al., 2003</xref>). The most downregulated gene was <italic>Ptgds</italic> (Prostaglandin D2 Synthase; log<sub>2</sub> fold change = −1.13, FDR-corrected p=1.13×10<sup>−30</sup>), which functions as a neuromodulator and a trophic factor in the brain (<xref ref-type="bibr" rid="bib57">Taniguchi et al., 2007</xref>). Out of 450 differentially expressed genes, 15 were homologs of known ASD genes, including <italic>Ace</italic>, <italic>Cnr1</italic>, <italic>Mfrp</italic>, <italic>Oxtr</italic>, and <italic>Ppp1r1b</italic>, and 33 were homologs of genes essential for brain development, including <italic>Cdh3</italic>, <italic>Otx2</italic>, <italic>Pcolce2</italic>, and <italic>Sema3b</italic>, highlighting the importance of KDM5A in brain development and function. Furthermore, we did not observe an increase in the expression of <italic>Kdm5b</italic>, <italic>Kdm5c</italic>, or <italic>Kdm5d</italic> in the <italic>Kdm5a</italic><sup>-/-</sup> hippocampus, suggesting that there is no compensation from other KDM5 family members following loss of KDM5A. Others have made a similar observation where transcript levels of KDM5 family members were unchanged following loss of <italic>Kdm5b</italic> (<xref ref-type="bibr" rid="bib3">Albert et al., 2013</xref>) and <italic>Kdm5c</italic> (<xref ref-type="bibr" rid="bib32">Iwase et al., 2016</xref>) in neurons and brain tissue. Taken together, our transcriptomics data identify many neuronal genes perturbed in the hippocampus of <italic>Kdm5a</italic><sup>-/-</sup> mice, and point to potential pathways through which KDM5A mediates its function in the brain.</p><p>In summary, using a forward genetics strategy, we identified a new gene, <italic>KDM5A</italic>, that is disrupted in patients with ASD and lack of speech. We further uncovered an essential role for KDM5A in brain development and function. Our approach underscores the value of leveraging forward genetics in mice to discover new gene defects that cause phenotypically complex and genetically heterogeneous disorders. Future studies dissecting the function of KDM5A in the developing brain will elucidate the molecular underpinnings of this subtype of ASD, and more broadly inform us on the role of chromatin remodeling in neurodevelopment and disease.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><table-wrap id="keyresource" position="anchor"><label>Key resources table</label><table frame="hsides" rules="groups"><thead><tr><th>Reagent type <break/>(species) or resource</th><th>Designation</th><th>Source or reference</th><th>Identifiers</th><th>Additional information</th></tr></thead><tbody><tr><td valign="top">Antibody</td><td valign="top">‘Mouse monoclonal’ anti-β-Actin</td><td valign="top">Abcam</td><td valign="top"># ab6276; RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2223210">AB_2223210</ext-link></td><td valign="top">WB (1:1000)</td></tr><tr><td valign="top">Antibody</td><td valign="top">‘Rabbit polyclonal’ anti-KDM5A</td><td valign="top">Abcam</td><td valign="top"># ab70892; RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2280628">AB_2280628</ext-link></td><td valign="top">WB (1:1000)</td></tr><tr><td valign="top">Antibody</td><td valign="top">‘Rabbit polyclonal’ anti-Vinculin</td><td valign="top">Cell Signaling</td><td valign="top"># 4650S; RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_10559207">AB_10559207</ext-link></td><td valign="top">WB (1:1000)</td></tr><tr><td valign="top">Blood samples (<italic>Homo sapiens</italic>)</td><td valign="top"/><td valign="top">Referring clinicians</td><td valign="top">N/A</td><td valign="top"/></tr><tr><td valign="top">Cell line (<italic>H. sapiens</italic>)</td><td valign="top">Lymphoblastoid cell lines</td><td valign="top">UTSW Human Genetics Clinical Laboratory</td><td valign="top">N/A</td><td valign="top"/></tr><tr><td valign="top">Cell line (<italic>H. sapiens</italic>)</td><td valign="top">HEK293T</td><td valign="top">ATCC</td><td valign="top"># CRL-3216; RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/CVCL_0063">CVCL_0063</ext-link></td><td valign="top"/></tr><tr><td valign="top">Strain, strain background (<italic>Mus musculus</italic>)</td><td valign="top">C57BL/6N</td><td valign="top">Charles River Laboratories</td><td valign="top">Strain Code: 027</td><td valign="top">Wild type mice</td></tr><tr><td valign="top">Strain, strain background (<italic>M. musculus</italic>)</td><td valign="top">C57BL/6J</td><td valign="top">In-house</td><td valign="top">In-house</td><td valign="top"><italic>Kdm5a</italic><sup>-/-</sup> CRISPR/Cas9 mice</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top"><italic>Kdm5a</italic><sup>-/-</sup> CRISPR/Cas9 sgRNA</td><td valign="top">Integrated DNA Technologies</td><td valign="top">N/A</td><td valign="top">TTAATACGACTCACTATAGGGGATACAACTTTGCCGAAG</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">Shh_F</td><td valign="top">Integrated DNA Technologies</td><td valign="top">qPCR primer</td><td valign="top">ACTGGGTCTACTATGAATCC</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">Shh_R</td><td valign="top">Integrated DNA Technologies</td><td valign="top">qPCR primer</td><td valign="top">GTAAGTCCTTCACCAGCTTG</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">Ccnd1_F</td><td valign="top">Integrated DNA Technologies</td><td valign="top">qPCR primer</td><td valign="top">TTCCCTTGACTGCCGAGAAG</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">Ccnd1_R</td><td valign="top">Integrated DNA Technologies</td><td valign="top">qPCR primer</td><td valign="top">AAATCGTGGGGAGTCATGGC</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">Efcab6_F</td><td valign="top">Integrated DNA Technologies</td><td valign="top">qPCR primer</td><td valign="top">CTGGAGCAGTGAGGGTCAAC</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">Efcab6_R</td><td valign="top">Integrated DNA Technologies</td><td valign="top">qPCR primer</td><td valign="top">ATGGTCCCCGTGTCCCTAAG</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">Ptgds_F</td><td valign="top">Integrated DNA Technologies</td><td valign="top">qPCR primer</td><td valign="top">GCTCCTTCTGCCCAGTTTTC</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">Ptgds_R</td><td valign="top">Integrated DNA Technologies</td><td valign="top">qPCR primer</td><td valign="top">CCCCAGGAACTTGTCTTGTTGA</td></tr><tr><td valign="top">Recombinant DNA reagent</td><td valign="top">pU6-(BbsI)_CBh-Cas9-T2A-mCherry (plasmid)</td><td valign="top">Addgene</td><td valign="top">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/Addgene_64324">Addgene_64324</ext-link></td><td valign="top">Plasmid for CRISPR knock-in</td></tr><tr><td valign="top">Software, algorithm</td><td valign="top">Adobe Illustrator</td><td valign="top">Adobe</td><td valign="top">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_010279">SCR_010279</ext-link></td><td valign="top"/></tr><tr><td valign="top">Software, algorithm</td><td valign="top">GraphPad Prism</td><td valign="top">GraphPad</td><td valign="top">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_002798">SCR_002798</ext-link></td><td valign="top"/></tr><tr><td valign="top">Software, algorithm</td><td valign="top">Avisoft-RECORDER</td><td valign="top">Avisoft Bioacoustics</td><td valign="top">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_014436">SCR_014436</ext-link></td><td valign="top"/></tr></tbody></table></table-wrap><sec id="s4-1"><title>Subjects and specimens</title><p>The study was approved by the University of Texas Southwestern Medical Center (UTSW) Institutional Review Board (protocol number STU 032015–014). Seven families (KD-1 through KD-7) with ASD and <italic>KDM5A</italic> mutations (<xref ref-type="table" rid="table1">Table 1</xref>) were identified through GeneDx and GeneMatcher (<xref ref-type="bibr" rid="bib55">Sobreira et al., 2015</xref>), and enrolled in our study after obtaining written informed consent from all study participants. Subjects were evaluated in a clinical setting and phenotypes of the affected individuals are detailed below under Clinical presentation. Peripheral blood samples were collected from the affected individuals and family members. Genomic DNA was isolated from circulating leukocytes using AutoPure (Qiagen) according to the manufacturer’s instructions. <italic>KDM5A</italic> variants were identified as detailed below for each family, either through whole exome or genome sequencing or microarray analysis. Lymphocytes were isolated and Epstein-Barr virus-transformed lymphoblastoid cell lines were generated at the UTSW Human Genetics Clinical Laboratory, for families KD-1, KD-2, KD-5, and KD-6.</p></sec><sec id="s4-2"><title>Clinical presentation</title><sec id="s4-2-1"><title>Family KD-1</title><p>The first proband (KD-1–3) is a boy from a United States family of European and Hispanic ancestry. The proband has two unaffected female siblings. He presented with ASD, absent speech, moderate to severe intellectual disability, and significant developmental delays. On physical exam at age five his growth parameters were normal and he had normal facial features with carious teeth. He is unable to feed himself and has feeding difficulties requiring a high calorie special formula. He is still in diapers and has sleep problems, in part related to low ferritin, for which he required an intravenous iron infusion. He attends a special school for children with ASD and is receiving applied behavioral analysis (ABA) therapy. He is very aggressive toward other family members and his classmates. Other findings include a flow murmur, tight phimosis, moderate pectus excavatum, a mild increase in joint range of motion, and slightly brisk deep tendon reflexes in his lower extremities. Clinical whole exome sequencing (WES) was performed at GeneDx. The identified variant was validated through targeted Sanger sequencing.</p></sec><sec id="s4-2-2"><title>Family KD-2</title><p>The probands (KD-2–3 and KD-2–4) are siblings from a consanguineous Canadian family of Afghani ancestry. The female proband (KD-2–3) presented to a pediatric hospital at 4 months of age with failure to thrive. The identified anomalies included: global developmental delay, hypotonia, feeding difficulty, gastroesophageal reflux, small accessory loop of the small bowel, anterior segment dysgenesis of the right ocular globe with an eccentric pupil, posterior embryotoxon, and iris hypoplasia, borderline microcephaly, atrial septal defect, hypoplastic and dysgenic corpus callosum, and unusual morphological features including hypertelorism and a prominent glabellar region. She was a first pregnancy for her healthy parents. Follow-up over time demonstrated limited developmental progress with ongoing dependence on gastrostomy feeding. She required surgery for strabismus and for repair of her heart defect. Nerve conduction studies were normal. Extensive metabolic screening, including analysis of the cerebrospinal fluid, was non-diagnostic. Genetic investigations included karyotyping, chromosomal microarray analysis, and later exome sequencing, none of which yielded a candidate cause for her condition. By 3 years of age she could ambulate with difficulty with her hands held, and she was diagnosed with cerebral palsy. She has remained non-verbal, and at 5 years of age was diagnosed with ASD on the basis of her limited social interaction and motor stereotypies, including hand-wringing and bruxism, as well as severe intellectual disability. She developed focal seizures at 9 years of age controlled with Lamotrigine.</p><p>The second child born to the parents was unaffected. The third child (KD-2–4), a male, was found at birth to have hypotonia, feeding difficulties, hypertelorism, and a prominent glabellar region. Growth parameters were normal. Brain magnetic resonance imaging (MRI) identified a dysgenic corpus callosum. He also required surgery for strabismus. He had profound global developmental delay and was diagnosed with ASD, intellectual disability, and cerebral palsy. He has remained non-ambulatory and non-verbal at 7 years of age. A fourth child was born who was unaffected.</p><p>The family enrolled in a research study, approved by the institutional review board of the University of British Columbia (H15-00092) for whole genome sequencing, which was performed with an Illumina platform at the British Columbia Genome Sciences Centre on both parents and affected siblings. A combination of read depth calling and split-read analysis identified a homozygous deletion encompassing four exons of <italic>KDM5A</italic>, spanning 10 kb on chr12:460,661–470,642. There were no other compelling candidate variants. The copy number variant was confirmed with chromosomal microarray for the four family members, which was also performed for the two unaffected siblings who were heterozygous carriers like their parents.</p></sec><sec id="s4-2-3"><title>Family KD-3</title><p>The proband (KD-3–3) is an 18 year old male from a United States family of European ancestry. He was first evaluated at 5 years of age and diagnosed with ASD, echolalia, and intellectual disability. He received physical, speech, and occupational therapies for many years. He was born at 34 weeks of gestation weighing 1.38 kg. The pregnancy was complicated by intrauterine growth restriction, oligohydramnios, and a small placenta. He was in the neonatal intensive care unit for 68 days post-delivery for complications including pulmonary hypertension, ventricular septal defect, failure to thrive, and multiple urinary tract infections. He had a gastrostomy-button placed at 13 months of age and continues to use a gastrostomy tube to supplement table feeds. He experienced his first seizure at 14 months of age. The seizures became well-controlled on Trileptal, he has not experienced a seizure since he was 5 years old, and was subsequently weaned off of anticonvulsants at 7 years of age. The proband was developmentally delayed, sitting at 12 months, walking at 26 months, and speaking his first words at 3 years of age. At 15 years of age, he was performing at a 5<sup>th</sup>-7<sup>th</sup> grade level in home school. Other findings include short stature, pectus excavatum, chronic sinusitis and bronchiectasis, and an abnormal rash present since childhood, with a reticulated pattern that was poikilodermatous in some areas and ichthyotic in other areas. Karyotype and chromosomal microarray analyses were normal. Clinical WES was performed at GeneDx.</p></sec><sec id="s4-2-4"><title>Family KD-4</title><p>The probands (KD-4–3 and KD-4–4) are siblings from a consanguineous Persian family. The male proband (KD-4–4) was born at full term and weighed 2.65 kg with a length of 32 cm. He was delayed in his early developmental milestones and first walked at 6 years of age. He was 20 years old at the time of last examination and his growth parameters were: weight of 36 kg, height of 166 cm, and head circumference of 52.5 cm. He was diagnosed with ASD and remains nonverbal with severe intellectual disability. Neurological exam showed hypotonia, tremor, ataxia, abnormal gait, kyphoscoliosis, and difficulty feeding and swallowing.</p><p>The affected sister (KD-4–3) was born at full term and weighed 2.97 kg with a length of 49 cm. She sat unsupported at about 9 months and walked at about 27 months but she could not speak yet. She was 3 years old at the time of last examination and her growth parameters were: weight of 16 kg, height of 111 cm, and head circumference of 48.5 cm. She was diagnosed with ASD and neurological exam showed abnormal gait. Other findings included vision impairment (astigmatism and hyperopia) and a cleft palate for which she had surgery in infancy. There were no specific findings on brain MRI and metabolic testing was normal. Karyotyping and chromosomal microarray analysis for both siblings were normal. WES was performed as previously described (<xref ref-type="bibr" rid="bib39">Makrythanasis et al., 2018</xref>).</p></sec><sec id="s4-2-5"><title>Family KD-5</title><p>The proband (KD-5–3) is a 4 year old female from a consanguineous family of Middle Eastern ancestry. She presented with ASD, intellectual disability, developmental delay, absent speech, and facial dysmorphisms. She was born at 35 weeks of gestation weighing 1.8 kg. She sat at 1 year of age and shuffled until she was able to walk at 4 years of age. Brain MRI at 2 years of age showed evidence of periventricular leukomalacia. At 4 years of age her weight was 16 kg, her height was 100 cm, and her head circumference was 47 cm indicative of microcephaly. Her dysmorphic features include frontal bossing, prominent eyes with blue sclera, lax lower eyelids, down slanted palpebral fissures, orbital hypertelorism, maxillary hypoplasia, hypoplastic ala nasi, smooth philtrum, micrognathia, and low set ears. Other findings include atrial septal defect secundum type, abnormal gait, sleep problems, hyperextensible joints, bilateral clinodactyly of the 5<sup>th</sup> fingers, syndactyly 2/3 toes, high degree exotropia, hyperpigmented skin in the pubic region, and nevoid telangiectasia on the left side of the back. Her hearing and her reflexes were normal. Chromosomal microarray analysis was normal. WES was performed as previously described (<xref ref-type="bibr" rid="bib43">Monies et al., 2019</xref>).</p></sec><sec id="s4-2-6"><title>Family KD-6</title><p>The proband (KD-6–3) is a 40 year old female of European ancestry. She presented with severe intellectual disability, developmental delay, focal epilepsy, tetraspastic gait, and ataxia. She exhibited behavioral difficulties, including aggression, self-injurious behavior, reluctant eye contact, and rigid rituals. At present the proband can only say a few words. The healthy parents described a protracted birth with total arrest. When the proband was eventually born with the help of a vacuum extractor, she was cyanotic, weighed 3.52 kg, and was 52 cm long. Her seizure disorder started on the first day of life. She exhibited febrile seizures as well as isolated tonic and generalized tonic clonic seizures. Additional findings include microcephaly, tented upper and full lower lip, anteverted nares, hallux valgus as well as hands with short fingers and large palms. Brain MRI showed gliosis of the parieto-central pyramidal tracts and mild atrophy of the parietal region.</p><p>WES was performed after negative gene panel diagnostics. Exome enrichment was carried out with the BGI Exome capture kit and the library was sequenced (100 bp paired-end) on a BGISEQ-500 at BGI. Primary and secondary bioinformatic processing of the raw data was performed using Varfeed (Limbus) and the variants were then annotated using Varvis (Limbus). A coverage of 10X was achieved for 95%, 94%, and 96% of targeted sequences for the proband, father, and mother, respectively. A total of 106,516,290, 100,890,598, and 178,119,532 reads were obtained, with an average read depth of 73X, 65X, and 141X for the proband, father, and mother, respectively. Single nucleotide variants and copy number variants were evaluated and all potential protein-influencing variants were prioritized with regard to their minor allele frequency in gnomAD, pathogenicity, inheritance modes, and gene attributes such as function and expression. Following variant filtration, only the <italic>KDM5A</italic> variant (c.4048C &gt; T) met all pathogenicity criteria.</p></sec><sec id="s4-2-7"><title>Family KD-7</title><p>The proband (KD-7–3) is a 13 year old female from a United States family of Hispanic ancestry. She presented with severe intellectual disability, lack of speech, self-abusive behaviors, microcephaly, and dysmorphic facies, including flat midface, proptosis, low set ears, broad forehead, broad nasal tip, high nasal bridge, and high palate. She was born at 40 weeks of gestation. Her developmental milestones were significantly delayed with sitting unassisted, crawling, and walking at 8–10 years of age. She is proportionately undergrown, has a history of independent ambulation with a reciprocating shuffling-type gait, but progressive joint contractures and muscle weakness have necessitated assisted ambulation. Additional findings include coarctation of the aorta, heart murmur, dextroscoliosis, Marfanoid habitus, progressive joint contractures at the knees and elbows, and recurrent infections. Chromosomal microarray revealed a 28.92 Mb region of loss of heterozygosity and a 50 kb microdeletion encompassing the <italic>KDM5A</italic> locus at 12p13.33 (chr12:458,096–507,789). Karyotyping and targeted sequencing of <italic>FGFR2</italic> and <italic>SKI</italic> were normal.</p></sec></sec><sec id="s4-3"><title>Patient lymphoblastoid cell lines</title><p>Cells were cultured in RPMI-1640 with 2 mM L-Glutamine, 10% fetal bovine serum (FBS), 1% v/v penicillin-streptomycin solution, and 1% v/v Fungizone. For immunoblotting, cells were lysed in SDS lysis buffer and western blot analysis was performed as described below.</p></sec><sec id="s4-4"><title>CRISPR knock-in of the KD-4 splice site mutation in HEK293T cells</title><p>We used CRISPR/Cas9 to introduce the splice site mutation of family KD-4 (c.2541+1G &gt; T) into the <italic>KDM5A</italic> locus in HEK293T cells. Prior to the experiment, cells were authenticated through STR profiling and were confirmed negative for mycoplasma contamination. The following primers were used for the single guide RNA (sgRNA): 5’-<named-content content-type="sequence">CACCGCCAAGCTCGGCAAGTAAAGG</named-content>-3’ and 5’-<named-content content-type="sequence">AAACCCTTTACTTGCCGAGCTTGGC</named-content>-3’. The sgRNA oligos were annealed and ligated into pX330 (pU6-(BbsI)_CBh-Cas9-T2A-mCherry) (<xref ref-type="bibr" rid="bib11">Chu et al., 2015</xref>) (Addgene plasmid # 64324, <ext-link ext-link-type="uri" xlink:href="http://www.addgene.org/64324">http://www.addgene.org/64324</ext-link>, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/Addgene_64324">Addgene_64324</ext-link>). The donor sequence used was: 5’-<named-content content-type="sequence">AACTAGTTTAGATATACCATTCTGTGAAACCCAGAACAGTGGACCATGTCACAAAGGACATTACCCAAAAAAAGGATGTAATACTCCAACTTTACTTGCCGAGCTTGGCTGATGACACACGGAAGAC</named-content>-3’. The asymmetric donor DNA was optimized for annealing by overlapping the Cas9 cut site with 36 bp on the PAM-distal side and with a 91 bp extension on the PAM-proximal side of the break (<xref ref-type="bibr" rid="bib49">Richardson et al., 2016</xref>).</p><p>HEK293T cells were cultured in DMEM with 10% FBS, 5% v/v penicillin-streptomycin solution, and 5% v/v Fungizone. Cells were transfected with polyethylenimine (PEI) in OptiMEM, and sorted using fluorescence-activated cell sorting (FACS) for mCherry fluorescence, present in the plasmid with Cas9 and the sgRNA. Individual clones were collected and sequenced to identify the knock-in. A successful knock-in clone and two wild type control clones were kept in culture for subsequent analyses.</p></sec><sec id="s4-5"><title>ENU mutagenesis and mouse breeding</title><p>All animal care and use procedures were approved by the UTSW Institutional Animal Care and Use Committee (protocol number 2017–102300) and were compliant with US Government principles about the care and use of animals, Public Health Service Policy on Humane Care and Use of Laboratory Animals, Guide for the Care and Use of Laboratory Animals, and the Animal Welfare Act. Animal husbandry was performed in the UTSW animal facility, accredited by the Association for Assessment and Accreditation of Laboratory Animal Care International. Male C57BL/6J mice were mutagenized with ENU and breeding was performed as previously described (<xref ref-type="bibr" rid="bib62">Wang et al., 2015</xref>; <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>). Whole exome sequencing, genotyping, and automated mapping were performed as previously described (<xref ref-type="bibr" rid="bib62">Wang et al., 2015</xref>).</p></sec><sec id="s4-6"><title>Generation of <italic>Kdm5a</italic> constitutive knockout mice</title><p>CRISPR/Cas9-mediated targeting of the <italic>Kdm5a</italic> locus was used to generate the <italic>Kdm5a</italic> knockout mouse model (<italic>Kdm5a</italic><sup>-/-</sup>). The sequence of the sgRNA used was: 5’-<named-content content-type="sequence">ttaatacgactcactatagGGGATACAACTTTGCCGAAG</named-content>-3’. The knockout allele contained a single base pair insertion in exon 13 shown in the square brackets (5’-<named-content content-type="sequence">ATAC AACTTTGCCG[G]AAGCGGTGAACTTCT</named-content>-3’), predicted to result in a frameshift after amino acid 581 of KDM5A and terminating after the inclusion of 8 aberrant amino acids. For genotyping, tail genomic DNA was amplified across the insertion site and sequenced. The PCR primers were: 5’-<named-content content-type="sequence">ACTTACAGGACTTAA</named-content> <named-content content-type="sequence">CTTAGGAAGTGAGTACA</named-content>-3’ and 5’-<named-content content-type="sequence">AAACTATCTATTCCCTCAGGAGAGACAAACA</named-content>-3’; the sequencing primer was: 5’-<named-content content-type="sequence">CAGAAGCAGAGACAGGTGG</named-content>-3’. Constitutive <italic>Kdm5a</italic><sup>-/-</sup> mice were bred as <italic>Kdm5a</italic><sup>+/-</sup> x <italic>Kdm5a</italic><sup>+/-</sup> for all experiments.</p></sec><sec id="s4-7"><title>Western blot analysis and antibodies</title><p>To detect endogenous proteins, cortical tissue was isolated from male and female mice and immediately frozen in liquid nitrogen. Tissue was lysed in SDS lysis buffer (250 mM Tris pH 6.8, 4% SDS, 3.2% glycerol, 10 mM NEM, 1 mM PMSF) supplemented with 2 mM OPT, and cOmplete mini EDTA-free protease inhibitor and phosSTOP phosphatase inhibitor tablets (Roche). Samples were boiled for 10 min (min), then centrifuged at 14,000 rpm for 15 min, and the supernatant was collected. Protein concentrations were determined using the DC protein assay (Bio-Rad). Samples were diluted in sample buffer and 50 μg of protein was loaded per lane, with β-mercaptoethanol and bromophenol blue, onto either 6% (for KDM5A) or 8% polyacrylamide gels. Gels were run and protein was transferred to polyvinylidene difluoride (PVDF) membranes (Millipore) for 2 hr (hr) on ice. Membranes were blocked in 5% milk in TBS-T (20 mM Tris pH 7.5, 150 mM NaCl, 0.1% Tween-20) for 1 hr at room temperature, and incubated with primary antibody overnight at 4°C. Membranes were washed in 5% TBS-T followed by a 1 hr incubation in secondary antibody (1:10,000) at room temperature using donkey anti-rabbit (Jackson ImmunoResearch, 711-035-152) or peroxidase AffiniPure donkey anti-mouse (Jackson ImmunoResearch, 715-035-150). Following antibody incubation, signal was detected with enhanced chemiluminescence (ECL; SuperSignal West Pico chemiluminescent substrate, Thermo Fisher Scientific). Primary antibodies used were: KDM5A (Abcam, ab70892, 1:1,000), vinculin (Cell Signaling, 4650S, 1:1,000), β-actin (Abcam, ab6276, 1:1,000).</p></sec><sec id="s4-8"><title>Golgi-Cox staining</title><p>Mice at 14–16 weeks of age were euthanized and brains were removed. Golgi-Cox staining was performed as described in <xref ref-type="bibr" rid="bib66">Zaqout and Kaindl, 2016</xref>. The brains were cut into two hemispheres and impregnated with Golgi-Cox solution (1% K<sub>2</sub>Cr<sub>2</sub>O<sub>7</sub>, 1% HgCl<sub>2</sub>, 0.8% K<sub>2</sub>CrO<sub>4</sub>) at room temperature for 7 days in the dark. Subsequently, they were protected with tissue protectant solution (30% sucrose, 1% PVP40, 30% ethylene glycol in 0.05 M phosphate buffer pH 7.2) at 4°C for 24 hr after which the solution was replaced with a fresh one and kept at 4°C for 5 days. Brains were embedded in OCT medium. Frozen sagittal sections (150 μm thickness) were prepared using a microtome (Leica) and loaded on 3% gelatin-coated glass slides. The slides were dried for 5 days at room temperature, dehydrated, and developed as described in Zaqout et al. 2016 (<xref ref-type="bibr" rid="bib66">Zaqout and Kaindl, 2016</xref>), and mounted with Cytoseal (Thermo Fisher Scientific). Brightfield images were acquired using Nikon Eclipse80i with 60X objective (zoom X1.4) at 0.5 µm steps in z axis. Dendritic and spine analyses were performed using Neurolucida 360 software (MBF Bioscience) at the UTSW Whole Brain Microscopy Facility. For Sholl analysis, images were processed and analyzed in Fiji (ImageJ v2.1.0/1.53 c) (<xref ref-type="bibr" rid="bib52">Schindelin et al., 2012</xref>).</p></sec><sec id="s4-9"><title>Behavioral assays</title><p>All mice were age- and sex-matched littermate progeny of heterozygous <italic>Kdm5a</italic> mutant crosses. An experimenter blind to genotypes performed all behavioral tests. Ambient lighting was maintained at 60 lux. Mice were tested at 5–9 weeks of age except where indicated, and tests were performed in the order in which they appear below.</p><sec id="s4-9-1"><title>Ultrasonic vocalization</title><p>USVs were recorded at P4 for both male and female pups isolated from their mothers during the daylight period of the light/dark cycle. Dams and their litters were acclimated to the test room for 30 min. Each pup was removed from the cage containing its mother and littermates and placed in a clean plastic container in a wooden sound-attenuating recording chamber. Each pup was first acclimated to the recording chamber for 30 s (sec) then recorded for 10 min. Recordings were acquired using an UltraSoundGate CM16/CMPA condenser microphone (Avisoft Bioacoustics) positioned at a fixed height of 8 cm above the pups, and were amplified and digitized (sampled at 16 bits, 250 kHz) using UltraSoundGate 416 hr 1.1 hardware and Avisoft-RECORDER software (Avisoft Bioacoustics). The data were transferred to Avisoft-SASLab Pro (version 5.2) to analyze spectrograms of vocalizations with settings of 0% overlapping FlatTop windows, 100% frame size, and 256 points fast Fourier transform (FFT) length. The following measures were recorded and analyzed for each group: number of USV calls, mean duration of USV calls, mean amplitude, mean peak frequency, maximum peak frequency, mean interval between USV calls, and the latency to call.</p></sec><sec id="s4-9-2"><title>Nest building</title><p>Test mice, at 4 weeks of age, were single-housed in their home cages right before the dark phase, and one nestlet was placed in each cage on day 1. At the beginning of the light phase on the next day (12 hr time point), the quality of the nest was examined, and the nest was photographed. The nest quality was subsequently assessed at 24 hr, 36 hr, 48 hr, and 72 hr time points. Nest quality was scored on a scale of 0 to 3 at each time point (0 being no nest construction, three being a well-structured nest) (<xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2B</xref>).</p></sec><sec id="s4-9-3"><title>Forepaw wringing</title><p>We used a modified version of the tail suspension test to quantify forepaw wringing and/or clasping. Test mice were acclimated to the test room for 30 min. Each mouse was suspended by the tail and videotaped for 3 min. Time spent forepaw wringing and/or clasping was measured, and data was plotted as percent of total time spent forepaw wringing and/or clasping.</p></sec><sec id="s4-9-4"><title>Grooming</title><p>Mice were placed into a new standard cage, without nestlets, food, or water, acclimated for 10 min, then videotaped for another 10 min. The amount of time spent grooming was recorded continuously to calculate the total time spent grooming. Grooming was considered self-grooming of any part of the body (including the face, head, ears, body, or tail).</p></sec><sec id="s4-9-5"><title>Open field test</title><p>Mice were acclimated to the test room for 30 min. The open field apparatus consisted of a white square box (45.7 × 45.7×30.5 cm) with photo beams to record horizontal and vertical movements of the mouse. Mice were individually placed in the center of the box. Activity was quantified over a 15 min period by EthoVision XT 13 software. Total distance traveled, time spent in the periphery of the box, and time spent in the non-periphery of the box were recorded.</p></sec><sec id="s4-9-6"><title>Direct social interaction</title><p>Test mice were single-housed in a standard housing cage with food and water for one night. The next day, mice were acclimated to the test room for 30 min and then a conspecific interactor mouse of the same sex and age was introduced into the housing cage. The activity of the mice was videotaped by EthoVision XT 13 software for 10 min and the total time the test mouse spent in direct social contact with the conspecific interactor mouse was manually recorded by the observer. Direct social contact included nose-nose, anogenital, or body sniffing.</p></sec><sec id="s4-9-7"><title>Morris water maze (MWM) test</title><p>Mice were acclimated to the test room for 30 min. MWM was carried out in a 144 cm diameter pool filled with room temperature water (~24°C) and made opaque with harmless white paint. A platform was submerged in the pool, not visible to mice while swimming. During the training phase, each mouse was given eight trials per day, in blocks of 4 trials, for four consecutive days, each time placed in the pool at a different starting point. The time taken to locate the hidden escape platform (latency) and the distance traveled were measured. For the probe test, the platform was removed and each mouse was given 1 min to search the pool. The amount of time each mouse spent in each quadrant was recorded. The mice were tracked during the training trials and probe test using EthoVision XT 13 software.</p></sec></sec><sec id="s4-10"><title>RNA sequencing and data analysis</title><p>RNA was extracted from hippocampal tissue of 10 animals at 6–8 weeks of age (5 WT and 5 <italic>Kdm5a</italic><sup>-/-</sup>) using Trizol reagent (Invitrogen) and RNeasy Mini Kit (Qiagen) and DNA was removed using RNase-free DNase kit (Qiagen). Samples were run on the Agilent Tapestation 4200 to assess quality and those with a RIN score of ≥8 were used for sequencing. Concentrations were measured on a Qubit fluorometer and 1 μg of total DNase-treated RNA was used for library preparation using the TruSeq Stranded mRNA Library Prep Kit from Illumina. Poly-A RNA was purified, fragmented, and strand specific samples were amplified and purified with AmpureXP beads. Samples were sequenced on the Illumina NextSeq 500 using V2.5 reagents. Raw data from the machine were de-multiplexed and converted to FASTQ files using bcl2fastq (v2.17, Illumina). The FASTQ files were checked for quality using FastQC (v0.11.2) and FastQ_Screen (v0.4.4). Quality control metrics are presented in <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1</xref>. Reads were mapped to mm10 reference Mouse genome using STAR (v2.5.3a) (<xref ref-type="bibr" rid="bib21">Dobin et al., 2013</xref>). Read counts were then generated using featureCounts (Subread v1.4.6) (<xref ref-type="bibr" rid="bib37">Liao et al., 2014</xref>). TMM normalization and differential expression analysis were performed using edgeR (v3.18.1) (<xref ref-type="bibr" rid="bib50">Robinson et al., 2010</xref>). Hierarchical clustering of differentially expressed genes was performed using hclust (R v3.4.0 ‘You Stupid Darkness’) and heatmaps were generated using heatmap2 (gplots v3.0.1). Principal component analysis was performed using ClustVis (<xref ref-type="bibr" rid="bib40">Metsalu and Vilo, 2015</xref>). GO analysis was performed using DAVID 6.8 (<xref ref-type="bibr" rid="bib29">Huang et al., 2009a</xref>; <xref ref-type="bibr" rid="bib30">Huang et al., 2009b</xref>) with the mouse genome as the background and redundant gene ontology terms were merged using Revigo (<xref ref-type="bibr" rid="bib56">Supek et al., 2011</xref>). The list of known ASD genes was obtained from the SFARI Gene database (<xref ref-type="bibr" rid="bib4">Banerjee-Basu and Packer, 2010</xref>), and the list of neurodevelopmental genes was obtained from the BrainSpan Atlas of the Developing Human Brain (<xref ref-type="bibr" rid="bib41">Miller et al., 2014</xref>).</p></sec><sec id="s4-11"><title>Quantitative RT-PCR</title><p>RNA was extracted from hippocampal tissue of 10 animals at 6–8 weeks of age (5 WT and 5 <italic>Kdm5a</italic><sup>-/-</sup>) and 1 μg of RNA was reverse transcribed into cDNA using Superscript III First Strand Synthesis System for RT-PCR (Invitrogen). Real-time quantitative PCR was performed using PowerUp SYBR Green (2X) master mix (Applied Biosystems) and the following primers:</p><list list-type="simple"><list-item><p><italic>Efcab6</italic> forward: 5’-<named-content content-type="sequence">CTGGAGCAGTGAGGGTCAAC</named-content>-3’, and reverse: 5’-<named-content content-type="sequence">ATGGTCCCCGTGTCCCTAAG</named-content>-3’;</p></list-item><list-item><p><italic>Ptgds</italic>, forward: 5’-<named-content content-type="sequence">GCTCCTTCTGCCCAGTTTTC</named-content>-3’, and reverse: 5’-<named-content content-type="sequence">CCCCAGGAACTTGTCTTGTTGA</named-content>-3’;</p></list-item><list-item><p><italic>Shh</italic>, forward: 5’-<named-content content-type="sequence">ACTGGGTCTACTATGAATCC</named-content>-3’, and reverse: 5’-<named-content content-type="sequence">GTAAGTCCTTCACCAGCTTG</named-content>-3’;</p></list-item><list-item><p><italic>Ccnd1</italic>, forward: 5’-<named-content content-type="sequence">TTCCCTTGACTGCCGAGAAG</named-content>-3’, and reverse: 5’-<named-content content-type="sequence">AAATCGTGGGGAGTCATGGC</named-content>-3’.</p></list-item></list></sec><sec id="s4-12"><title>Statistical analysis</title><p>All statistical analyses were performed using GraphPad Prism (<ext-link ext-link-type="uri" xlink:href="http://www.graphpad.com/">http://www.graphpad.com/</ext-link>scientific-software/prism, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_002798">SCR_002798</ext-link>). All analyses were performed using at least three different animals of each genotype or three replicates for cell lines. Data are represented as mean ± SEM and two-tailed <italic>P</italic> values are reported. GraphPad Prism was used to perform either one-way ANOVA (factor: genotype), two-way ANOVA (factors: genotype and age or time), or a mixed-effects model (restricted maximum likelihood; REML) (factors: genotype and age or time) with Tukey’s multiple comparisons test, or ratio paired or unpaired t test where applicable. All figures were prepared using Adobe Illustrator (<ext-link ext-link-type="uri" xlink:href="http://www.adobe.com/">http://www.adobe.com/</ext-link>products/illustrator, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_010279">SCR_010279</ext-link>).</p></sec><sec id="s4-13"><title>Electronic resources</title><list list-type="simple"><list-item><p>Allen Brain Atlas Mouse Brain: <ext-link ext-link-type="uri" xlink:href="https://mouse.brain-map.org">https://mouse.brain-map.org</ext-link></p></list-item><list-item><p>BrainSpan: <ext-link ext-link-type="uri" xlink:href="https://www.brainspan.org">https://www.brainspan.org</ext-link></p></list-item><list-item><p>FastQC: <ext-link ext-link-type="uri" xlink:href="https://www.bioinformatics.babraham.ac.uk/projects/fastqc/">https://www.bioinformatics.babraham.ac.uk/projects/fastqc/</ext-link></p></list-item><list-item><p>Fiji: <ext-link ext-link-type="uri" xlink:href="https://fiji.sc/">https://fiji.sc/</ext-link> gnomAD Browser: <ext-link ext-link-type="uri" xlink:href="http://gnomad.broadinstitute.org">http://gnomad.broadinstitute.org</ext-link></p></list-item><list-item><p>GeneMatcher: <ext-link ext-link-type="uri" xlink:href="https://genematcher.org/">https://genematcher.org/</ext-link></p></list-item><list-item><p>GTEx Portal: <ext-link ext-link-type="uri" xlink:href="https://www.gtexportal.org/home">https://www.gtexportal.org/home</ext-link></p></list-item><list-item><p>MGI: <ext-link ext-link-type="uri" xlink:href="http://www.informatics.jax.org/">http://www.informatics.jax.org/</ext-link></p></list-item><list-item><p>OMIM: <ext-link ext-link-type="uri" xlink:href="http://www.omim.org">http://www.omim.org</ext-link></p></list-item><list-item><p>SFARI Gene: <ext-link ext-link-type="uri" xlink:href="https://gene.sfari.org/database/human-gene/">https://gene.sfari.org/database/human-gene/</ext-link></p></list-item><list-item><p>UCSC Genome Browser: <ext-link ext-link-type="uri" xlink:href="http://genome.ucsc.edu">http://genome.ucsc.edu</ext-link></p></list-item></list></sec><sec id="s4-14"><title>Contact for reagent and resource sharing</title><p>Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Maria H. Chahrour (<ext-link ext-link-type="uri" xlink:href="http://maria.chahrour@utsouthwestern.edu">maria.chahrour@utsouthwestern.edu</ext-link>).</p></sec></sec></body><back><ack id="ack"><title>Acknowledgements</title><p>We are grateful to the families for their participation in our study. We thank Daniel A Schmitz and Carlos A Pinzon-Arteaga for technical help and advice in designing the CRISPR knock-in experiment. We thank Chelsea Burroughs for assistance in preparing the Figures. The CAUSES Study investigators include Shelin Adam, Christele Du Souich, Alison Elliott, Jan Friedman, Anna Lehman, Jill Mwenifumbo, Tanya Nelson, and Clara Van Karnebeek. The CAUSES Study was funded by Mining for Miracles, British Columbia Children’s Hospital Foundation, and Genome British Columbia. This work was supported by the University of Texas Southwestern Medical Center and grants from the Welch Foundation and the Walter and Lillian Cantor Foundation to MHC.</p></ack><sec id="s5" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Data curation, Software, Formal analysis, Validation, Investigation, Visualization, Methodology, Writing - original draft, Writing - review and editing</p></fn><fn fn-type="con" id="con2"><p>Software, Formal analysis, Validation, Investigation, Writing - review and editing</p></fn><fn fn-type="con" id="con3"><p>Software, Formal analysis, Investigation, Methodology, Writing - review and editing</p></fn><fn fn-type="con" id="con4"><p>Resources, Investigation, Writing - review and editing</p></fn><fn fn-type="con" id="con5"><p>Resources, Investigation, Writing - review and editing</p></fn><fn fn-type="con" id="con6"><p>Formal analysis, Investigation, Methodology, Writing - review and editing</p></fn><fn fn-type="con" id="con7"><p>Resources, Investigation, Methodology, Writing - review and editing</p></fn><fn fn-type="con" id="con8"><p>Resources, Investigation, Methodology, Writing - review and editing</p></fn><fn fn-type="con" id="con9"><p>Resources, Investigation, Methodology, Writing - review and editing</p></fn><fn fn-type="con" id="con10"><p>Resources, Investigation, Writing - review and editing</p></fn><fn fn-type="con" id="con11"><p>Resources, Investigation, Writing - review and editing</p></fn><fn fn-type="con" id="con12"><p>Resources, Investigation, Writing - review and editing</p></fn><fn fn-type="con" id="con13"><p>Resources, Investigation, Writing - review and editing</p></fn><fn fn-type="con" id="con14"><p>Resources, Investigation, Writing - review and editing</p></fn><fn fn-type="con" id="con15"><p>Resources, Investigation, Writing - review and editing</p></fn><fn fn-type="con" id="con16"><p>Resources, Investigation, Writing - review and editing</p></fn><fn fn-type="con" id="con17"><p>Resources, Investigation, Writing - review and editing</p></fn><fn fn-type="con" id="con18"><p>Resources, Investigation, Writing - review and editing</p></fn><fn fn-type="con" id="con19"><p>Resources, Investigation, Writing - review and editing</p></fn><fn fn-type="con" id="con20"><p>Resources, Investigation, Writing - review and editing</p></fn><fn fn-type="con" id="con21"><p>Resources, Investigation, Writing - review and editing</p></fn><fn fn-type="con" id="con22"><p>Resources, Investigation, Writing - review and editing</p></fn><fn fn-type="con" id="con23"><p>Resources, Investigation, Writing - review and editing</p></fn><fn fn-type="con" id="con24"><p>Resources, Investigation, Writing - review and editing</p></fn><fn fn-type="con" id="con25"><p>Resources, Investigation, Writing - review and editing</p></fn><fn fn-type="con" id="con26"><p>Resources, Investigation, Writing - review and editing</p></fn><fn fn-type="con" id="con27"><p>Resources, Writing - review and editing</p></fn><fn fn-type="con" id="con28"><p>Resources, Investigation, Writing - review and editing</p></fn><fn fn-type="con" id="con29"><p>Conceptualization, Resources, Supervision, Validation, Writing - review and editing</p></fn><fn fn-type="con" id="con30"><p>Conceptualization, Resources, Data curation, Formal analysis, Supervision, Funding acquisition, Validation, Investigation, Visualization, Methodology, Writing - original draft, Project administration, Writing - review and editing</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other" id="fn1"><p>Human subjects: The study was approved by the University of Texas Southwestern Medical Center Institutional Review Board (protocol number STU 032015-014). Written informed consent was obtained from all study participants.</p></fn><fn fn-type="other" id="fn2"><p>Animal experimentation: All animal care and use procedures were approved by the University of Texas Southwestern Medical Center Institutional Animal Care and Use Committee (protocol number 2017-102300).</p></fn></fn-group></sec><sec id="s6" sec-type="supplementary-material"><title>Additional files</title><supplementary-material id="transrepform"><label>Transparent reporting form</label><media mime-subtype="pdf" mimetype="application" xlink:href="elife-56883-transrepform-v1.pdf"/></supplementary-material></sec><sec id="s7" sec-type="data-availability"><title>Data availability</title><p>All data are available in the main text or the supplementary materials. The gene expression data reported in this study are available in the NCBI Gene Expression Omnibus (GEO) repository with accession GSE147435.</p><p>The following dataset was generated:</p><p><element-citation id="dataset1" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><name><surname>El</surname><given-names>Hayek L</given-names></name><name><surname>Chahrour</surname><given-names>MH</given-names></name></person-group><year iso-8601-date="2020">2020</year><data-title>Impaired transcriptional profile in the hippocampus following loss of Kdm5a</data-title><source>NCBI Gene Expression Omnibus</source><pub-id assigning-authority="NCBI" pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE147435">GSE147435</pub-id></element-citation></p></sec><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adegbola</surname> <given-names>A</given-names></name><name><surname>Gao</surname> <given-names>H</given-names></name><name><surname>Sommer</surname> <given-names>S</given-names></name><name><surname>Browning</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>A novel mutation in JARID1C/SMCX in a patient with autism spectrum disorder (ASD)</article-title><source>American Journal of Medical Genetics Part A</source><volume>146A</volume><fpage>505</fpage><lpage>511</lpage><pub-id pub-id-type="doi">10.1002/ajmg.a.32142</pub-id><pub-id pub-id-type="pmid">18203167</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Al-Mubarak</surname> <given-names>B</given-names></name><name><surname>Abouelhoda</surname> <given-names>M</given-names></name><name><surname>Omar</surname> <given-names>A</given-names></name><name><surname>AlDhalaan</surname> <given-names>H</given-names></name><name><surname>Aldosari</surname> <given-names>M</given-names></name><name><surname>Nester</surname> <given-names>M</given-names></name><name><surname>Alshamrani</surname> <given-names>HA</given-names></name><name><surname>El-Kalioby</surname> <given-names>M</given-names></name><name><surname>Goljan</surname> <given-names>E</given-names></name><name><surname>Albar</surname> <given-names>R</given-names></name><name><surname>Subhani</surname> <given-names>S</given-names></name><name><surname>Tahir</surname> <given-names>A</given-names></name><name><surname>Asfahani</surname> <given-names>S</given-names></name><name><surname>Eskandrani</surname> <given-names>A</given-names></name><name><surname>Almusaiab</surname> <given-names>A</given-names></name><name><surname>Magrashi</surname> <given-names>A</given-names></name><name><surname>Shinwari</surname> <given-names>J</given-names></name><name><surname>Monies</surname> <given-names>D</given-names></name><name><surname>Al Tassan</surname> <given-names>N</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Whole exome sequencing reveals inherited and de novo variants in autism spectrum disorder: a trio study from saudi families</article-title><source>Scientific Reports</source><volume>7</volume><elocation-id>5679</elocation-id><pub-id pub-id-type="doi">10.1038/s41598-017-06033-1</pub-id><pub-id pub-id-type="pmid">28720891</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Albert</surname> <given-names>M</given-names></name><name><surname>Schmitz</surname> <given-names>SU</given-names></name><name><surname>Kooistra</surname> <given-names>SM</given-names></name><name><surname>Malatesta</surname> <given-names>M</given-names></name><name><surname>Morales Torres</surname> <given-names>C</given-names></name><name><surname>Rekling</surname> <given-names>JC</given-names></name><name><surname>Johansen</surname> <given-names>JV</given-names></name><name><surname>Abarrategui</surname> <given-names>I</given-names></name><name><surname>Helin</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>The histone demethylase Jarid1b ensures faithful mouse development by protecting developmental genes from aberrant H3K4me3</article-title><source>PLOS Genetics</source><volume>9</volume><elocation-id>e1003461</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1003461</pub-id><pub-id pub-id-type="pmid">23637629</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Banerjee-Basu</surname> <given-names>S</given-names></name><name><surname>Packer</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>SFARI gene: an evolving database for the autism research community</article-title><source>Disease Models &amp; Mechanisms</source><volume>3</volume><fpage>133</fpage><lpage>135</lpage><pub-id pub-id-type="doi">10.1242/dmm.005439</pub-id><pub-id pub-id-type="pmid">20212079</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Betancur</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Etiological heterogeneity in autism spectrum disorders: more than 100 genetic and genomic disorders and still counting</article-title><source>Brain Research</source><volume>1380</volume><fpage>42</fpage><lpage>77</lpage><pub-id pub-id-type="doi">10.1016/j.brainres.2010.11.078</pub-id><pub-id pub-id-type="pmid">21129364</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beutler</surname> <given-names>B</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Innate immunity and the new forward genetics</article-title><source>Best Practice &amp; Research Clinical Haematology</source><volume>29</volume><fpage>379</fpage><lpage>387</lpage><pub-id pub-id-type="doi">10.1016/j.beha.2016.10.018</pub-id><pub-id pub-id-type="pmid">27890263</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boyle</surname> <given-names>EA</given-names></name><name><surname>Li</surname> <given-names>YI</given-names></name><name><surname>Pritchard</surname> <given-names>JK</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>An expanded view of complex traits: from polygenic to omnigenic</article-title><source>Cell</source><volume>169</volume><fpage>1177</fpage><lpage>1186</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2017.05.038</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Branchi</surname> <given-names>I</given-names></name><name><surname>Santucci</surname> <given-names>D</given-names></name><name><surname>Alleva</surname> <given-names>E</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Ultrasonic vocalisation emitted by infant rodents: a tool for assessment of neurobehavioural development</article-title><source>Behavioural Brain Research</source><volume>125</volume><fpage>49</fpage><lpage>56</lpage><pub-id pub-id-type="doi">10.1016/S0166-4328(01)00277-7</pub-id><pub-id pub-id-type="pmid">11682093</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname> <given-names>Y</given-names></name><name><surname>Cole</surname> <given-names>TB</given-names></name><name><surname>Costa</surname> <given-names>LG</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Behavioral phenotyping for autism spectrum disorders in mice</article-title><source>Current Protocols in Toxicology</source><volume>72</volume><fpage>1</fpage><lpage>21</lpage><pub-id pub-id-type="doi">10.1002/cptx.19</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chao</surname> <given-names>HT</given-names></name><name><surname>Chen</surname> <given-names>H</given-names></name><name><surname>Samaco</surname> <given-names>RC</given-names></name><name><surname>Xue</surname> <given-names>M</given-names></name><name><surname>Chahrour</surname> <given-names>M</given-names></name><name><surname>Yoo</surname> <given-names>J</given-names></name><name><surname>Neul</surname> <given-names>JL</given-names></name><name><surname>Gong</surname> <given-names>S</given-names></name><name><surname>Lu</surname> <given-names>HC</given-names></name><name><surname>Heintz</surname> <given-names>N</given-names></name><name><surname>Ekker</surname> <given-names>M</given-names></name><name><surname>Rubenstein</surname> <given-names>JL</given-names></name><name><surname>Noebels</surname> <given-names>JL</given-names></name><name><surname>Rosenmund</surname> <given-names>C</given-names></name><name><surname>Zoghbi</surname> <given-names>HY</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Dysfunction in GABA signalling mediates autism-like stereotypies and rett syndrome phenotypes</article-title><source>Nature</source><volume>468</volume><fpage>263</fpage><lpage>269</lpage><pub-id pub-id-type="doi">10.1038/nature09582</pub-id><pub-id pub-id-type="pmid">21068835</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chu</surname> <given-names>VT</given-names></name><name><surname>Weber</surname> <given-names>T</given-names></name><name><surname>Wefers</surname> <given-names>B</given-names></name><name><surname>Wurst</surname> <given-names>W</given-names></name><name><surname>Sander</surname> <given-names>S</given-names></name><name><surname>Rajewsky</surname> <given-names>K</given-names></name><name><surname>Kühn</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Increasing the efficiency of homology-directed repair for CRISPR-Cas9-induced precise gene editing in mammalian cells</article-title><source>Nature Biotechnology</source><volume>33</volume><fpage>543</fpage><lpage>548</lpage><pub-id pub-id-type="doi">10.1038/nbt.3198</pub-id><pub-id pub-id-type="pmid">25803306</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Collins</surname> <given-names>BE</given-names></name><name><surname>Sweatt</surname> <given-names>JD</given-names></name><name><surname>Greer</surname> <given-names>CB</given-names></name></person-group><year iso-8601-date="2019">2019a</year><article-title>Broad domains of histone 3 lysine 4 trimethylation are associated with transcriptional activation in CA1 neurons of the Hippocampus during memory formation</article-title><source>Neurobiology of Learning and Memory</source><volume>161</volume><fpage>149</fpage><lpage>157</lpage><pub-id pub-id-type="doi">10.1016/j.nlm.2019.04.009</pub-id><pub-id pub-id-type="pmid">31002880</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Collins</surname> <given-names>BE</given-names></name><name><surname>Greer</surname> <given-names>CB</given-names></name><name><surname>Coleman</surname> <given-names>BC</given-names></name><name><surname>Sweatt</surname> <given-names>JD</given-names></name></person-group><year iso-8601-date="2019">2019b</year><article-title>Histone H3 lysine K4 methylation and its role in learning and memory</article-title><source>Epigenetics &amp; Chromatin</source><volume>12</volume><elocation-id>7</elocation-id><pub-id pub-id-type="doi">10.1186/s13072-018-0251-8</pub-id><pub-id pub-id-type="pmid">30616667</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Colvert</surname> <given-names>E</given-names></name><name><surname>Tick</surname> <given-names>B</given-names></name><name><surname>McEwen</surname> <given-names>F</given-names></name><name><surname>Stewart</surname> <given-names>C</given-names></name><name><surname>Curran</surname> <given-names>SR</given-names></name><name><surname>Woodhouse</surname> <given-names>E</given-names></name><name><surname>Gillan</surname> <given-names>N</given-names></name><name><surname>Hallett</surname> <given-names>V</given-names></name><name><surname>Lietz</surname> <given-names>S</given-names></name><name><surname>Garnett</surname> <given-names>T</given-names></name><name><surname>Ronald</surname> <given-names>A</given-names></name><name><surname>Plomin</surname> <given-names>R</given-names></name><name><surname>Rijsdijk</surname> <given-names>F</given-names></name><name><surname>Happé</surname> <given-names>F</given-names></name><name><surname>Bolton</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Heritability of autism spectrum disorder in a UK Population-Based twin sample</article-title><source>JAMA Psychiatry</source><volume>72</volume><fpage>415</fpage><lpage>423</lpage><pub-id pub-id-type="doi">10.1001/jamapsychiatry.2014.3028</pub-id><pub-id pub-id-type="pmid">25738232</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Crawley</surname> <given-names>JN</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Designing mouse behavioral tasks relevant to autistic-like behaviors</article-title><source>Mental Retardation and Developmental Disabilities Research Reviews</source><volume>10</volume><fpage>248</fpage><lpage>258</lpage><pub-id pub-id-type="doi">10.1002/mrdd.20039</pub-id><pub-id pub-id-type="pmid">15666335</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Crawley</surname> <given-names>JN</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Mouse behavioral assays relevant to the symptoms of autism</article-title><source>Brain Pathology</source><volume>17</volume><fpage>448</fpage><lpage>459</lpage><pub-id pub-id-type="doi">10.1111/j.1750-3639.2007.00096.x</pub-id><pub-id pub-id-type="pmid">17919130</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Crawley</surname> <given-names>JN</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Translational animal models of autism and neurodevelopmental disorders</article-title><source>Dialogues in Clinical Neuroscience</source><volume>14</volume><fpage>293</fpage><lpage>305</lpage><pub-id pub-id-type="pmid">23226954</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de la Torre-Ubieta</surname> <given-names>L</given-names></name><name><surname>Won</surname> <given-names>H</given-names></name><name><surname>Stein</surname> <given-names>JL</given-names></name><name><surname>Geschwind</surname> <given-names>DH</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Advancing the understanding of autism disease mechanisms through genetics</article-title><source>Nature Medicine</source><volume>22</volume><fpage>345</fpage><lpage>361</lpage><pub-id pub-id-type="doi">10.1038/nm.4071</pub-id><pub-id pub-id-type="pmid">27050589</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Rubeis</surname> <given-names>S</given-names></name><name><surname>He</surname> <given-names>X</given-names></name><name><surname>Goldberg</surname> <given-names>AP</given-names></name><name><surname>Poultney</surname> <given-names>CS</given-names></name><name><surname>Samocha</surname> <given-names>K</given-names></name><name><surname>Cicek</surname> <given-names>AE</given-names></name><name><surname>Kou</surname> <given-names>Y</given-names></name><name><surname>Liu</surname> <given-names>L</given-names></name><name><surname>Fromer</surname> <given-names>M</given-names></name><name><surname>Walker</surname> <given-names>S</given-names></name><name><surname>Singh</surname> <given-names>T</given-names></name><name><surname>Klei</surname> <given-names>L</given-names></name><name><surname>Kosmicki</surname> <given-names>J</given-names></name><name><surname>Shih-Chen</surname> <given-names>F</given-names></name><name><surname>Aleksic</surname> <given-names>B</given-names></name><name><surname>Biscaldi</surname> <given-names>M</given-names></name><name><surname>Bolton</surname> <given-names>PF</given-names></name><name><surname>Brownfeld</surname> <given-names>JM</given-names></name><name><surname>Cai</surname> <given-names>J</given-names></name><name><surname>Campbell</surname> <given-names>NG</given-names></name><name><surname>Carracedo</surname> <given-names>A</given-names></name><name><surname>Chahrour</surname> <given-names>MH</given-names></name><name><surname>Chiocchetti</surname> <given-names>AG</given-names></name><name><surname>Coon</surname> <given-names>H</given-names></name><name><surname>Crawford</surname> <given-names>EL</given-names></name><name><surname>Curran</surname> <given-names>SR</given-names></name><name><surname>Dawson</surname> <given-names>G</given-names></name><name><surname>Duketis</surname> <given-names>E</given-names></name><name><surname>Fernandez</surname> <given-names>BA</given-names></name><name><surname>Gallagher</surname> <given-names>L</given-names></name><name><surname>Geller</surname> <given-names>E</given-names></name><name><surname>Guter</surname> <given-names>SJ</given-names></name><name><surname>Hill</surname> <given-names>RS</given-names></name><name><surname>Ionita-Laza</surname> <given-names>J</given-names></name><name><surname>Jimenz Gonzalez</surname> <given-names>P</given-names></name><name><surname>Kilpinen</surname> <given-names>H</given-names></name><name><surname>Klauck</surname> <given-names>SM</given-names></name><name><surname>Kolevzon</surname> <given-names>A</given-names></name><name><surname>Lee</surname> <given-names>I</given-names></name><name><surname>Lei</surname> <given-names>I</given-names></name><name><surname>Lei</surname> <given-names>J</given-names></name><name><surname>Lehtimäki</surname> <given-names>T</given-names></name><name><surname>Lin</surname> <given-names>CF</given-names></name><name><surname>Ma'ayan</surname> <given-names>A</given-names></name><name><surname>Marshall</surname> <given-names>CR</given-names></name><name><surname>McInnes</surname> <given-names>AL</given-names></name><name><surname>Neale</surname> <given-names>B</given-names></name><name><surname>Owen</surname> <given-names>MJ</given-names></name><name><surname>Ozaki</surname> <given-names>N</given-names></name><name><surname>Parellada</surname> <given-names>M</given-names></name><name><surname>Parr</surname> <given-names>JR</given-names></name><name><surname>Purcell</surname> <given-names>S</given-names></name><name><surname>Puura</surname> <given-names>K</given-names></name><name><surname>Rajagopalan</surname> <given-names>D</given-names></name><name><surname>Rehnström</surname> <given-names>K</given-names></name><name><surname>Reichenberg</surname> <given-names>A</given-names></name><name><surname>Sabo</surname> <given-names>A</given-names></name><name><surname>Sachse</surname> <given-names>M</given-names></name><name><surname>Sanders</surname> <given-names>SJ</given-names></name><name><surname>Schafer</surname> <given-names>C</given-names></name><name><surname>Schulte-Rüther</surname> <given-names>M</given-names></name><name><surname>Skuse</surname> <given-names>D</given-names></name><name><surname>Stevens</surname> <given-names>C</given-names></name><name><surname>Szatmari</surname> <given-names>P</given-names></name><name><surname>Tammimies</surname> <given-names>K</given-names></name><name><surname>Valladares</surname> <given-names>O</given-names></name><name><surname>Voran</surname> <given-names>A</given-names></name><name><surname>Li-San</surname> <given-names>W</given-names></name><name><surname>Weiss</surname> <given-names>LA</given-names></name><name><surname>Willsey</surname> <given-names>AJ</given-names></name><name><surname>Yu</surname> <given-names>TW</given-names></name><name><surname>Yuen</surname> <given-names>RK</given-names></name><name><surname>Cook</surname> <given-names>EH</given-names></name><name><surname>Freitag</surname> <given-names>CM</given-names></name><name><surname>Gill</surname> <given-names>M</given-names></name><name><surname>Hultman</surname> <given-names>CM</given-names></name><name><surname>Lehner</surname> <given-names>T</given-names></name><name><surname>Palotie</surname> <given-names>A</given-names></name><name><surname>Schellenberg</surname> <given-names>GD</given-names></name><name><surname>Sklar</surname> <given-names>P</given-names></name><name><surname>State</surname> <given-names>MW</given-names></name><name><surname>Sutcliffe</surname> <given-names>JS</given-names></name><name><surname>Walsh</surname> <given-names>CA</given-names></name><name><surname>Scherer</surname> <given-names>SW</given-names></name><name><surname>Zwick</surname> <given-names>ME</given-names></name><name><surname>Barett</surname> <given-names>JC</given-names></name><name><surname>Cutler</surname> <given-names>DJ</given-names></name><name><surname>Roeder</surname> <given-names>K</given-names></name><name><surname>Devlin</surname> <given-names>B</given-names></name><name><surname>Daly</surname> <given-names>MJ</given-names></name><name><surname>Buxbaum</surname> <given-names>JD</given-names></name><collab>DDD Study</collab><collab>Homozygosity Mapping Collaborative for Autism</collab><collab>UK10K Consortium</collab></person-group><year iso-8601-date="2014">2014</year><article-title>Synaptic, transcriptional and chromatin genes disrupted in autism</article-title><source>Nature</source><volume>515</volume><fpage>209</fpage><lpage>215</lpage><pub-id pub-id-type="doi">10.1038/nature13772</pub-id><pub-id pub-id-type="pmid">25363760</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dias</surname> <given-names>CM</given-names></name><name><surname>Walsh</surname> <given-names>CA</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Recent advances in understanding the genetic architecture of autism</article-title><source>Annual Review of Genomics and Human Genetics</source><volume>21</volume><fpage>289</fpage><lpage>304</lpage><pub-id pub-id-type="doi">10.1146/annurev-genom-121219-082309</pub-id><pub-id pub-id-type="pmid">32396753</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dobin</surname> <given-names>A</given-names></name><name><surname>Davis</surname> <given-names>CA</given-names></name><name><surname>Schlesinger</surname> <given-names>F</given-names></name><name><surname>Drenkow</surname> <given-names>J</given-names></name><name><surname>Zaleski</surname> <given-names>C</given-names></name><name><surname>Jha</surname> <given-names>S</given-names></name><name><surname>Batut</surname> <given-names>P</given-names></name><name><surname>Chaisson</surname> <given-names>M</given-names></name><name><surname>Gingeras</surname> <given-names>TR</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>STAR: ultrafast universal RNA-seq aligner</article-title><source>Bioinformatics</source><volume>29</volume><fpage>15</fpage><lpage>21</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/bts635</pub-id><pub-id pub-id-type="pmid">23104886</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dong</surname> <given-names>X</given-names></name><name><surname>Shen</surname> <given-names>K</given-names></name><name><surname>Bülow</surname> <given-names>HE</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Intrinsic and extrinsic mechanisms of dendritic morphogenesis</article-title><source>Annual Review of Physiology</source><volume>77</volume><fpage>271</fpage><lpage>300</lpage><pub-id pub-id-type="doi">10.1146/annurev-physiol-021014-071746</pub-id><pub-id pub-id-type="pmid">25386991</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gandal</surname> <given-names>MJ</given-names></name><name><surname>Anderson</surname> <given-names>RL</given-names></name><name><surname>Billingslea</surname> <given-names>EN</given-names></name><name><surname>Carlson</surname> <given-names>GC</given-names></name><name><surname>Roberts</surname> <given-names>TP</given-names></name><name><surname>Siegel</surname> <given-names>SJ</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Mice with reduced NMDA receptor expression: more consistent with autism than schizophrenia?</article-title><source>Genes, Brain and Behavior</source><volume>11</volume><fpage>740</fpage><lpage>750</lpage><pub-id pub-id-type="doi">10.1111/j.1601-183X.2012.00816.x</pub-id><pub-id pub-id-type="pmid">22726567</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><collab>Genome Aggregation Database Consortium</collab><name><surname>Karczewski</surname> <given-names>KJ</given-names></name><name><surname>Francioli</surname> <given-names>LC</given-names></name><name><surname>Tiao</surname> <given-names>G</given-names></name><name><surname>Cummings</surname> <given-names>BB</given-names></name><name><surname>Alföldi</surname> <given-names>J</given-names></name><name><surname>Wang</surname> <given-names>Q</given-names></name><name><surname>Collins</surname> <given-names>RL</given-names></name><name><surname>Laricchia</surname> <given-names>KM</given-names></name><name><surname>Ganna</surname> <given-names>A</given-names></name><name><surname>Birnbaum</surname> <given-names>DP</given-names></name><name><surname>Gauthier</surname> <given-names>LD</given-names></name><name><surname>Brand</surname> <given-names>H</given-names></name><name><surname>Solomonson</surname> <given-names>M</given-names></name><name><surname>Watts</surname> <given-names>NA</given-names></name><name><surname>Rhodes</surname> <given-names>D</given-names></name><name><surname>Singer-Berk</surname> <given-names>M</given-names></name><name><surname>England</surname> <given-names>EM</given-names></name><name><surname>Seaby</surname> <given-names>EG</given-names></name><name><surname>Kosmicki</surname> <given-names>JA</given-names></name><name><surname>Walters</surname> <given-names>RK</given-names></name><name><surname>Tashman</surname> <given-names>K</given-names></name><name><surname>Farjoun</surname> <given-names>Y</given-names></name><name><surname>Banks</surname> <given-names>E</given-names></name><name><surname>Poterba</surname> <given-names>T</given-names></name><name><surname>Wang</surname> <given-names>A</given-names></name><name><surname>Seed</surname> <given-names>C</given-names></name><name><surname>Whiffin</surname> <given-names>N</given-names></name><name><surname>Chong</surname> <given-names>JX</given-names></name><name><surname>Samocha</surname> <given-names>KE</given-names></name><name><surname>Pierce-Hoffman</surname> <given-names>E</given-names></name><name><surname>Zappala</surname> <given-names>Z</given-names></name><name><surname>O'Donnell-Luria</surname> <given-names>AH</given-names></name><name><surname>Minikel</surname> <given-names>EV</given-names></name><name><surname>Weisburd</surname> <given-names>B</given-names></name><name><surname>Lek</surname> <given-names>M</given-names></name><name><surname>Ware</surname> <given-names>JS</given-names></name><name><surname>Vittal</surname> <given-names>C</given-names></name><name><surname>Armean</surname> <given-names>IM</given-names></name><name><surname>Bergelson</surname> <given-names>L</given-names></name><name><surname>Cibulskis</surname> <given-names>K</given-names></name><name><surname>Connolly</surname> <given-names>KM</given-names></name><name><surname>Covarrubias</surname> <given-names>M</given-names></name><name><surname>Donnelly</surname> <given-names>S</given-names></name><name><surname>Ferriera</surname> <given-names>S</given-names></name><name><surname>Gabriel</surname> <given-names>S</given-names></name><name><surname>Gentry</surname> <given-names>J</given-names></name><name><surname>Gupta</surname> <given-names>N</given-names></name><name><surname>Jeandet</surname> <given-names>T</given-names></name><name><surname>Kaplan</surname> <given-names>D</given-names></name><name><surname>Llanwarne</surname> <given-names>C</given-names></name><name><surname>Munshi</surname> <given-names>R</given-names></name><name><surname>Novod</surname> <given-names>S</given-names></name><name><surname>Petrillo</surname> <given-names>N</given-names></name><name><surname>Roazen</surname> <given-names>D</given-names></name><name><surname>Ruano-Rubio</surname> <given-names>V</given-names></name><name><surname>Saltzman</surname> <given-names>A</given-names></name><name><surname>Schleicher</surname> <given-names>M</given-names></name><name><surname>Soto</surname> <given-names>J</given-names></name><name><surname>Tibbetts</surname> <given-names>K</given-names></name><name><surname>Tolonen</surname> <given-names>C</given-names></name><name><surname>Wade</surname> <given-names>G</given-names></name><name><surname>Talkowski</surname> <given-names>ME</given-names></name><name><surname>Neale</surname> <given-names>BM</given-names></name><name><surname>Daly</surname> <given-names>MJ</given-names></name><name><surname>MacArthur</surname> <given-names>DG</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>The mutational constraint spectrum quantified from variation in 141,456 humans</article-title><source>Nature</source><volume>581</volume><fpage>434</fpage><lpage>443</lpage><pub-id pub-id-type="doi">10.1038/s41586-020-2308-7</pub-id><pub-id pub-id-type="pmid">32461654</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Geschwind</surname> <given-names>DH</given-names></name><name><surname>State</surname> <given-names>MW</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Gene hunting in autism spectrum disorder: on the path to precision medicine</article-title><source>The Lancet Neurology</source><volume>14</volume><fpage>1109</fpage><lpage>1120</lpage><pub-id pub-id-type="doi">10.1016/S1474-4422(15)00044-7</pub-id><pub-id pub-id-type="pmid">25891009</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guo</surname> <given-names>H</given-names></name><name><surname>Wang</surname> <given-names>T</given-names></name><name><surname>Wu</surname> <given-names>H</given-names></name><name><surname>Long</surname> <given-names>M</given-names></name><name><surname>Coe</surname> <given-names>BP</given-names></name><name><surname>Li</surname> <given-names>H</given-names></name><name><surname>Xun</surname> <given-names>G</given-names></name><name><surname>Ou</surname> <given-names>J</given-names></name><name><surname>Chen</surname> <given-names>B</given-names></name><name><surname>Duan</surname> <given-names>G</given-names></name><name><surname>Bai</surname> <given-names>T</given-names></name><name><surname>Zhao</surname> <given-names>N</given-names></name><name><surname>Shen</surname> <given-names>Y</given-names></name><name><surname>Li</surname> <given-names>Y</given-names></name><name><surname>Wang</surname> <given-names>Y</given-names></name><name><surname>Zhang</surname> <given-names>Y</given-names></name><name><surname>Baker</surname> <given-names>C</given-names></name><name><surname>Liu</surname> <given-names>Y</given-names></name><name><surname>Pang</surname> <given-names>N</given-names></name><name><surname>Huang</surname> <given-names>L</given-names></name><name><surname>Han</surname> <given-names>L</given-names></name><name><surname>Jia</surname> <given-names>X</given-names></name><name><surname>Liu</surname> <given-names>C</given-names></name><name><surname>Ni</surname> <given-names>H</given-names></name><name><surname>Yang</surname> <given-names>X</given-names></name><name><surname>Xia</surname> <given-names>L</given-names></name><name><surname>Chen</surname> <given-names>J</given-names></name><name><surname>Shen</surname> <given-names>L</given-names></name><name><surname>Li</surname> <given-names>Y</given-names></name><name><surname>Zhao</surname> <given-names>R</given-names></name><name><surname>Zhao</surname> <given-names>W</given-names></name><name><surname>Peng</surname> <given-names>J</given-names></name><name><surname>Pan</surname> <given-names>Q</given-names></name><name><surname>Long</surname> <given-names>Z</given-names></name><name><surname>Su</surname> <given-names>W</given-names></name><name><surname>Tan</surname> <given-names>J</given-names></name><name><surname>Du</surname> <given-names>X</given-names></name><name><surname>Ke</surname> <given-names>X</given-names></name><name><surname>Yao</surname> <given-names>M</given-names></name><name><surname>Hu</surname> <given-names>Z</given-names></name><name><surname>Zou</surname> <given-names>X</given-names></name><name><surname>Zhao</surname> <given-names>J</given-names></name><name><surname>Bernier</surname> <given-names>RA</given-names></name><name><surname>Eichler</surname> <given-names>EE</given-names></name><name><surname>Xia</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Inherited and multiple de novo mutations in autism/developmental delay risk genes suggest a multifactorial model</article-title><source>Molecular Autism</source><volume>9</volume><elocation-id>64</elocation-id><pub-id pub-id-type="doi">10.1186/s13229-018-0247-z</pub-id><pub-id pub-id-type="pmid">30564305</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gupta</surname> <given-names>S</given-names></name><name><surname>Kim</surname> <given-names>SY</given-names></name><name><surname>Artis</surname> <given-names>S</given-names></name><name><surname>Molfese</surname> <given-names>DL</given-names></name><name><surname>Schumacher</surname> <given-names>A</given-names></name><name><surname>Sweatt</surname> <given-names>JD</given-names></name><name><surname>Paylor</surname> <given-names>RE</given-names></name><name><surname>Lubin</surname> <given-names>FD</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Histone methylation regulates memory formation</article-title><source>Journal of Neuroscience</source><volume>30</volume><fpage>3589</fpage><lpage>3599</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.3732-09.2010</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Horton</surname> <given-names>JR</given-names></name><name><surname>Engstrom</surname> <given-names>A</given-names></name><name><surname>Zoeller</surname> <given-names>EL</given-names></name><name><surname>Liu</surname> <given-names>X</given-names></name><name><surname>Shanks</surname> <given-names>JR</given-names></name><name><surname>Zhang</surname> <given-names>X</given-names></name><name><surname>Johns</surname> <given-names>MA</given-names></name><name><surname>Vertino</surname> <given-names>PM</given-names></name><name><surname>Fu</surname> <given-names>H</given-names></name><name><surname>Cheng</surname> <given-names>X</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Characterization of a linked Jumonji domain of the KDM5/JARID1 family of histone H3 lysine 4 demethylases</article-title><source>Journal of Biological Chemistry</source><volume>291</volume><fpage>2631</fpage><lpage>2646</lpage><pub-id pub-id-type="doi">10.1074/jbc.M115.698449</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname> <given-names>DW</given-names></name><name><surname>Sherman</surname> <given-names>BT</given-names></name><name><surname>Lempicki</surname> <given-names>RA</given-names></name></person-group><year iso-8601-date="2009">2009a</year><article-title>Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources</article-title><source>Nature Protocols</source><volume>4</volume><fpage>44</fpage><lpage>57</lpage><pub-id pub-id-type="doi">10.1038/nprot.2008.211</pub-id><pub-id pub-id-type="pmid">19131956</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname> <given-names>DW</given-names></name><name><surname>Sherman</surname> <given-names>BT</given-names></name><name><surname>Lempicki</surname> <given-names>RA</given-names></name></person-group><year iso-8601-date="2009">2009b</year><article-title>Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists</article-title><source>Nucleic Acids Research</source><volume>37</volume><fpage>1</fpage><lpage>13</lpage><pub-id pub-id-type="doi">10.1093/nar/gkn923</pub-id><pub-id pub-id-type="pmid">19033363</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iossifov</surname> <given-names>I</given-names></name><name><surname>O'Roak</surname> <given-names>BJ</given-names></name><name><surname>Sanders</surname> <given-names>SJ</given-names></name><name><surname>Ronemus</surname> <given-names>M</given-names></name><name><surname>Krumm</surname> <given-names>N</given-names></name><name><surname>Levy</surname> <given-names>D</given-names></name><name><surname>Stessman</surname> <given-names>HA</given-names></name><name><surname>Witherspoon</surname> <given-names>KT</given-names></name><name><surname>Vives</surname> <given-names>L</given-names></name><name><surname>Patterson</surname> <given-names>KE</given-names></name><name><surname>Smith</surname> <given-names>JD</given-names></name><name><surname>Paeper</surname> <given-names>B</given-names></name><name><surname>Nickerson</surname> <given-names>DA</given-names></name><name><surname>Dea</surname> <given-names>J</given-names></name><name><surname>Dong</surname> <given-names>S</given-names></name><name><surname>Gonzalez</surname> <given-names>LE</given-names></name><name><surname>Mandell</surname> <given-names>JD</given-names></name><name><surname>Mane</surname> <given-names>SM</given-names></name><name><surname>Murtha</surname> <given-names>MT</given-names></name><name><surname>Sullivan</surname> <given-names>CA</given-names></name><name><surname>Walker</surname> <given-names>MF</given-names></name><name><surname>Waqar</surname> <given-names>Z</given-names></name><name><surname>Wei</surname> <given-names>L</given-names></name><name><surname>Willsey</surname> <given-names>AJ</given-names></name><name><surname>Yamrom</surname> <given-names>B</given-names></name><name><surname>Lee</surname> <given-names>YH</given-names></name><name><surname>Grabowska</surname> <given-names>E</given-names></name><name><surname>Dalkic</surname> <given-names>E</given-names></name><name><surname>Wang</surname> <given-names>Z</given-names></name><name><surname>Marks</surname> <given-names>S</given-names></name><name><surname>Andrews</surname> <given-names>P</given-names></name><name><surname>Leotta</surname> <given-names>A</given-names></name><name><surname>Kendall</surname> <given-names>J</given-names></name><name><surname>Hakker</surname> <given-names>I</given-names></name><name><surname>Rosenbaum</surname> <given-names>J</given-names></name><name><surname>Ma</surname> <given-names>B</given-names></name><name><surname>Rodgers</surname> <given-names>L</given-names></name><name><surname>Troge</surname> <given-names>J</given-names></name><name><surname>Narzisi</surname> <given-names>G</given-names></name><name><surname>Yoon</surname> <given-names>S</given-names></name><name><surname>Schatz</surname> <given-names>MC</given-names></name><name><surname>Ye</surname> <given-names>K</given-names></name><name><surname>McCombie</surname> <given-names>WR</given-names></name><name><surname>Shendure</surname> <given-names>J</given-names></name><name><surname>Eichler</surname> <given-names>EE</given-names></name><name><surname>State</surname> <given-names>MW</given-names></name><name><surname>Wigler</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>The contribution of de novo coding mutations to autism spectrum disorder</article-title><source>Nature</source><volume>515</volume><fpage>216</fpage><lpage>221</lpage><pub-id pub-id-type="doi">10.1038/nature13908</pub-id><pub-id pub-id-type="pmid">25363768</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iwase</surname> <given-names>S</given-names></name><name><surname>Brookes</surname> <given-names>E</given-names></name><name><surname>Agarwal</surname> <given-names>S</given-names></name><name><surname>Badeaux</surname> <given-names>AI</given-names></name><name><surname>Ito</surname> <given-names>H</given-names></name><name><surname>Vallianatos</surname> <given-names>CN</given-names></name><name><surname>Tomassy</surname> <given-names>GS</given-names></name><name><surname>Kasza</surname> <given-names>T</given-names></name><name><surname>Lin</surname> <given-names>G</given-names></name><name><surname>Thompson</surname> <given-names>A</given-names></name><name><surname>Gu</surname> <given-names>L</given-names></name><name><surname>Kwan</surname> <given-names>KY</given-names></name><name><surname>Chen</surname> <given-names>C</given-names></name><name><surname>Sartor</surname> <given-names>MA</given-names></name><name><surname>Egan</surname> <given-names>B</given-names></name><name><surname>Xu</surname> <given-names>J</given-names></name><name><surname>Shi</surname> <given-names>Y</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>A mouse model of X-linked intellectual disability associated with impaired removal of histone methylation</article-title><source>Cell Reports</source><volume>14</volume><fpage>1000</fpage><lpage>1009</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2015.12.091</pub-id><pub-id pub-id-type="pmid">26804915</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jensen</surname> <given-names>LR</given-names></name><name><surname>Amende</surname> <given-names>M</given-names></name><name><surname>Gurok</surname> <given-names>U</given-names></name><name><surname>Moser</surname> <given-names>B</given-names></name><name><surname>Gimmel</surname> <given-names>V</given-names></name><name><surname>Tzschach</surname> <given-names>A</given-names></name><name><surname>Janecke</surname> <given-names>AR</given-names></name><name><surname>Tariverdian</surname> <given-names>G</given-names></name><name><surname>Chelly</surname> <given-names>J</given-names></name><name><surname>Fryns</surname> <given-names>JP</given-names></name><name><surname>Van Esch</surname> <given-names>H</given-names></name><name><surname>Kleefstra</surname> <given-names>T</given-names></name><name><surname>Hamel</surname> <given-names>B</given-names></name><name><surname>Moraine</surname> <given-names>C</given-names></name><name><surname>Gecz</surname> <given-names>J</given-names></name><name><surname>Turner</surname> <given-names>G</given-names></name><name><surname>Reinhardt</surname> <given-names>R</given-names></name><name><surname>Kalscheuer</surname> <given-names>VM</given-names></name><name><surname>Ropers</surname> <given-names>HH</given-names></name><name><surname>Lenzner</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Mutations in the JARID1C gene, which is involved in transcriptional regulation and chromatin remodeling, cause X-linked mental retardation</article-title><source>The American Journal of Human Genetics</source><volume>76</volume><fpage>227</fpage><lpage>236</lpage><pub-id pub-id-type="doi">10.1086/427563</pub-id><pub-id pub-id-type="pmid">15586325</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lai</surname> <given-names>JK</given-names></name><name><surname>Sobala-Drozdowski</surname> <given-names>M</given-names></name><name><surname>Zhou</surname> <given-names>L</given-names></name><name><surname>Doering</surname> <given-names>LC</given-names></name><name><surname>Faure</surname> <given-names>PA</given-names></name><name><surname>Foster</surname> <given-names>JA</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Temporal and spectral differences in the ultrasonic vocalizations of fragile X knock out mice during postnatal development</article-title><source>Behavioural Brain Research</source><volume>259</volume><fpage>119</fpage><lpage>130</lpage><pub-id pub-id-type="doi">10.1016/j.bbr.2013.10.049</pub-id><pub-id pub-id-type="pmid">24211451</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lebrun</surname> <given-names>N</given-names></name><name><surname>Mehler-Jacob</surname> <given-names>C</given-names></name><name><surname>Poirier</surname> <given-names>K</given-names></name><name><surname>Zordan</surname> <given-names>C</given-names></name><name><surname>Lacombe</surname> <given-names>D</given-names></name><name><surname>Carion</surname> <given-names>N</given-names></name><name><surname>Billuart</surname> <given-names>P</given-names></name><name><surname>Bienvenu</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Novel KDM5B splice variants identified in patients with developmental disorders: functional consequences</article-title><source>Gene</source><volume>679</volume><fpage>305</fpage><lpage>313</lpage><pub-id pub-id-type="doi">10.1016/j.gene.2018.09.016</pub-id><pub-id pub-id-type="pmid">30217758</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname> <given-names>B</given-names></name><name><surname>Liu</surname> <given-names>DJ</given-names></name><name><surname>Leal</surname> <given-names>SM</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Identifying rare variants associated with complex traits via sequencing</article-title><source>Current Protocols in Human Genetics</source><volume>1</volume><elocation-id>26</elocation-id><pub-id pub-id-type="doi">10.1002/0471142905.hg0126s78</pub-id><pub-id pub-id-type="pmid">23853079</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liao</surname> <given-names>Y</given-names></name><name><surname>Smyth</surname> <given-names>GK</given-names></name><name><surname>Shi</surname> <given-names>W</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>featureCounts: an efficient general purpose program for assigning sequence reads to genomic features</article-title><source>Bioinformatics</source><volume>30</volume><fpage>923</fpage><lpage>930</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btt656</pub-id><pub-id pub-id-type="pmid">24227677</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Longbotham</surname> <given-names>JE</given-names></name><name><surname>Chio</surname> <given-names>CM</given-names></name><name><surname>Dharmarajan</surname> <given-names>V</given-names></name><name><surname>Trnka</surname> <given-names>MJ</given-names></name><name><surname>Torres</surname> <given-names>IO</given-names></name><name><surname>Goswami</surname> <given-names>D</given-names></name><name><surname>Ruiz</surname> <given-names>K</given-names></name><name><surname>Burlingame</surname> <given-names>AL</given-names></name><name><surname>Griffin</surname> <given-names>PR</given-names></name><name><surname>Fujimori</surname> <given-names>DG</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Histone H3 binding to the PHD1 domain of histone demethylase KDM5A enables active site remodeling</article-title><source>Nature Communications</source><volume>10</volume><elocation-id>94</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-018-07829-z</pub-id><pub-id pub-id-type="pmid">30626866</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Makrythanasis</surname> <given-names>P</given-names></name><name><surname>Maroofian</surname> <given-names>R</given-names></name><name><surname>Stray-Pedersen</surname> <given-names>A</given-names></name><name><surname>Musaev</surname> <given-names>D</given-names></name><name><surname>Zaki</surname> <given-names>MS</given-names></name><name><surname>Mahmoud</surname> <given-names>IG</given-names></name><name><surname>Selim</surname> <given-names>L</given-names></name><name><surname>Elbadawy</surname> <given-names>A</given-names></name><name><surname>Jhangiani</surname> <given-names>SN</given-names></name><name><surname>Coban Akdemir</surname> <given-names>ZH</given-names></name><name><surname>Gambin</surname> <given-names>T</given-names></name><name><surname>Sorte</surname> <given-names>HS</given-names></name><name><surname>Heiberg</surname> <given-names>A</given-names></name><name><surname>McEvoy-Venneri</surname> <given-names>J</given-names></name><name><surname>James</surname> <given-names>KN</given-names></name><name><surname>Stanley</surname> <given-names>V</given-names></name><name><surname>Belandres</surname> <given-names>D</given-names></name><name><surname>Guipponi</surname> <given-names>M</given-names></name><name><surname>Santoni</surname> <given-names>FA</given-names></name><name><surname>Ahangari</surname> <given-names>N</given-names></name><name><surname>Tara</surname> <given-names>F</given-names></name><name><surname>Doosti</surname> <given-names>M</given-names></name><name><surname>Iwaszkiewicz</surname> <given-names>J</given-names></name><name><surname>Zoete</surname> <given-names>V</given-names></name><name><surname>Backe</surname> <given-names>PH</given-names></name><name><surname>Hamamy</surname> <given-names>H</given-names></name><name><surname>Gleeson</surname> <given-names>JG</given-names></name><name><surname>Lupski</surname> <given-names>JR</given-names></name><name><surname>Karimiani</surname> <given-names>EG</given-names></name><name><surname>Antonarakis</surname> <given-names>SE</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Biallelic variants in KIF14 cause intellectual disability with microcephaly</article-title><source>European Journal of Human Genetics</source><volume>26</volume><fpage>330</fpage><lpage>339</lpage><pub-id pub-id-type="doi">10.1038/s41431-017-0088-9</pub-id><pub-id pub-id-type="pmid">29343805</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Metsalu</surname> <given-names>T</given-names></name><name><surname>Vilo</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>ClustVis: a web tool for visualizing clustering of multivariate data using principal component analysis and heatmap</article-title><source>Nucleic Acids Research</source><volume>43</volume><fpage>W566</fpage><lpage>W570</lpage><pub-id pub-id-type="doi">10.1093/nar/gkv468</pub-id><pub-id pub-id-type="pmid">25969447</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miller</surname> <given-names>JA</given-names></name><name><surname>Ding</surname> <given-names>SL</given-names></name><name><surname>Sunkin</surname> <given-names>SM</given-names></name><name><surname>Smith</surname> <given-names>KA</given-names></name><name><surname>Ng</surname> <given-names>L</given-names></name><name><surname>Szafer</surname> <given-names>A</given-names></name><name><surname>Ebbert</surname> <given-names>A</given-names></name><name><surname>Riley</surname> <given-names>ZL</given-names></name><name><surname>Royall</surname> <given-names>JJ</given-names></name><name><surname>Aiona</surname> <given-names>K</given-names></name><name><surname>Arnold</surname> <given-names>JM</given-names></name><name><surname>Bennet</surname> <given-names>C</given-names></name><name><surname>Bertagnolli</surname> <given-names>D</given-names></name><name><surname>Brouner</surname> <given-names>K</given-names></name><name><surname>Butler</surname> <given-names>S</given-names></name><name><surname>Caldejon</surname> <given-names>S</given-names></name><name><surname>Carey</surname> <given-names>A</given-names></name><name><surname>Cuhaciyan</surname> <given-names>C</given-names></name><name><surname>Dalley</surname> <given-names>RA</given-names></name><name><surname>Dee</surname> <given-names>N</given-names></name><name><surname>Dolbeare</surname> <given-names>TA</given-names></name><name><surname>Facer</surname> <given-names>BA</given-names></name><name><surname>Feng</surname> <given-names>D</given-names></name><name><surname>Fliss</surname> <given-names>TP</given-names></name><name><surname>Gee</surname> <given-names>G</given-names></name><name><surname>Goldy</surname> <given-names>J</given-names></name><name><surname>Gourley</surname> <given-names>L</given-names></name><name><surname>Gregor</surname> <given-names>BW</given-names></name><name><surname>Gu</surname> <given-names>G</given-names></name><name><surname>Howard</surname> <given-names>RE</given-names></name><name><surname>Jochim</surname> <given-names>JM</given-names></name><name><surname>Kuan</surname> <given-names>CL</given-names></name><name><surname>Lau</surname> <given-names>C</given-names></name><name><surname>Lee</surname> <given-names>CK</given-names></name><name><surname>Lee</surname> <given-names>F</given-names></name><name><surname>Lemon</surname> <given-names>TA</given-names></name><name><surname>Lesnar</surname> <given-names>P</given-names></name><name><surname>McMurray</surname> <given-names>B</given-names></name><name><surname>Mastan</surname> <given-names>N</given-names></name><name><surname>Mosqueda</surname> <given-names>N</given-names></name><name><surname>Naluai-Cecchini</surname> <given-names>T</given-names></name><name><surname>Ngo</surname> <given-names>NK</given-names></name><name><surname>Nyhus</surname> <given-names>J</given-names></name><name><surname>Oldre</surname> <given-names>A</given-names></name><name><surname>Olson</surname> <given-names>E</given-names></name><name><surname>Parente</surname> <given-names>J</given-names></name><name><surname>Parker</surname> <given-names>PD</given-names></name><name><surname>Parry</surname> <given-names>SE</given-names></name><name><surname>Stevens</surname> <given-names>A</given-names></name><name><surname>Pletikos</surname> <given-names>M</given-names></name><name><surname>Reding</surname> <given-names>M</given-names></name><name><surname>Roll</surname> <given-names>K</given-names></name><name><surname>Sandman</surname> <given-names>D</given-names></name><name><surname>Sarreal</surname> <given-names>M</given-names></name><name><surname>Shapouri</surname> <given-names>S</given-names></name><name><surname>Shapovalova</surname> <given-names>NV</given-names></name><name><surname>Shen</surname> <given-names>EH</given-names></name><name><surname>Sjoquist</surname> <given-names>N</given-names></name><name><surname>Slaughterbeck</surname> <given-names>CR</given-names></name><name><surname>Smith</surname> <given-names>M</given-names></name><name><surname>Sodt</surname> <given-names>AJ</given-names></name><name><surname>Williams</surname> <given-names>D</given-names></name><name><surname>Zöllei</surname> <given-names>L</given-names></name><name><surname>Fischl</surname> <given-names>B</given-names></name><name><surname>Gerstein</surname> <given-names>MB</given-names></name><name><surname>Geschwind</surname> <given-names>DH</given-names></name><name><surname>Glass</surname> <given-names>IA</given-names></name><name><surname>Hawrylycz</surname> <given-names>MJ</given-names></name><name><surname>Hevner</surname> <given-names>RF</given-names></name><name><surname>Huang</surname> <given-names>H</given-names></name><name><surname>Jones</surname> <given-names>AR</given-names></name><name><surname>Knowles</surname> <given-names>JA</given-names></name><name><surname>Levitt</surname> <given-names>P</given-names></name><name><surname>Phillips</surname> <given-names>JW</given-names></name><name><surname>Sestan</surname> <given-names>N</given-names></name><name><surname>Wohnoutka</surname> <given-names>P</given-names></name><name><surname>Dang</surname> <given-names>C</given-names></name><name><surname>Bernard</surname> <given-names>A</given-names></name><name><surname>Hohmann</surname> <given-names>JG</given-names></name><name><surname>Lein</surname> <given-names>ES</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Transcriptional landscape of the prenatal human brain</article-title><source>Nature</source><volume>508</volume><fpage>199</fpage><lpage>206</lpage><pub-id pub-id-type="doi">10.1038/nature13185</pub-id><pub-id pub-id-type="pmid">24695229</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mitchell</surname> <given-names>KJ</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>The genetics of neurodevelopmental disease</article-title><source>Current Opinion in Neurobiology</source><volume>21</volume><fpage>197</fpage><lpage>203</lpage><pub-id pub-id-type="doi">10.1016/j.conb.2010.08.009</pub-id><pub-id pub-id-type="pmid">20832285</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Monies</surname> <given-names>D</given-names></name><name><surname>Abouelhoda</surname> <given-names>M</given-names></name><name><surname>Assoum</surname> <given-names>M</given-names></name><name><surname>Moghrabi</surname> <given-names>N</given-names></name><name><surname>Rafiullah</surname> <given-names>R</given-names></name><name><surname>Almontashiri</surname> <given-names>N</given-names></name><name><surname>Alowain</surname> <given-names>M</given-names></name><name><surname>Alzaidan</surname> <given-names>H</given-names></name><name><surname>Alsayed</surname> <given-names>M</given-names></name><name><surname>Subhani</surname> <given-names>S</given-names></name><name><surname>Cupler</surname> <given-names>E</given-names></name><name><surname>Faden</surname> <given-names>M</given-names></name><name><surname>Alhashem</surname> <given-names>A</given-names></name><name><surname>Qari</surname> <given-names>A</given-names></name><name><surname>Chedrawi</surname> <given-names>A</given-names></name><name><surname>Aldhalaan</surname> <given-names>H</given-names></name><name><surname>Kurdi</surname> <given-names>W</given-names></name><name><surname>Khan</surname> <given-names>S</given-names></name><name><surname>Rahbeeni</surname> <given-names>Z</given-names></name><name><surname>Alotaibi</surname> <given-names>M</given-names></name><name><surname>Goljan</surname> <given-names>E</given-names></name><name><surname>Elbardisy</surname> <given-names>H</given-names></name><name><surname>ElKalioby</surname> <given-names>M</given-names></name><name><surname>Shah</surname> <given-names>Z</given-names></name><name><surname>Alruwaili</surname> <given-names>H</given-names></name><name><surname>Jaafar</surname> <given-names>A</given-names></name><name><surname>Albar</surname> <given-names>R</given-names></name><name><surname>Akilan</surname> <given-names>A</given-names></name><name><surname>Tayeb</surname> <given-names>H</given-names></name><name><surname>Tahir</surname> <given-names>A</given-names></name><name><surname>Fawzy</surname> <given-names>M</given-names></name><name><surname>Nasr</surname> <given-names>M</given-names></name><name><surname>Makki</surname> <given-names>S</given-names></name><name><surname>Alfaifi</surname> <given-names>A</given-names></name><name><surname>Akleh</surname> <given-names>H</given-names></name><name><surname>Yamani</surname> <given-names>S</given-names></name><name><surname>Bubshait</surname> <given-names>D</given-names></name><name><surname>Mahnashi</surname> <given-names>M</given-names></name><name><surname>Basha</surname> <given-names>T</given-names></name><name><surname>Alsagheir</surname> <given-names>A</given-names></name><name><surname>Abu Khaled</surname> <given-names>M</given-names></name><name><surname>Alsaleem</surname> <given-names>K</given-names></name><name><surname>Almugbel</surname> <given-names>M</given-names></name><name><surname>Badawi</surname> <given-names>M</given-names></name><name><surname>Bashiri</surname> <given-names>F</given-names></name><name><surname>Bohlega</surname> <given-names>S</given-names></name><name><surname>Sulaiman</surname> <given-names>R</given-names></name><name><surname>Tous</surname> <given-names>E</given-names></name><name><surname>Ahmed</surname> <given-names>S</given-names></name><name><surname>Algoufi</surname> <given-names>T</given-names></name><name><surname>Al-Mousa</surname> <given-names>H</given-names></name><name><surname>Alaki</surname> <given-names>E</given-names></name><name><surname>Alhumaidi</surname> <given-names>S</given-names></name><name><surname>Alghamdi</surname> <given-names>H</given-names></name><name><surname>Alghamdi</surname> <given-names>M</given-names></name><name><surname>Sahly</surname> <given-names>A</given-names></name><name><surname>Nahrir</surname> <given-names>S</given-names></name><name><surname>Al-Ahmari</surname> <given-names>A</given-names></name><name><surname>Alkuraya</surname> <given-names>H</given-names></name><name><surname>Almehaidib</surname> <given-names>A</given-names></name><name><surname>Abanemai</surname> <given-names>M</given-names></name><name><surname>Alsohaibaini</surname> <given-names>F</given-names></name><name><surname>Alsaud</surname> <given-names>B</given-names></name><name><surname>Arnaout</surname> <given-names>R</given-names></name><name><surname>Abdel-Salam</surname> <given-names>GMH</given-names></name><name><surname>Aldhekri</surname> <given-names>H</given-names></name><name><surname>AlKhater</surname> <given-names>S</given-names></name><name><surname>Alqadi</surname> <given-names>K</given-names></name><name><surname>Alsabban</surname> <given-names>E</given-names></name><name><surname>Alshareef</surname> <given-names>T</given-names></name><name><surname>Awartani</surname> <given-names>K</given-names></name><name><surname>Banjar</surname> <given-names>H</given-names></name><name><surname>Alsahan</surname> <given-names>N</given-names></name><name><surname>Abosoudah</surname> <given-names>I</given-names></name><name><surname>Alashwal</surname> <given-names>A</given-names></name><name><surname>Aldekhail</surname> <given-names>W</given-names></name><name><surname>Alhajjar</surname> <given-names>S</given-names></name><name><surname>Al-Mayouf</surname> <given-names>S</given-names></name><name><surname>Alsemari</surname> <given-names>A</given-names></name><name><surname>Alshuaibi</surname> <given-names>W</given-names></name><name><surname>Altala</surname> <given-names>S</given-names></name><name><surname>Altalhi</surname> <given-names>A</given-names></name><name><surname>Baz</surname> <given-names>S</given-names></name><name><surname>Hamad</surname> <given-names>M</given-names></name><name><surname>Abalkhail</surname> <given-names>T</given-names></name><name><surname>Alenazi</surname> <given-names>B</given-names></name><name><surname>Alkaff</surname> <given-names>A</given-names></name><name><surname>Almohareb</surname> <given-names>F</given-names></name><name><surname>Al Mutairi</surname> <given-names>F</given-names></name><name><surname>Alsaleh</surname> <given-names>M</given-names></name><name><surname>Alsonbul</surname> <given-names>A</given-names></name><name><surname>Alzelaye</surname> <given-names>S</given-names></name><name><surname>Bahzad</surname> <given-names>S</given-names></name><name><surname>Manee</surname> <given-names>AB</given-names></name><name><surname>Jarrad</surname> <given-names>O</given-names></name><name><surname>Meriki</surname> <given-names>N</given-names></name><name><surname>Albeirouti</surname> <given-names>B</given-names></name><name><surname>Alqasmi</surname> <given-names>A</given-names></name><name><surname>AlBalwi</surname> <given-names>M</given-names></name><name><surname>Makhseed</surname> <given-names>N</given-names></name><name><surname>Hassan</surname> <given-names>S</given-names></name><name><surname>Salih</surname> <given-names>I</given-names></name><name><surname>Salih</surname> <given-names>MA</given-names></name><name><surname>Shaheen</surname> <given-names>M</given-names></name><name><surname>Sermin</surname> <given-names>S</given-names></name><name><surname>Shahrukh</surname> <given-names>S</given-names></name><name><surname>Hashmi</surname> <given-names>S</given-names></name><name><surname>Shawli</surname> <given-names>A</given-names></name><name><surname>Tajuddin</surname> <given-names>A</given-names></name><name><surname>Tamim</surname> <given-names>A</given-names></name><name><surname>Alnahari</surname> <given-names>A</given-names></name><name><surname>Ghemlas</surname> <given-names>I</given-names></name><name><surname>Hussein</surname> <given-names>M</given-names></name><name><surname>Wali</surname> <given-names>S</given-names></name><name><surname>Murad</surname> <given-names>H</given-names></name><name><surname>Meyer</surname> <given-names>BF</given-names></name><name><surname>Alkuraya</surname> <given-names>FS</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Lessons learned from Large-Scale, First-Tier clinical exome sequencing in a highly consanguineous population</article-title><source>The American Journal of Human Genetics</source><volume>104</volume><fpage>1182</fpage><lpage>1201</lpage><pub-id pub-id-type="doi">10.1016/j.ajhg.2019.04.011</pub-id><pub-id pub-id-type="pmid">31130284</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Najmabadi</surname> <given-names>H</given-names></name><name><surname>Hu</surname> <given-names>H</given-names></name><name><surname>Garshasbi</surname> <given-names>M</given-names></name><name><surname>Zemojtel</surname> <given-names>T</given-names></name><name><surname>Abedini</surname> <given-names>SS</given-names></name><name><surname>Chen</surname> <given-names>W</given-names></name><name><surname>Hosseini</surname> <given-names>M</given-names></name><name><surname>Behjati</surname> <given-names>F</given-names></name><name><surname>Haas</surname> <given-names>S</given-names></name><name><surname>Jamali</surname> <given-names>P</given-names></name><name><surname>Zecha</surname> <given-names>A</given-names></name><name><surname>Mohseni</surname> <given-names>M</given-names></name><name><surname>Püttmann</surname> <given-names>L</given-names></name><name><surname>Vahid</surname> <given-names>LN</given-names></name><name><surname>Jensen</surname> <given-names>C</given-names></name><name><surname>Moheb</surname> <given-names>LA</given-names></name><name><surname>Bienek</surname> <given-names>M</given-names></name><name><surname>Larti</surname> <given-names>F</given-names></name><name><surname>Mueller</surname> <given-names>I</given-names></name><name><surname>Weissmann</surname> <given-names>R</given-names></name><name><surname>Darvish</surname> <given-names>H</given-names></name><name><surname>Wrogemann</surname> <given-names>K</given-names></name><name><surname>Hadavi</surname> <given-names>V</given-names></name><name><surname>Lipkowitz</surname> <given-names>B</given-names></name><name><surname>Esmaeeli-Nieh</surname> <given-names>S</given-names></name><name><surname>Wieczorek</surname> <given-names>D</given-names></name><name><surname>Kariminejad</surname> <given-names>R</given-names></name><name><surname>Firouzabadi</surname> <given-names>SG</given-names></name><name><surname>Cohen</surname> <given-names>M</given-names></name><name><surname>Fattahi</surname> <given-names>Z</given-names></name><name><surname>Rost</surname> <given-names>I</given-names></name><name><surname>Mojahedi</surname> <given-names>F</given-names></name><name><surname>Hertzberg</surname> <given-names>C</given-names></name><name><surname>Dehghan</surname> <given-names>A</given-names></name><name><surname>Rajab</surname> <given-names>A</given-names></name><name><surname>Banavandi</surname> <given-names>MJ</given-names></name><name><surname>Hoffer</surname> <given-names>J</given-names></name><name><surname>Falah</surname> <given-names>M</given-names></name><name><surname>Musante</surname> <given-names>L</given-names></name><name><surname>Kalscheuer</surname> <given-names>V</given-names></name><name><surname>Ullmann</surname> <given-names>R</given-names></name><name><surname>Kuss</surname> <given-names>AW</given-names></name><name><surname>Tzschach</surname> <given-names>A</given-names></name><name><surname>Kahrizi</surname> <given-names>K</given-names></name><name><surname>Ropers</surname> <given-names>HH</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Deep sequencing reveals 50 novel genes for recessive cognitive disorders</article-title><source>Nature</source><volume>478</volume><fpage>57</fpage><lpage>63</lpage><pub-id pub-id-type="doi">10.1038/nature10423</pub-id><pub-id pub-id-type="pmid">21937992</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Niki</surname> <given-names>T</given-names></name><name><surname>Takahashi-Niki</surname> <given-names>K</given-names></name><name><surname>Taira</surname> <given-names>T</given-names></name><name><surname>Iguchi-Ariga</surname> <given-names>SM</given-names></name><name><surname>Ariga</surname> <given-names>H</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>DJBP: a novel DJ-1-binding protein, negatively regulates the androgen receptor by recruiting histone deacetylase complex, and DJ-1 antagonizes this inhibition by abrogation of this complex</article-title><source>Molecular Cancer Research : MCR</source><volume>1</volume><fpage>247</fpage><lpage>261</lpage><pub-id pub-id-type="pmid">12612053</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O'Roak</surname> <given-names>BJ</given-names></name><name><surname>Vives</surname> <given-names>L</given-names></name><name><surname>Girirajan</surname> <given-names>S</given-names></name><name><surname>Karakoc</surname> <given-names>E</given-names></name><name><surname>Krumm</surname> <given-names>N</given-names></name><name><surname>Coe</surname> <given-names>BP</given-names></name><name><surname>Levy</surname> <given-names>R</given-names></name><name><surname>Ko</surname> <given-names>A</given-names></name><name><surname>Lee</surname> <given-names>C</given-names></name><name><surname>Smith</surname> <given-names>JD</given-names></name><name><surname>Turner</surname> <given-names>EH</given-names></name><name><surname>Stanaway</surname> <given-names>IB</given-names></name><name><surname>Vernot</surname> <given-names>B</given-names></name><name><surname>Malig</surname> <given-names>M</given-names></name><name><surname>Baker</surname> <given-names>C</given-names></name><name><surname>Reilly</surname> <given-names>B</given-names></name><name><surname>Akey</surname> <given-names>JM</given-names></name><name><surname>Borenstein</surname> <given-names>E</given-names></name><name><surname>Rieder</surname> <given-names>MJ</given-names></name><name><surname>Nickerson</surname> <given-names>DA</given-names></name><name><surname>Bernier</surname> <given-names>R</given-names></name><name><surname>Shendure</surname> <given-names>J</given-names></name><name><surname>Eichler</surname> <given-names>EE</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations</article-title><source>Nature</source><volume>485</volume><fpage>246</fpage><lpage>250</lpage><pub-id pub-id-type="doi">10.1038/nature10989</pub-id><pub-id pub-id-type="pmid">22495309</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pilka</surname> <given-names>ES</given-names></name><name><surname>James</surname> <given-names>T</given-names></name><name><surname>Lisztwan</surname> <given-names>JH</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Structural definitions of Jumonji family demethylase selectivity</article-title><source>Drug Discovery Today</source><volume>20</volume><fpage>743</fpage><lpage>749</lpage><pub-id pub-id-type="doi">10.1016/j.drudis.2014.12.013</pub-id><pub-id pub-id-type="pmid">25555749</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Portfors</surname> <given-names>CV</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Types and functions of ultrasonic vocalizations in laboratory rats and mice</article-title><source>Journal of the American Association for Laboratory Animal Science : JAALAS</source><volume>46</volume><fpage>28</fpage><lpage>34</lpage><pub-id pub-id-type="pmid">17203913</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Richardson</surname> <given-names>CD</given-names></name><name><surname>Ray</surname> <given-names>GJ</given-names></name><name><surname>DeWitt</surname> <given-names>MA</given-names></name><name><surname>Curie</surname> <given-names>GL</given-names></name><name><surname>Corn</surname> <given-names>JE</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Enhancing homology-directed genome editing by catalytically active and inactive CRISPR-Cas9 using asymmetric donor DNA</article-title><source>Nature Biotechnology</source><volume>34</volume><fpage>339</fpage><lpage>344</lpage><pub-id pub-id-type="doi">10.1038/nbt.3481</pub-id><pub-id pub-id-type="pmid">26789497</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robinson</surname> <given-names>MD</given-names></name><name><surname>McCarthy</surname> <given-names>DJ</given-names></name><name><surname>Smyth</surname> <given-names>GK</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>edgeR: a Bioconductor package for differential expression analysis of digital gene expression data</article-title><source>Bioinformatics</source><volume>26</volume><fpage>139</fpage><lpage>140</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btp616</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scattoni</surname> <given-names>ML</given-names></name><name><surname>Crawley</surname> <given-names>J</given-names></name><name><surname>Ricceri</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Ultrasonic vocalizations: a tool for behavioural phenotyping of mouse models of neurodevelopmental disorders</article-title><source>Neuroscience &amp; Biobehavioral Reviews</source><volume>33</volume><fpage>508</fpage><lpage>515</lpage><pub-id pub-id-type="doi">10.1016/j.neubiorev.2008.08.003</pub-id><pub-id pub-id-type="pmid">18771687</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schindelin</surname> <given-names>J</given-names></name><name><surname>Arganda-Carreras</surname> <given-names>I</given-names></name><name><surname>Frise</surname> <given-names>E</given-names></name><name><surname>Kaynig</surname> <given-names>V</given-names></name><name><surname>Longair</surname> <given-names>M</given-names></name><name><surname>Pietzsch</surname> <given-names>T</given-names></name><name><surname>Preibisch</surname> <given-names>S</given-names></name><name><surname>Rueden</surname> <given-names>C</given-names></name><name><surname>Saalfeld</surname> <given-names>S</given-names></name><name><surname>Schmid</surname> <given-names>B</given-names></name><name><surname>Tinevez</surname> <given-names>JY</given-names></name><name><surname>White</surname> <given-names>DJ</given-names></name><name><surname>Hartenstein</surname> <given-names>V</given-names></name><name><surname>Eliceiri</surname> <given-names>K</given-names></name><name><surname>Tomancak</surname> <given-names>P</given-names></name><name><surname>Cardona</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Fiji: an open-source platform for biological-image analysis</article-title><source>Nature Methods</source><volume>9</volume><fpage>676</fpage><lpage>682</lpage><pub-id pub-id-type="doi">10.1038/nmeth.2019</pub-id><pub-id pub-id-type="pmid">22743772</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shen</surname> <given-names>H</given-names></name><name><surname>Xu</surname> <given-names>W</given-names></name><name><surname>Lan</surname> <given-names>F</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Histone lysine demethylases in mammalian embryonic development</article-title><source>Experimental &amp; Molecular Medicine</source><volume>49</volume><elocation-id>e325</elocation-id><pub-id pub-id-type="doi">10.1038/emm.2017.57</pub-id><pub-id pub-id-type="pmid">28450736</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname> <given-names>CM</given-names></name><name><surname>Hayamizu</surname> <given-names>TF</given-names></name><name><surname>Finger</surname> <given-names>JH</given-names></name><name><surname>Bello</surname> <given-names>SM</given-names></name><name><surname>McCright</surname> <given-names>IJ</given-names></name><name><surname>Xu</surname> <given-names>J</given-names></name><name><surname>Baldarelli</surname> <given-names>RM</given-names></name><name><surname>Beal</surname> <given-names>JS</given-names></name><name><surname>Campbell</surname> <given-names>J</given-names></name><name><surname>Corbani</surname> <given-names>LE</given-names></name><name><surname>Frost</surname> <given-names>PJ</given-names></name><name><surname>Lewis</surname> <given-names>JR</given-names></name><name><surname>Giannatto</surname> <given-names>SC</given-names></name><name><surname>Miers</surname> <given-names>D</given-names></name><name><surname>Shaw</surname> <given-names>DR</given-names></name><name><surname>Kadin</surname> <given-names>JA</given-names></name><name><surname>Richardson</surname> <given-names>JE</given-names></name><name><surname>Smith</surname> <given-names>CL</given-names></name><name><surname>Ringwald</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>The mouse gene expression database (GXD): 2019 update</article-title><source>Nucleic Acids Research</source><volume>47</volume><fpage>D774</fpage><lpage>D779</lpage><pub-id pub-id-type="doi">10.1093/nar/gky922</pub-id><pub-id pub-id-type="pmid">30335138</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sobreira</surname> <given-names>N</given-names></name><name><surname>Schiettecatte</surname> <given-names>F</given-names></name><name><surname>Valle</surname> <given-names>D</given-names></name><name><surname>Hamosh</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>GeneMatcher: a matching tool for connecting investigators with an interest in the same gene</article-title><source>Human Mutation</source><volume>36</volume><fpage>928</fpage><lpage>930</lpage><pub-id pub-id-type="doi">10.1002/humu.22844</pub-id><pub-id pub-id-type="pmid">26220891</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Supek</surname> <given-names>F</given-names></name><name><surname>Bošnjak</surname> <given-names>M</given-names></name><name><surname>Škunca</surname> <given-names>N</given-names></name><name><surname>Šmuc</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>REVIGO summarizes and visualizes long lists of gene ontology terms</article-title><source>PLOS ONE</source><volume>6</volume><elocation-id>e21800</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0021800</pub-id><pub-id pub-id-type="pmid">21789182</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taniguchi</surname> <given-names>H</given-names></name><name><surname>Mohri</surname> <given-names>I</given-names></name><name><surname>Okabe-Arahori</surname> <given-names>H</given-names></name><name><surname>Aritake</surname> <given-names>K</given-names></name><name><surname>Wada</surname> <given-names>K</given-names></name><name><surname>Kanekiyo</surname> <given-names>T</given-names></name><name><surname>Narumiya</surname> <given-names>S</given-names></name><name><surname>Nakayama</surname> <given-names>M</given-names></name><name><surname>Ozono</surname> <given-names>K</given-names></name><name><surname>Urade</surname> <given-names>Y</given-names></name><name><surname>Taniike</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Prostaglandin D2 protects neonatal mouse brain from hypoxic ischemic injury</article-title><source>Journal of Neuroscience</source><volume>27</volume><fpage>4303</fpage><lpage>4312</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.0321-07.2007</pub-id><pub-id pub-id-type="pmid">17442814</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Torres</surname> <given-names>IO</given-names></name><name><surname>Kuchenbecker</surname> <given-names>KM</given-names></name><name><surname>Nnadi</surname> <given-names>CI</given-names></name><name><surname>Fletterick</surname> <given-names>RJ</given-names></name><name><surname>Kelly</surname> <given-names>MJ</given-names></name><name><surname>Fujimori</surname> <given-names>DG</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Histone demethylase KDM5A is regulated by its reader domain through a positive-feedback mechanism</article-title><source>Nature Communications</source><volume>6</volume><elocation-id>6204</elocation-id><pub-id pub-id-type="doi">10.1038/ncomms7204</pub-id><pub-id pub-id-type="pmid">25686748</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Turner</surname> <given-names>TN</given-names></name><name><surname>Hormozdiari</surname> <given-names>F</given-names></name><name><surname>Duyzend</surname> <given-names>MH</given-names></name><name><surname>McClymont</surname> <given-names>SA</given-names></name><name><surname>Hook</surname> <given-names>PW</given-names></name><name><surname>Iossifov</surname> <given-names>I</given-names></name><name><surname>Raja</surname> <given-names>A</given-names></name><name><surname>Baker</surname> <given-names>C</given-names></name><name><surname>Hoekzema</surname> <given-names>K</given-names></name><name><surname>Stessman</surname> <given-names>HA</given-names></name><name><surname>Zody</surname> <given-names>MC</given-names></name><name><surname>Nelson</surname> <given-names>BJ</given-names></name><name><surname>Huddleston</surname> <given-names>J</given-names></name><name><surname>Sandstrom</surname> <given-names>R</given-names></name><name><surname>Smith</surname> <given-names>JD</given-names></name><name><surname>Hanna</surname> <given-names>D</given-names></name><name><surname>Swanson</surname> <given-names>JM</given-names></name><name><surname>Faustman</surname> <given-names>EM</given-names></name><name><surname>Bamshad</surname> <given-names>MJ</given-names></name><name><surname>Stamatoyannopoulos</surname> <given-names>J</given-names></name><name><surname>Nickerson</surname> <given-names>DA</given-names></name><name><surname>McCallion</surname> <given-names>AS</given-names></name><name><surname>Darnell</surname> <given-names>R</given-names></name><name><surname>Eichler</surname> <given-names>EE</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Genome sequencing of Autism-Affected families reveals disruption of putative noncoding regulatory DNA</article-title><source>The American Journal of Human Genetics</source><volume>98</volume><fpage>58</fpage><lpage>74</lpage><pub-id pub-id-type="doi">10.1016/j.ajhg.2015.11.023</pub-id><pub-id pub-id-type="pmid">26749308</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vallianatos</surname> <given-names>CN</given-names></name><name><surname>Farrehi</surname> <given-names>C</given-names></name><name><surname>Friez</surname> <given-names>MJ</given-names></name><name><surname>Burmeister</surname> <given-names>M</given-names></name><name><surname>Keegan</surname> <given-names>CE</given-names></name><name><surname>Iwase</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Altered Gene-Regulatory function of KDM5C by a novel mutation associated with autism and intellectual disability</article-title><source>Frontiers in Molecular Neuroscience</source><volume>11</volume><elocation-id>104</elocation-id><pub-id pub-id-type="doi">10.3389/fnmol.2018.00104</pub-id><pub-id pub-id-type="pmid">29670509</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vallianatos</surname> <given-names>CN</given-names></name><name><surname>Iwase</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Disrupted intricacy of histone H3K4 methylation in neurodevelopmental disorders</article-title><source>Epigenomics</source><volume>7</volume><fpage>503</fpage><lpage>519</lpage><pub-id pub-id-type="doi">10.2217/epi.15.1</pub-id><pub-id pub-id-type="pmid">26077434</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname> <given-names>T</given-names></name><name><surname>Zhan</surname> <given-names>X</given-names></name><name><surname>Bu</surname> <given-names>CH</given-names></name><name><surname>Lyon</surname> <given-names>S</given-names></name><name><surname>Pratt</surname> <given-names>D</given-names></name><name><surname>Hildebrand</surname> <given-names>S</given-names></name><name><surname>Choi</surname> <given-names>JH</given-names></name><name><surname>Zhang</surname> <given-names>Z</given-names></name><name><surname>Zeng</surname> <given-names>M</given-names></name><name><surname>Wang</surname> <given-names>KW</given-names></name><name><surname>Turer</surname> <given-names>E</given-names></name><name><surname>Chen</surname> <given-names>Z</given-names></name><name><surname>Zhang</surname> <given-names>D</given-names></name><name><surname>Yue</surname> <given-names>T</given-names></name><name><surname>Wang</surname> <given-names>Y</given-names></name><name><surname>Shi</surname> <given-names>H</given-names></name><name><surname>Wang</surname> <given-names>J</given-names></name><name><surname>Sun</surname> <given-names>L</given-names></name><name><surname>SoRelle</surname> <given-names>J</given-names></name><name><surname>McAlpine</surname> <given-names>W</given-names></name><name><surname>Hutchins</surname> <given-names>N</given-names></name><name><surname>Zhan</surname> <given-names>X</given-names></name><name><surname>Fina</surname> <given-names>M</given-names></name><name><surname>Gobert</surname> <given-names>R</given-names></name><name><surname>Quan</surname> <given-names>J</given-names></name><name><surname>Kreutzer</surname> <given-names>M</given-names></name><name><surname>Arnett</surname> <given-names>S</given-names></name><name><surname>Hawkins</surname> <given-names>K</given-names></name><name><surname>Leach</surname> <given-names>A</given-names></name><name><surname>Tate</surname> <given-names>C</given-names></name><name><surname>Daniel</surname> <given-names>C</given-names></name><name><surname>Reyna</surname> <given-names>C</given-names></name><name><surname>Prince</surname> <given-names>L</given-names></name><name><surname>Davis</surname> <given-names>S</given-names></name><name><surname>Purrington</surname> <given-names>J</given-names></name><name><surname>Bearden</surname> <given-names>R</given-names></name><name><surname>Weatherly</surname> <given-names>J</given-names></name><name><surname>White</surname> <given-names>D</given-names></name><name><surname>Russell</surname> <given-names>J</given-names></name><name><surname>Sun</surname> <given-names>Q</given-names></name><name><surname>Tang</surname> <given-names>M</given-names></name><name><surname>Li</surname> <given-names>X</given-names></name><name><surname>Scott</surname> <given-names>L</given-names></name><name><surname>Moresco</surname> <given-names>EM</given-names></name><name><surname>McInerney</surname> <given-names>GM</given-names></name><name><surname>Karlsson Hedestam</surname> <given-names>GB</given-names></name><name><surname>Xie</surname> <given-names>Y</given-names></name><name><surname>Beutler</surname> <given-names>B</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Real-time resolution of point mutations that cause phenovariance in mice</article-title><source>PNAS</source><volume>112</volume><fpage>E440</fpage><lpage>E449</lpage><pub-id pub-id-type="doi">10.1073/pnas.1423216112</pub-id><pub-id pub-id-type="pmid">25605905</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Webb</surname> <given-names>WM</given-names></name><name><surname>Sanchez</surname> <given-names>RG</given-names></name><name><surname>Perez</surname> <given-names>G</given-names></name><name><surname>Butler</surname> <given-names>AA</given-names></name><name><surname>Hauser</surname> <given-names>RM</given-names></name><name><surname>Rich</surname> <given-names>MC</given-names></name><name><surname>O'Bierne</surname> <given-names>AL</given-names></name><name><surname>Jarome</surname> <given-names>TJ</given-names></name><name><surname>Lubin</surname> <given-names>FD</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Dynamic association of epigenetic H3K4me3 and DNA 5hmc marks in the dorsal Hippocampus and anterior cingulate cortex following reactivation of a fear memory</article-title><source>Neurobiology of Learning and Memory</source><volume>142</volume><fpage>66</fpage><lpage>78</lpage><pub-id pub-id-type="doi">10.1016/j.nlm.2017.02.010</pub-id><pub-id pub-id-type="pmid">28232238</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yao</surname> <given-names>PJ</given-names></name><name><surname>Petralia</surname> <given-names>RS</given-names></name><name><surname>Ott</surname> <given-names>C</given-names></name><name><surname>Wang</surname> <given-names>Y-X</given-names></name><name><surname>Lippincott-Schwartz</surname> <given-names>J</given-names></name><name><surname>Mattson</surname> <given-names>MP</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Dendrosomatic sonic hedgehog signaling in hippocampal neurons regulates axon elongation</article-title><source>Journal of Neuroscience</source><volume>35</volume><fpage>16126</fpage><lpage>16141</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.1360-15.2015</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yao</surname> <given-names>PJ</given-names></name><name><surname>Petralia</surname> <given-names>RS</given-names></name><name><surname>Mattson</surname> <given-names>MP</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Sonic hedgehog signaling and hippocampal neuroplasticity</article-title><source>Trends in Neurosciences</source><volume>39</volume><fpage>840</fpage><lpage>850</lpage><pub-id pub-id-type="doi">10.1016/j.tins.2016.10.001</pub-id><pub-id pub-id-type="pmid">27865563</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zaqout</surname> <given-names>S</given-names></name><name><surname>Kaindl</surname> <given-names>AM</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Golgi-Cox staining step by step</article-title><source>Frontiers in Neuroanatomy</source><volume>10</volume><elocation-id>38</elocation-id><pub-id pub-id-type="doi">10.3389/fnana.2016.00038</pub-id><pub-id pub-id-type="pmid">27065817</pub-id></element-citation></ref></ref-list></back><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.56883.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group><contrib contrib-type="editor"><name><surname>Brose</surname><given-names>Nils</given-names></name><role>Reviewing Editor</role><aff><institution>Max Planck Institute of Experimental Medicine</institution><country>Germany</country></aff></contrib></contrib-group><contrib-group><contrib contrib-type="reviewer"><name><surname>Ehrenreich</surname><given-names>Hannelore</given-names> </name><role>Reviewer</role><aff><institution>Max Planck Institute of Experimental Medicine</institution><country>Germany</country></aff></contrib></contrib-group></front-stub><body><boxed-text><p>In the interests of transparency, eLife publishes the most substantive revision requests and the accompanying author responses.</p></boxed-text><p><bold>Acceptance summary:</bold></p><p>El Hayek and colleagues pursued an elegant forward genetics screening approach to identify <italic>KDM5A</italic>, which encodes a histone lysine demethylase, as a possible autism-spectrum-disorder-related gene. The study provides interesting new information on the genetic background of neurodevelopmental disorders and represents a valuable contribution to the field of neuropsychiatric genetics.</p><p><bold>Decision letter after peer review:</bold></p><p>Thank you for submitting your article &quot;<italic>KDM5A</italic> mutations identified in autism spectrum disorder using forward genetics&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by two peer reviewers, and the evaluation has been overseen by a Reviewing Editor and Huda Zoghbi as the Senior Editor. The following individual involved in review of your submission has agreed to reveal their identity: Hannelore Ehrenreich (Reviewer #1).</p><p>The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.</p><p>As the editors have judged that your manuscript is of interest, but as described below that additional experiments are required before it is published, we would like to draw your attention to changes in our revision policy that we have made in response to COVID-19 (https://elifesciences.org/articles/57162). First, because many researchers have temporarily lost access to the labs, we will give authors as much time as they need to submit revised manuscripts. We are also offering, if you choose, to post the manuscript to bioRxiv (if it is not already there) along with this decision letter and a formal designation that the manuscript is &quot;in revision at <italic>eLife</italic>&quot;. Please let us know if you would like to pursue this option. (If your work is more suitable for medRxiv, you will need to post the preprint yourself, as the mechanisms for us to do so are still in development.)</p><p>Summary:</p><p>El Hayek employed a forward genetics approach in mice to identify <italic>Kdm5a</italic> as a candidate ASD gene. Behavioral analysis of carriers of the mutation revealed altered ultrasonic vocalization (USV) along with impaired nest-building behavior, as known behavioral features of ASD mouse models. Constitutive genetic ablation of <italic>Kdm5a</italic> (<italic>Kdm5a</italic><sup>-/-</sup> or KO) confirmed the physiological relevance of the gene with respect to vocalization. The observed increased clasping in a modified version of the tail suspension test is interpreted as a measure of stereotypic behavior. Hippocampal transcripts of WT and KO mice were assessed and compared to each other, resulting in a total of 450 dysregulated genes in KO mice, of which 191 were up- and 259 downregulated. The latter were mostly associated with neurogenesis and cell proliferation, while upregulated genes largely reflected genes related to RNA splicing and neurological processes. The findings of this manuscript point to <italic>Kdm5a</italic> as a possible candidate gene for neurodevelopmental disorders.</p><p>All reviewers agree that your identification of <italic>KDM5A</italic> as a possible ASD-related gene has been elegantly conducted and that your study provides interesting new information on the genetic background of neurodevelopmental disorders. The reviewers support ultimate publication of your study in <italic>eLife</italic>, but a series of issues need to be addressed before a final decision can be made.</p><p>Essential revisions:</p><p>Behavioral Testing</p><p>1) A general issue is that only very few ASD-specific behavioral tests were conducted; social behavior was not tested systematically, and neither was cognitive performance. In view of these limitations, the current dataset indicates a role of <italic>KDM5A</italic> variants in a general and as yet undefined neurodevelopmental disorder rather than ASD specifically. This notion is not contradicted by the fact that pathogenic <italic>KDM5A</italic> variants are detected in patients with ASD since other genetic variations or even non-genetic causes may have contributed to the clinical picture, which resembles a neurodevelopmental syndrome with autistic features.</p><p>2) Throughout all mouse studies, inconsistent and often problematically low numbers of animals of different genotypes (WT vs. Het vs. KO) for behavioral and particularly statistical analysis are used (e.g. Figure 2—figure supplements 1 and 2). Here, additional experiments are necessary to bolster the statistics.</p><p>3) In the linkage analysis for maximum peak frequency of USV and nesting score (Figure 1), the authors used only 3 KO (Mut) mice, while using 17 WT and 24 Het mice. It is unclear whether a low number of KO mice (n=3) is sufficiently representative in this approach or may possibly cause an analytical misrepresentation. This needs to be rectified.</p><p>The issues mentioned above (1-3) need to be addressed to bolster the notion of <italic>KDM5A</italic> variants being involved in an as yet undefined neurodevelopmental disorder.</p><p>4) If a specific link to ASD is to be made, more experiments are necessary:</p><p>– The tail suspension test does not apply to the measurement of repetitive and/or stereotypic phenotypes. Alternative assays for repetitive and/or stereotypic phenotypes (e.g. marble burying tests, standardized observation of grooming, circling behavior) should be performed.</p><p>– The clasping assay reads out multiple features, including central paresis, and its usefulness and specificity as a reliable measure of stereotypic behavior in ASD mouse models is questionable. The authors refer to Chao et al., 2010, in this regard, but the respective reference in this article is not obvious. This needs to be clarified.</p><p>– The authors only performed a very limited set of assays that assess ASD-related behavior. A more detailed analysis of ASD-related behavioral features is required, most importantly social interaction/preference (e.g. in tripartite chamber).</p><p>– Given that <italic>KDM5A</italic> function is thought to be associated with memory formation and retrieval, tests for cognitive disabilities (spatial learning, working memory, object memory, social memory) should be performed – for 'differential diagnosis'.</p><p>The experiments summarized under (4) would not be necessary if the thrust of the paper were changed from the ASD focus toward a more general neurodevelopmental disorder.</p><p>Statistics</p><p>5) It has to specified in every instance – in the text and legends – which statistical test was used to analyze the corresponding datasets.</p><p>6) A systematic justification of the adequacy of statistical tests used is required in every case. Some statistical tests have to be re-interpreted, and different statistical tests are required in several instances to address the issues at hand. In Figure 2—figure supplement 1, for instance: In order to show that there was no significant difference in body weight across time and genotypes, a mixed ANOVA has to be applied. The currently described 1-way ANOVA seems inappropriate in this context – and it is unclear on which data and how this ANOVA was performed. Similarly, in the conclusion that &quot;Male and female KO mice do not show any significant change in body length compared to WT or Het littermates&quot; is not possible using just ANOVA, which is an omnibus test. For the current conclusion, a post-hoc test would be necessary. Alternatively, the conclusion should be adjusted to &quot;do not show any significant differences in body length between genotypes&quot;. For an ANOVA to be justified (instead of a non-parametric alternative), it needs to be tested whether assumptions are held.</p><p>Genetics</p><p>7) Whole-exome sequencing and microarray data details from patients are required.</p><p><italic>Kdm5a</italic> KO Studies8) The characterization of the <italic>KDM5A</italic> mutants is still rather superficial. It is said that the chromatin remodeler <italic>KDM5A</italic> is leading to a neurodevelopmental disturbance, but no data on protein expression of <italic>KDM5A</italic> and other neuronal proteins or on brain development and morphology are provided. Moreover, the expression of the other genes of the KDM family (which are also leading to neurodevelopmental disorders when mutated) are not analysed. This should be rectified by adding corresponding additional data on the KO.</p><p>9) The RNA profiling data are simply listed and the putative targets are described. The validation of some of the targets is, however, missing so that in the end this part of the study is not more than a starting point for the identification of a <italic>KDM5A</italic> related pathomechanism. At the least, the misregulation of a select small subset of genes needs to be validated (e.g. by Western blotting).</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.56883.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Essential revisions:</p><p>Behavioral Testing</p><p>1) A general issue is that only very few ASD-specific behavioral tests were conducted; social behavior was not tested systematically, and neither was cognitive performance. In view of these limitations, the current dataset indicates a role of KDM5A variants in a general and as yet undefined neurodevelopmental disorder rather than ASD specifically. This notion is not contradicted by the fact that pathogenic KDM5A variants are detected in patients with ASD since other genetic variations or even non-genetic causes may have contributed to the clinical picture, which resembles a neurodevelopmental syndrome with autistic features.</p></disp-quote><p>The pathogenic mutations that we identified in the reported patients are the only pathogenic variants that segregated with phenotype in these families. We now clarify this in the Results section and explicitly state that apart from the <italic>KDM5A</italic> variants that we identified, there were no variants in known disease-causing genes that accounted for the clinical phenotype of the nine individuals. Furthermore, we identified seven independent alleles in nine patients with ASD (Table 1 and Figure 4). Importantly, all the single nucleotide variants that we identified in the patients were absent from gnomAD, a database of 125,748 whole exome and 15,708 whole genome sequences from unrelated individuals, further strengthening the evidence for the pathogenicity of these <italic>KDM5A</italic> variants. In fact, according to gnomAD data, the probability of loss-of-function intolerance (pLI) for <italic>KDM5A</italic> is 1.00, and there is strong selection against predicted loss-of-function variation in <italic>KDM5A</italic> (LOEUF score=0.16) (Definition of LOEUF from gnomAD: LOEUF: loss-of-function observed/expected upper bound fraction. It is a conservative estimate of the observed/expected ratio, based on the upper bound of a Poisson-derived confidence interval around the ratio. Low LOEUF scores indicate strong selection against predicted loss-of-function variation in a given gene, while high LOEUF scores suggest a relatively higher tolerance to inactivation).</p><p>In addition, for 5 out of the 7 identified <italic>KDM5A</italic> variants, we show a direct effect of the variant on KDM5A protein levels (Figure 4, Figure 4—figure supplement 5, and Figure 4—figure supplement 6), demonstrating that these variants are damaging. According to current clinical genetics guidelines for the interpretation of sequence variants (Richards et al., 2015), our data constitute a preponderance of evidence in favor of the conclusion that the identified <italic>KDM5A</italic> variants are pathogenic and causative.</p><p>Furthermore, as suggested by the reviewer, and detailed in our subsequent responses below, we now present data demonstrating that the <italic>Kdm5a</italic> knockout mice have deficits in sociability and cognitive function (Figure 2 and Figure 2—figure supplement 4).</p><disp-quote content-type="editor-comment"><p>2) Throughout all mouse studies, inconsistent and often problematically low numbers of animals of different genotypes (WT vs. Het vs. KO) for behavioral and particularly statistical analysis are used (e.g. Figure 2—figure supplements 1 and 2). Here, additional experiments are necessary to bolster the statistics.</p></disp-quote><p>We bolstered the number of mice per experiment and added the new data to the revised manuscript.</p><disp-quote content-type="editor-comment"><p>3) In the linkage analysis for maximum peak frequency of USV and nesting score (Figure 1), the authors used only 3 KO (Mut) mice, while using 17 WT and 24 Het mice. It is unclear whether a low number of KO mice (n=3) is sufficiently representative in this approach or may possibly cause an analytical misrepresentation. This needs to be rectified.</p></disp-quote><p>Since the initial screen was a forward genetics screen (Figure 1 and Figure 1—figure supplement 1), we had no control over the number of animals tested per genotype. The behavioral screening is performed in pedigrees and is blinded to genotype, and the genotyping, mapping, and linkage are performed subsequently. Nonetheless, the data was highly statistically significant and linkage was detected (<italic>P</italic>=2.9 X 10<sup>-5</sup> for the USV phenotype and <italic>P</italic>=7.0 X 10<sup>-5</sup> for the nesting phenotype) despite the n=3 mutant mice (Figures 1D and E). Furthermore, in the validation experiment, where we directly and specifically targeted the <italic>Kdm5a</italic> locus, we confirmed the USV phenotype by analyzing additional mice (n=9 knockout mice; Figure 2 and Figure 2—figure supplement 4). The mutant mice in Figure 1 are part of the ENU mutagenesis screen, while the <italic>Kdm5a</italic> knockout mice analyzed in the rest of the experiments were generated via targeted disruption of the <italic>Kdm5a</italic> locus, thus our findings in the knockout mice represent independent validation of the behavioral phenotypes identified in the mutagenized mice.</p><disp-quote content-type="editor-comment"><p>The issues mentioned above (1-3) need to be addressed to bolster the notion of KDM5A variants being involved in an as yet undefined neurodevelopmental disorder.</p><p>4) If a specific link to ASD is to be made, more experiments are necessary:</p><p>– The tail suspension test does not apply to the measurement of repetitive and/or stereotypic phenotypes. Alternative assays for repetitive and/or stereotypic phenotypes (e.g. marble burying tests, standardized observation of grooming, circling behavior) should be performed.</p></disp-quote><p>As suggested by the reviewer, we measured self-grooming and found that the <italic>Kdm5a</italic> knockout mice spent twice as much time self-grooming compared to control littermates. We included this new data in Figure 2E.</p><disp-quote content-type="editor-comment"><p>– The clasping assay reads out multiple features, including central paresis, and its usefulness and specificity as a reliable measure of stereotypic behavior in ASD mouse models is questionable. The authors refer to Chao et al., 2010, in this regard, but the respective reference in this article is not obvious. This needs to be clarified.</p></disp-quote><p>During our routine handling of the <italic>Kdm5a</italic> knockout (KO) mice, we noticed a distinct repetitive forepaw wringing and clasping behavior. We quantified this behavior and found that the KO mice spend significantly more time wringing and clasping their forepaws (60% of the time) compared to their control littermates (4-5% of the time) (Figure 2D). This repetitive wringing and clasping behavior has been observed in mouse models of several neurodevelopmental disorders. In Chao et al., 2010, the authors characterize this behavior in a mouse model generated to study Rett syndrome (Figure 1D in Chao et al., 2010). We reference the study as an example of paw wringing and clasping behavior in mouse models of ASD and related neurodevelopmental disorders.</p><disp-quote content-type="editor-comment"><p>– The authors only performed a very limited set of assays that assess ASD-related behavior. A more detailed analysis of ASD-related behavioral features is required, most importantly social interaction/preference (e.g. in tripartite chamber).</p></disp-quote><p>Of the behavioral assays we performed, analyses of ultrasonic vocalizations (USVs) and nest building ability are often used to uncover social deficits in mice. USV quantification is a well-documented tool to assess social communication, social interest, and motivation in mice (Branchi et al., 2001, Portfors, 2007, Vogel et al., 2019). Abnormalities in these socially evoked USVs are typically seen in mouse models of autism and related neurodevelopmental disorders and are indicators of social behavior deficits and abnormal brain development (Crawley, 2007, Scattoni et al., 2009). Another indicator of sociability in mice is the ability to build a communal nest and their inability to do so demonstrates social deficits (Crawley, 2007). Assessment of USVs and nest building ability identified defects in these behaviors in the <italic>Kdm5a</italic> knockout mice compared to littermate controls (Figures 1 and 2, and Figure 2—figure supplement 4).</p><p>Furthermore, as suggested by the reviewer, we assessed sociability of the <italic>Kdm5a</italic> knockout mice through a direct social interaction test, which allows for detailed assessment of intrinsic mouse interactions and is commonly used to assess social interactions in ASD mouse models (Crawley, 2012, Chang et al., 2017). We found that the knockout mice spend significantly less time interacting with a novel partner compared to their control littermates (Figure 2G). We included this new data in Figure 2.</p><disp-quote content-type="editor-comment"><p>– Given that KDM5A function is thought to be associated with memory formation and retrieval, tests for cognitive disabilities (spatial learning, working memory, object memory, social memory) should be performed – for 'differential diagnosis'.</p></disp-quote><p>To assess cognitive function in <italic>Kdm5a</italic> knockout mice, we performed the Morris water maze test. We found that the knockout mice failed to learn the location of the hidden platform during the training phase compared to their control littermates (Figure 2H). In addition, the knockout mice had a significant deficit in memory in the probe test compared to their control littermates (Figure 2I). We included this new data in Figure 2.</p><disp-quote content-type="editor-comment"><p>The experiments summarized under (4) would not be necessary if the thrust of the paper were changed from the ASD focus toward a more general neurodevelopmental disorder.</p><p>Statistics</p><p>5) It has to specified in every instance – in the text and legends – which statistical test was used to analyze the corresponding datasets.</p></disp-quote><p>We listed all the specific statistical tests used in the figure legends and the Materials and methods.</p><disp-quote content-type="editor-comment"><p>6) A systematic justification of the adequacy of statistical tests used is required in every case. Some statistical tests have to be re-interpreted, and different statistical tests are required in several instances to address the issues at hand. In Figure 2—figure supplement 1, for instance: In order to show that there was no significant difference in body weight across time and genotypes, a mixed ANOVA has to be applied. The currently described 1-way ANOVA seems inappropriate in this context – and it is unclear on which data and how this ANOVA was performed. Similarly, in the conclusion that &quot;Male and female KO mice do not show any significant change in body length compared to WT or Het littermates&quot; is not possible using just ANOVA, which is an omnibus test. For the current conclusion, a post-hoc test would be necessary. Alternatively, the conclusion should be adjusted to &quot;do not show any significant differences in body length between genotypes&quot;. For an ANOVA to be justified (instead of a non-parametric alternative), it needs to be tested whether assumptions are held.</p></disp-quote><p>We agree with the reviewer and thank them for pointing this out. As suggested by the reviewer, we conducted the appropriate mixed-effects model test (restricted maximum likelihood; REML) for repeated measures followed by Tukey's multiple comparisons test for the body weight data in Figure 2—figure supplement 3A. We also performed a post-hoc test for the one-way ANOVA for the data in Figure 2—figure supplement 3B and Figure 2—figure supplement 3C.</p><disp-quote content-type="editor-comment"><p>Genetics</p><p>7) Whole-exome sequencing and microarray data details from patients are required.</p></disp-quote><p>We added all the details for the whole exome sequencing and microarray data in the Materials and methods under “Subjects and specimens” and “Clinical presentation”.</p><disp-quote content-type="editor-comment"><p>Kdm5a KO Studies</p><p>8) The characterization of the KDM5A mutants is still rather superficial. It is said that the chromatin remodeler KDM5A is leading to a neurodevelopmental disturbance, but no data on protein expression of KDM5A and other neuronal proteins or on brain development and morphology are provided. Moreover, the expression of the other genes of the KDM family (which are also leading to neurodevelopmental disorders when mutated) are not analysed. This should be rectified by adding corresponding additional data on the KO.</p></disp-quote><p>We thank the reviewer for this comment. We had presented data on the loss of KDM5A protein from <italic>Kdm5a</italic> knockout tissue (Figure 2B). As suggested by the reviewer, we analyzed the neuronal phenotype of <italic>Kdm5a</italic> knockout mice using Golgi-Cox staining and we included this new data in Figure 3. We found that cortical layer II/III neurons from the knockout mice had significant reduction in dendritic complexity, length, and spine density, compared to neurons from WT littermates.</p><p>Furthermore, we found that many genes that function in and regulate neurological processes, including neurogenesis, are dysregulated upon loss of KDM5A in the knockout mice. Among the dysregulated genes we identified <italic>Shh</italic>, which plays a role in early nervous system development and regulates adult hippocampal neurogenesis and neural progenitor cell proliferation and differentiation. Dysregulation of <italic>Shh</italic> in adult mice has been shown to disrupt neurogenesis. We validated the upregulation of <italic>Shh</italic>, and its downstream target <italic>Ccnd1</italic>, in the <italic>Kdm5a</italic> knockout with qRT-PCR and included this new data in Figure 5C. Thus, the neuronal (Figure 3) and behavioral (Figure 2 and Figure 2—figure supplement 4) phenotypes and the transcriptional changes (Figure 5) observed in the <italic>Kdm5a</italic> knockout mice indicate that KDM5A plays an important role in neuronal development and function.</p><p>In addition, as suggested by the reviewer, we now provide data on the expression of the other KDM5 family members (<italic>Kdm5b</italic>, <italic>Kdm5c</italic>, and <italic>Kdm5d</italic>), demonstrating that their levels do not change in the <italic>Kdm5a</italic> knockout, suggesting no compensation from other KDM5 family members following loss of <italic>Kdm5a</italic> (Figure 5—figure supplement 9).</p><disp-quote content-type="editor-comment"><p>9) The RNA profiling data are simply listed and the putative targets are described. The validation of some of the targets is, however, missing so that in the end this part of the study is not more than a starting point for the identification of a KDM5A related pathomechanism. At the least, the misregulation of a select small subset of genes needs to be validated (e.g. by Western blotting).</p></disp-quote><p>We validated the dysregulation of four genes by quantitative RT-PCR and included this new data in Figure 5C. We found that <italic>Shh</italic> and its downstream target <italic>Ccnd1</italic> are upregulated upon loss of <italic>Kdm5a</italic>. Given the role of <italic>Shh</italic> in neuronal development, the data suggests a potential mechanism by which loss of <italic>Kdm5a</italic> gives rise to the observed neurobehavioral phenotypes.</p></body></sub-article></article>